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ABSTRACT
Seasonal affective disorder (SAD) is characterized by annual recurrence of
clinical depression in the fall and winter months. The importance of SAD as a public
health problem is underscored by its high prevalence (an estimated 5%) and by the large
amount of time individuals with SAD are impaired (on average, 5 months each year). The
specific cause of SAD remains unknown; however, researchers have identified possible
chronobiological and psychological vulnerabilities to SAD. The study aimed to clarify
psychological and chronobiological correlates of SAD in the first test of an integrative
model of SAD.
The project used a longitudinal design to test the respective contributions of the
chronobiological and cognitive vulnerabilities on winter depression severity in 31 SAD
patients and 33 never-depressed controls at sites in Burlington, VT and Pittsburgh, PA.
The measures selected for the cognitive vulnerability were established measures of
vulnerability to nonseasonal depression with empirical support for their relevance to
SAD: brooding rumination, dysfunctional attitudes, cognitive reactivity to an induced sad
mood, and season-specific cognitions. The chronobiological vulnerability was measured
as Phase Angle Difference (PAD) and deviation from PAD of 6 hours. All measures were
completed once in the summer, when the SAD patients were remitted, and once in the
winter, when patients were clinically depressed. Patients were distinguished from
controls on most cognitive vulnerability measures (brooding, as well as rumination,
dysfunctional attitudes, and seasonal beliefs). SAD patients exhibited shorter PAD than
controls, but did not exhibit greater deviation from PAD-6. Results provide further
support for specific cognitive, but not chronobiological, vulnerabilities in prediction of
SAD. Limitations of the current sample are discussed.
Results hold implications for future SAD research bridging the chronobiological
and psychological disciplines with the ultimate aim of improved understanding,
assessment, treatment, and prevention of SAD.
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CHAPTER 1: Seasonal Affective Disorder (SAD)
Winter seasonal affective disorder (SAD) is a subtype of Major Depressive
Disorder, Recurrent characterized by a distinct seasonal pattern of major depressive
episodes in the fall and/or winter months that remit in the spring and summer months
(Rosenthal, Sack, & Gillin, 1984). In addition to the common symptoms of depression
(depressed mood, anhedonia, fatigue, low self-esteem), individuals with SAD often
experience ‘atypical’ symptoms, which present as a reversal of the vegetative symptoms
typical of nonseasonal depression, and include hypersomnia, weight gain, and
carbohydrate craving rather than insomnia, weight loss, and low appetite (Rosenthal et
al., 1984). To meet DSM-IV-TR criteria for SAD, an individual’s current course of
depression must show a clear seasonal pattern over the past 2 years (APA, 2000). Of
individuals with recurrent major depression, an estimated 10-20% follow a seasonal
pattern (Magnusson, 2000). Some individuals experience the opposite seasonal pattern of
major depression exclusively in the summer months with remission in the winter months,
a syndrome referred to as summer SAD (Wehr et al., 1989). Summer SAD is thought to
be due to mood sensitivity to summer climate conditions (e.g., heat, humidity) and is
considered etiologically distinct from winter-type SAD. For the purpose of this study
investigating etiological factors in the annual recurrence of winter SAD, the generic term
“SAD” is used, herein, to refer to SAD-winter type.
The experience of some seasonal changes is very common, with only 8% of
individuals reporting no seasonal variation in mood or behavior (Kasper, Wehr, &
Bartko, 1989). A milder form of SAD, termed subsyndromal SAD (S-SAD) involves
similar symptoms to a lesser degree of severity and without significant impairment
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(Bartko & Kasper, 1989). Individuals with SAD experience seasonal depressive
symptoms to an extreme degree (i.e., full-blown major depression) with functional
impairment. In the U.S. population, SAD affects an estimated 5% of adults, a total of
14.5 million Americans. SAD is associated with functional impairment for the individual
within the family and at work for an average of 5 months per year, with typical onset in
early adulthood (Magnusson, 2000). As in most other mood and anxiety disorders, SAD
is more commonly reported in females, with an estimated gender ratio in SAD of 3:1
(Magnusson, 2000; Magnusson & Boivin, 2003).
Prevalence Across Latitude
Given that low light availability in winter is hypothesized as the environmental
trigger of SAD episode onset, studies have examined whether SAD prevalence varies by
latitude. Rosen, Targum, & Terman (1990) were the first to examine SAD and S-SAD
prevalence across latitudes in the United States, comparing Nashua, NH, New York, NY,
Montgomery County, MD, and Saratoga, FL. Participants were randomly selected via
telephone directory and contacted to complete a seasonality questionnaire. Across
locations, seasonality scores were significantly higher in females, and inversely related to
age. After controlling for these demographic effects, seasonality scores were generally
higher in NH and NY as compared to MD and FL, with SAD prevalence estimates
highest in NH at 42.5°N (9.7%) and lowest in FL at 27°N (1.4%). Similar patterns were
found for subscales measuring seasonal fluctuation in mood, sleep length, and weight.
Additionally, a larger proportion of individuals at higher latitudes endorsed their seasonal
changes as problematic as compared with individuals at lower latitudes (26.1% in NH vs.
13.5% in FL). Individuals at the three higher latitudes were also over two times more
2

likely to identify winter months as the worst months than individuals in FL. Similar
investigations of latitude and prevalence were implemented in Scandinavia, with mixed
results, whereas no effect of latitude was found on SAD prevalence in Italy, Turkey, or
Australia, as reviewed by Magnusson (2000). In a study examining the prevalence of
SAD across eight degrees of latitude in Canada from 41.50°N to 49.49°N, latitude was
found to be only weakly negatively correlated with seasonal change in mood (Levitt &
Boyle, 2002). Thus, the strongest evidence for an effect of latitude on prevalence has
been found in U.S. populations (Mersch, Middendorp, Bouhuys, Beersma, & van den
Hoofdatter, 1999), suggesting that socio-cultural influences may impact SAD as well.
Environmental Triggers of SAD
Epidemiological studies examining SAD across latitude were indirectly testing
the effect of light availability on SAD. However, these studies did not control for
potentially confounding factors such as time spent outdoors, geographical climate, or the
tendency of individuals with SAD to migrate southward for symptom remission
(Magnusson, 2000; Mersch et al., 1999). Two survey studies in Japan compared the
effects of latitude and local hours of sunshine on SAD prevalence. Although both factors
significantly correlated with SAD prevalence, a regression analysis revealed that hours of
sunshine, but not latitude, was related to SAD prevalence (Okawa, Shirakawa, &
Uchiyama, 1996; Sakamoto, Kamo, Nakadaia, Tamura, & Takahaski, 1993). In a direct
test of environmental factors on SAD symptom severity, Molin, Mellerup, Bolwig,
Scheike, and Dam (1996) assessed depression severity biweekly from September to May
in a sample of SAD patients in Copenhagen, Denmark. Depression severity was found to
correspond to local meterological data, whereby light availability factors (e.g., minutes of
3

sunshine, global radiation, and photoperiod) inversely predicted depression severity
across the winter season in SAD patients. Young, Meaden, Fogg, Cherin, and Eastman
(1997) tested the effects of different environmental triggers on the annual timing of SAD
onset by pooling data on the timing of SAD symptom onset across seven fall seasons,
from 1988-1994 in SAD patients in Chicago, IL. Weekly onset risk for SAD was derived
using a survival analysis, and a multiple regression analysis was utilized to test the
relative impact of variations in weather (hours of sunshine, temperature, solar radiation)
and photoperiod (i.e., daylength from dawn to dusk) on the timing of SAD onset.
Photoperiod was the only significant predictor of onset risk, accounting for 26% of the
variance in risk (Young et al., 1997). Thus, despite being highly correlated with the
seasonal pattern of SAD risk, none of the other environmental variables, or their
interaction with photoperiod, accounted for significant variance in SAD risk above and
beyond that by photoperiod alone, supporting photoperiod as the primary environmental
predictor of SAD risk.
Chronobiological Vulnerability to SAD
To further explain the relation between photoperiod and seasonal depression
severity, psychiatric researchers have proposed several theories implicating circadian
rhythm abnormalities in SAD, suggesting that SAD patients demonstrate unique
chronobiological responses to the seasonal changes in photoperiod. In order to articulate
these theories, a brief description of the circadian pacemaker is needed.
The human circadian pacemaker, located in the suprachiasmatic nucleus (SCN) of
the anterior hypothalamus, is responsible for synchronizing physiological processes to the
external 24-hour light/dark cycle. The circadian clock is calibrated to the light/dark cycle
4

on a daily basis via input from external time cues, or zeitgebers, with light being the most
potent zeitgeber. Ocular light input is projected to the SCN via the retinohypothalamic
tract. The pacemaker, in turn, emits an endogenous neural signal of day length to
regulate the timing of circadian rhythms in hormone secretion, sleep, alertness, and other
behaviors (Wehr, 2001).
The human circadian system cannot be examined directly, thus, pacemaker output
is measured by the timing of rhythms regulated by the daily resetting of circadian phase
(e.g., core body temperature, melatonin, and cortisol release). Melatonin is secreted by
the pineal gland at night, with daytime suppression by light. In humans, melatonin
typically remains elevated for 10-12 hours at night, increasing significantly 2-3 hours
prior to bedtime (Benloucif et al., 2008). The clock time of the onset of melatonin
release captured under dim light conditions is referred to as the dim light melatonin onset
(DLMO), and is the most commonly utilized biomarker for circadian phase as it appears
to be relatively robust to changes in sleep, stress, and activity as compared to other
measures of circadian phase such as core body temperature and cortisol (Arendt, 2005;
Benloucif et al., 2008; Burgess & Fogg, 2008; Lewy, Wehr & Goodwin, 1980). See
Figure 2 for an illustration of the temporal relation between DLMO and sleep.
Photoperiodic hypothesis. In mammals, the duration of nocturnal melatonin
release varies by photoperiod and serves as a physiological signal of season for regulation
of seasonal changes in physiology (e.g., thermoregulation, metabolism) and behavior
(e.g., reproduction) where shorter photoperiods correspond to longer, and longer
photoperiods correspond to shorter, melatonin release durations (Wehr, 2001).
Therefore, the photoperiodic hypothesis proposes that people with SAD are like other
5

mammals in that they have retained this circadian signal of season and uniquely exhibit
prolonged duration of nocturnal melatonin release in response to the shortened
photoperiod of winter (Wehr, 2001). This effect has been experimentally tested in
studies examining circadian responses to natural and contrived variations in photoperiod
in humans.
An initial investigation of the adaptation of melatonin duration to artificial
photoperiods in healthy individuals exposed participants to two counterbalanced,
contrived photoperiods: very short (10 hours of light/14 hours of darkness) and also very
long (16 hours of light/8 hours of darkness) photoperiods corresponding to winter and
summer day lengths, respectively (Wehr, Moul, Barbato, Giesen, & Seidel, 1993).
Circadian rhythms were found to be expanded after exposure to the shortened
photoperiod (long night) as compared to the same individuals exposed to longer
photoperiods, as measured by the durations of nocturnal melatonin release, low core body
temperature, and sleep. These effects retained after 24 hours in dim light conditions,
providing further support to the circadian effects induced by photoperiod. These findings
provide support that humans have retained the ability to track seasonal changes in this
manner.
To test whether a unique response in melatonin duration was present in SAD,
Wehr et al. (2001) compared SAD patients with healthy controls on duration of melatonin
release in summer and winter. Patients exhibited longer active melatonin release
durations during winter relative to themselves in summer (an average difference of 36
minutes), with the variance largely accounted (67%) for by a winter delay in timing of the
offset of melatonin. However, control individuals did not show a significant seasonal
6

difference in the duration of melatonin release. This finding suggests that expanded
melatonin duration in winter relative to summer may be involved in SAD. However, this
is the only study to date comparing melatonin duration across seasons in SAD patients
and controls, the results need to be replicated.
Phase Shift Hypothesis. The Phase Shift Hypothesis (PSH) postulates that SAD
results from a seasonal misalignment between the circadian clock and the external
light/dark cycle or other biological rhythms (e.g., sleep/wake; Lewy, Sack, & Singer,
1988). Specifically, the PSH suggests that SAD patients become depressed in winter due
to the later dawn, which causes a circadian phase delay relative to the light/dark cycle
(clock time) or sleep/wake cycle. This hypothesis arose out of an observation that a
group of SAD patients exhibited more delayed circadian rhythms relative to
nondepressed controls in winter prior to treatment (Lewy, Sack, Singer, & White, 1987).
In this study, morning light therapy phase advanced SAD patients’ circadian rhythms to
simulate those of the nondepressed controls, and was also shown to elicit a stronger
antidepressant effect than evening light administration (Lewy et al., 1987). Thus, Lewy
and colleagues inferred that SAD patients may exhibit phase-delayed circadian rhythms
in winter, and that morning bright light may reduce depressive symptoms by correcting
delayed circadian rhythms via advancing the circadian clock to simulate summer
rhythms. The theory has become one of the most widely studied in SAD (Lewy, 2015),
yet has yielded highly inconsistent findings, as reviewed below.
The PSH has largely been indirectly tested in bright light treatment trials
comparing antidepressant responses to light administered at various times of day. Light
is the primary zeitgeber for entrainment of the circadian system and has consistently been
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shown to induce circadian phase resetting in humans according to a phase response curve
(PRC; Czeisler et al., 1989). With the core body temperature minimum (t-min) marked
as an estimator of the crossover point between the advance zone and delay zone of the
PRC, studies have found the direction and magnitude of circadian phase shift achieved to
be a sinusoidal function of the time of light administration relative to the circadian clock,
with the largest phase shifts resulting from light exposure within 2 to 6 hours before
(delay) and after (advance) the time of the t-min (as reviewed in Eastman & Martin,
1999). Consistent with the PRC to light, Terman, Terman, and Cooper (2001) found
morning light to advance, and evening light to delay, melatonin onset in SAD patients.
According to the PSH, morning administration of bright light should elicit better
treatment response, as compared to other administration times, because morning light
advances the circadian clock per the phase response curve and is thought to correct the
proposed pathophysiologic phase delay in SAD. Thalen, Morkrid, Kjellman, and
Wetterberg (1995) reported no differences in degree of improvement associated with
morning vs. evening light; however, a greater proportion of SAD patients exhibited a
significant treatment response to light (defined as a 50% reduction in symptoms) than
nonseasonally depressed patients, suggesting that SAD patients may have a unique
physiological or psychological response to light. One meta-analysis reported that dual
(morning-plus-evening) light exposure was superior to single exposures at morning,
evening, or midday (Lee, Blashko, Janzen, Paterson, & Chan, 1997). Two early studies
utilizing cross-over designs to compare the efficacy of morning versus evening light both
reported that morning light administration elicited a superior antidepressant response to
evening light (Avery, Khan, & Dager, 1991; Lewy et al., 1987). In a review of light
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therapy trials, Terman, Terman, and Quitkin (1989) concluded that morning light
administration was associated with the greatest antidepressant response (53% remission
rate), relative to light administered in the evening (38%) or midday (32%), all superior to
placebo response (11%). Morning-plus-evening light exposure was not superior to
morning light alone. Three independent research groups published data in 1998 each
corroborating earlier findings that morning light is associated with better antidepressant
response than evening light (Eastman, Young, & Fogg, 1998; Lewy et al., 1998; Terman,
Terman, & Ross, 1998). Cool white fluorescent light exposure (10,000 lux) administered
in the morning daily for a minimum of 30 minutes is the current gold standard treatment
for SAD (Golden et al., 2005), with optimal administration on the advance zone of the
PRC, clinically derived as 2.5 hours after the midpoint of sleep (Terman et al., 2001).
According to the PSH, evening light would be expected to worsen SAD
symptoms due to inducing or exacerbating a circadian phase delay. However, Terman et
al. (1989) found that although morning light provided a stronger antidepressant response,
evening light alone was also associated with full remission in some (38%) patients, an
effect that directly opposes the phase delay theory of SAD and stands as a primary
critique of the PSH.
The superiority of response to morning light over evening indirectly supports the
PSH; however, this finding alone does not necessarily implicate a corrective phase
advance as the mechanism of the antidepressant response to light. Terman et al. (2001)
examined the relation between the antidepressant response and phase shift magnitude to
morning or evening light exposure utilizing a within-subject cross-over design with SAD
patients. The magnitude of phase advance with morning light was significantly
9

positively correlated with symptom improvement, yet phase shifts with evening light
were not significantly associated with antidepressant response. Similarly, Thompson,
Childs, Martin, Rodin, and Smythe (1997) found SAD patients uniquely exhibited a
phase advance of the melatonin rhythm to morning bright light treatment in winter;
however, the degree of phase advance in patients did not correlate with symptom
improvement. Eastman, Gallo, Lahmeyer, and Fogg (1993) found no association
between the direction or magnitude of temperature rhythm phase shifts to morning light
treatment and improvement in symptoms, nor were differences in phase shifts reported
between SAD patients and controls. However, as noted by Eastman et al. (1993), the
data were pooled across cross-over trials despite order in sequence of light treatments.
Thus, the inconsistent findings could be due to the confound of carry-over effects.
Rosenthal, Levendosky, and Skwerer (1990) also reported a nonsignificant relation
between phase shift of the core-body temperature rhythm and antidepressant response to
morning+evening light therapy. However, when analyzed by phase-type, individuals
whose rhythms phase advanced during light treatment exhibited a greater antidepressant
response. Studies testing phase shifts as a necessary component of the antidepressant
response have largely indicated that phase shifts accompany, but may not be necessary
for, an antidepressant response to light in SAD.
Bright light treatment trials have provided indirect tests of the PSH by comparing
circadian phases at pretreatment (when depressed) and posttreatment (when
nondepressed) during winter in patients to controls. Other studies have more directly
tested the PSH by comparing circadian rhythms across seasons in untreated SAD patients
and controls to examine whether SAD patients exhibit a unique seasonal misalignment of
10

circadian rhythms. Checkley et al. (1993) compared the 24-hour melatonin release
profiles during winter (November to March) in a sample of SAD individuals relative to
nondepressed, healthy controls matched for age, sex, and month of study. The groups
exhibited similar nocturnal melatonin profiles, such that there were no significant group
differences found in the clock time of the onset, mean, amplitude, or acrophase (peak) of
nocturnal melatonin release. The PSH predicts that the DLMO should be phase-delayed
(shifted later) in SAD patients relative to controls in winter, which was not supported.
Another study reported no differences in the timing of other 24/hour biological rhythms
(cortisol, prolactin, and thyrotropin) between SAD patients when depressed and
nondepressed controls (Oren, Levendosky, Kasper, Duncan, & Rosenthal, 1996), thus
providing no evidence of other phase-delayed rhythms in SAD.
In 2001, Wehr et al. published a longitudinal study comparing 24-hour melatonin
profiles of SAD patients and nondepressed controls in winter and in summer. There were
no differences in the clock time of circadian phase (e.g., DLMO) in patients vs. controls.
Therefore, this initial study of seasonal shift in the clock time of circadian phase did not
support the posited phase delay in the DLMO as proposed by the PSH. However, Wehr
et al. (2001) did not control for the timing of sleep, but did note in a secondary analysis
that variation in wake time accounted for 7% of the variance in the winter duration of
melatonin release in SAD patients. The lack of control for the effect of the rest/activity
cycle (also referred to as sleep/wake cycle) on the clock time of circadian phase (e.g.,
DLMO) is a limitation across some naturalistic and treatment studies examining
biological rhythms in SAD patients. Although light is the strongest zeitgeber to the
circadian pacemaker, nonphotic zeitgebers informed by the timing of the sleep/wake
11

cycle (e.g., sleep, activity) have been shown to alter the timing of circadian phase, thus
possibly confounding or masking the influence of other factors of interest (e.g., season,
psychopathology) on circadian phase.
Although the melatonin profile is more robust to influences from the sleep/wake
cycle (i.e., activity and posture) than core body temperature or cortisol (Benloucif et al.,
2012), there is a bidirectional relation between the sleep/wake cycle and circadian phase
such that changes in sleep induce some shift in the timing of melatonin production and
vice-versa, which reflects the dual oscillator model of the mammalian circadian rhythm
(Arendt, 2005). Burgess and Eastman (2006) found that adjusting sleep times results in
parallel phase shifts of the human melatonin rhythm, such that later wake times were
shown to phase delay, and earlier wake times were shown to phase advance, the DLMO
and dim light melatonin offset (DLMOff). The coupling of the timing of sleep with that
of melatonin release has been recorded in healthy individuals as well, such that a 1-hour
change in sleep time corresponded to a .87-hour (i.e., 52 min.) change in the timing of the
DLMO (Sletten, Vincenzi, Redman, Lockley, & Rajaratnam, 2010; Wright, Gronifer,
Duffy, & Czeisler, 2005).
Given the close coupling of the sleep/wake and circadian oscillators, studies
examining the clock times of circadian biomarkers (e.g., DLMO) have not adequately
controlled for effects of sleep variability on DLMO. Winkler et al. (2005) found the
timing of wrist actigraph-measured sleep and activity in SAD patients was phase delayed
(by an average of 50 minutes) in winter at baseline, prior to treatment with bright light
relative to controls. This evidence of seasonal shift in sleep timing in SAD highlights the
importance of controlling for the timing of the sleep/wake cycle when examining
12

circadian markers across individuals, for classification of circadian functioning in SAD.
Additionally, morning light treatment has also been shown to phase advance sleep and
activity patterns in SAD patients to match those of nondepressed individuals (Winkler et
al., 2005), suggesting light exposure patterns phase shift sleep as well as circadian phase.
The inter-individual variation in the timing of the rest/activity cycle is also reflected in
sleep. This variation is due to inter-individual differences in activity demands (e.g., work
schedules), light exposure patterns and diurnal variation (i.e., morning or evening type).
Thus, comparing the DLMO across individuals without controlling for these factors does
not accurately measure pure individual differences in circadian functioning. The effects
of the sleep/wake cycle can be removed in extensive unmasking protocols that stabilize
the timing of sleep in order to allow isolation of assessment of true effects on circadian
phase.
The forced desynchrony protocol is the most extensive unmasking procedure,
which requires participants to spend one week to one month in an inpatient temporal
isolation chamber void of external zeitgebers while placed on artificial day lengths of
either very short (20 hour) or long (28 hour) regimens that are incompatible with
pacemaker functioning (Aschoff & Wever, 1976). The contrived “day” is spent in dim
light, and the “night” is spent in darkness to avoid photic resetting of the circadian clock.
This abnormal day length forces the endogenous circadian pacemaker to become
desynchronized from the sleep/wake cycle and run at the natural rate of the individual’s
intrinsic period length (Czeisler et al., 1999). This uncoupling of the circadian oscillators
allows measurement of an individual’s circadian pacemaker functioning independent of
the effects by sleep and activity, as captured via the intrinsic period length (assessed by
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the rate of shift in the timing of the DLMO or t-min from baseline to the end of the
desynchrony protocol).
To investigate the effect of circadian functioning on mood in SAD patients,
Koorengevel, Beersma, den Boer, and van den Hoofdakker (2003) studied seven SAD
patients and eight matched controls under forced desynchrony (20-hour day) for 10 days
across the following conditions: during a Major Depressive Episode in winter, upon full
remission from light treatment, and when naturally remitted in summer. Healthy
matched-control participants were assessed once in summer, once in winter. Circadian
phase was measured by serial salivary melatonin (DLMO) and continuous rectal core
body temperature (t-min) for one day at the start and end of the protocol. This protocol
revealed no significant group differences in circadian period or phase (assessed by
DLMO or t-min) and no significant within-subject changes in circadian period or phase
across conditions. Although the small sample size may have affected power to detect
minor fluctuations across conditions, this study did not support the PSH’s assertion of
pacemaker abnormalities in SAD. However, significant mood-dependent circadian phase
shifts were reported in a patient with SAD studied under two forced desynchrony
protocols, when depressed and when euthymic (Koorengevel, Beersma, Gordijn, den
Boer, & van den Hoofdakker, 2000). A significant phase delay in the circadian
temperature rhythm (t-min) was observed during the depressed mood state, as compared
to the euthymic mood. This subject highlights possible inter-individual variation for
SAD patients to experience circadian misalignments when depressed.
A second unmasking protocol is referred to as a constant routine procedure, which
involves an inpatient stay where the exogenous factors (e.g., sleep, activity, food, light,
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and temperature) are kept constant between all participants via bed rest, forced
wakefulness for 24 hours in dim light, and regularly-timed meals (Czeisler et al., 1985).
This protocol has been utilized by the majority of light therapy trials conducted to
indirectly test whether SAD patients exhibit circadian phase-shift corresponding to
treatment response. Avery et al. (1997) assessed the circadian response to light therapy
while controlling for the inter-individual differences in sleep times by utilizing a constant
routine protocol with standardized sleep schedules across all participants. The degree of
advance in the temperature minimum (t-min) correlated with degree of change in
Hamilton Depression Rating Scale scores from baseline to posttreatment in SAD patients
(Avery et al., 1997). Similarly, Dahl, Avery, and Lewy (1993) compared the DLMO and
core body temperature rhythms under constant routine conditions in six SAD patients and
six nondepressed healthy controls during winter. Both the DLMO and t-min
(temperature minima) were significantly phase-delayed in patients relative to controls,
providing support for winter phase-delayed circadian rhythms in SAD. However, as
noted by Avery et al. (1997), the imposed sleep schedule may differentially alter the
natural timing of circadian function between participants due to inter-individual variation
of previous circadian phase, sleep, and diurnal variation. These factors have been shown
to correspond to inter-individual variation in intrinsic period length, the endogenous rate
of circadian oscillation which is near 24-hours in humans (Czeisler et al., 1999; Duffy,
Rimmer, & Czeisler, 2001).
In addition to the constant routine procedures and forced desynchrony protocols
mentioned above, a third method to control for the effects of the sleep/wake cycle on
circadian phase in ambulatory conditions is to calculate the timing of circadian phase
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relative to sleep. Phase Angle Difference (PAD) is defined as the temporal interval (in
hours) between the circadian marker (e.g., DLMO) and sleep (e.g., midpoint of sleep).
PAD is a better measure than clock time of circadian phase because PAD controls for the
inter-individual variability in the timing of sleep, obviating the need to standardize sleep
schedules across participants, thereby reducing noise in circadian phase assessment.
PAD measures the temporal relation of circadian phase to the sleep/wake cycle.
The PSH postulated that SAD may involve a circadian misalignment between the
pacemaker and the external light/dark cycle, or between the pacemaker and other
biological rhythms such as the sleep/wake cycle (Lewy et al., 1988). The majority of the
studies to date have tested the PSH as delays in circadian phase (e.g., DLMO) relative to
the light/dark cycle (clock time). However, Lewy et al. (2003) proposed an optimal
antidepressant phase angle between the circadian rhythm and sleep, as the DLMO in
euthymic controls typically occurs 14 hours after wake time and 2 hours prior to sleep
onset (Sletten et al., 2010). The 14-hour waketime-DLMO interval corresponds to a
DLMO-midsleep interval of 6 hours, assuming an 8-hour sleep duration. Initial evidence
for PSH was reported in an initial trial of exogenous melatonin for treatment of SAD
(Lewy et al., 2003), whereby baseline-to-post-treatment reductions in mood were
correlated with circadian shifts towards this proposed therapeutic window for phasedelayed SAD patients. To date, there have been two primary studies examining the
relation between PAD and mood in SAD patients.
In 2006, Lewy et al. tested a placebo-controlled trial of exogenous melatonin as a
phase shifting agent and potential treatment for individuals with SAD. SAD patients and
controls were administered a low-dose of melatonin in the morning or afternoon/evening.
16

DLMO and SIGH-SAD assessments were completed at baseline and post-treatment.
PAD was found to be parabolically associated with pre-treatment depression severity,
such that greater absolute deviations (either shorter or longer) from a PAD of 6 hours
(DLMO to midsleep) were associated with significantly greater baseline symptom
severity, accounting for 17% of the variance in pre-treatment Structured Interview Guide
for the Hamilton Depression Scale – Seasonal Affective Disorder Version scores (Lewy
et al., 2006). Neither parabolic, nor linear absolute deviation relations, were found
between depression severity and DLMO or midpoint of sleep alone, suggesting the
relevant marker is the circadian misalignment between these two oscillators. This study
was based on the melatonin PRC that is 12 hours out of phase with the PRC to light, such
that morning exogenous melatonin has been shown to induce phase delays, whereas
evening melatonin induces phase advances of the circadian clock (Lewy, Ahmed,
Jackson, & Sack, 1992; Lewy, et al., 1998). Consistent with the PRC, evening melatonin
was shown to phase delay the DLMO and lengthen PAD; whereas morning melatonin did
not significantly shift the DLMO or change PAD. In patients who received evening
melatonin (the group that demonstrated the greatest phase shifts across treatment),
individual absolute deviation (toward or away) from PAD-6 across treatment
significantly predicted pre- to post-treatment change in depression severity, such that
reduced deviation (shift toward) PAD-6 across treatment predicted greater reduction in
depression severity. This study supports the PSH as depression severity in SAD patients
corresponded to the degree of circadian misalignment relative to an optimally entrained
circadian phase of 6 hours between the DLMO and midpoint of sleep (PAD-6), at
baseline and across treatment with melatonin.
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Burgess, Fogg, Young, and Eastman (2004) further examined whether the
antidepressant effect of light therapy is related to circadian timing of core body
temperature, and the PAD between the core body temperature minimum (t-min) and sleep
offset. Twenty-six patients with SAD were randomly assigned to receive 4 weeks of
morning light, evening light, or placebo (deactivated negative ion generator). Circadian
phase was captured via rectal core body temperature measured continuously for five
weeks (baseline and during treatment). To minimize variation of circadian phase due to
sleep changes throughout treatment, each participant kept an individualized stable sleep
schedule (i.e., sleep timing and duration of 7-8 hours) for the four weeks of treatment.
Average sleep duration and wake time did not differ between groups. Consistent with the
phase response curve, morning light advanced, and evening light delayed, the t-min by 1
hour, resulting in lengthened with PAD with morning light, and shortened PAD with
evening light. Yet, neither the degree of phase shift in the clock time of t-min nor the
degree of shift in the interval between t-min and sleep offset, were signfiicantly
correlated with the antidepressant response. However, Burgess et al. (2004) examined
antidepressant response and PAD-3 (t-min to sleep offset), which corresponds to the
proposed “sweet spot” of PAD-6 (DLMO to midsleep) in SAD. Patients with a t-min to
sleep offset PAD of 3 hrs at week 4 exhibited the greatest improvement in mood. Further,
SAD patients whose PADs moved closer to the proposed core body temperature “sweet
spot” (PAD-3 hr) across the 4 weeks of treatment exhibited, on average, a two-fold
reduction in symptoms as compared to patients whose PADs moved away from 3 hours
from baseline to post-treatment. Absolute deviation from PAD-3 accounted for 33% of
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the variance in SIGH-SAD scores at post-treatment (Burgess et al., 2004), with 38% of
patients’ PADs falling near 3 hrs (i.e., 2.5-3.5) hrs at week 4.
The findings of Lewy et al. (2006) and Burgess et al. (2004) elucidated the need
to account for phase type (direction of shift) when assessing the relation between
circadian phase shifts and depression severity in SAD. Lewy et al. (2006) reported that a
majority (71%) of patients exhibited phase delays (PADs less than 6), and a minority
(29%) exhibited phase advances (PADs greater than 6). The timing of melatonin
treatment (morning or evening) was randomly assigned prior to phase-typing, and
therefore, was not necessarily consistent with the direction of phase shift expected to be
antidepressant (e.g., AM melatonin for phase-advanced patients and PM melatonin for
phase-delayed patients). Before accounting for the confounding effect of phase type in
response to exogenous melatonin treatment, there were no significant differences in
percentage change in depression severity across treatment between morning melatonin,
evening melatonin, or placebo treatment groups. However, when comparing treatment
improvement across phase type (e.g., advance or delay), patients who received the
“correct” treatment, as matched to their phase type, exhibited a significantly greater
reduction (34%) in depression severity, as compared to those who received the incorrect
(19%), or placebo (20%) treatments (Lewy et al., 2006). This effect indirectly supports
the PSH because a treatment matched to the circadian misalignment was associated with
better treatment response. Similarly, Burgess et al. (2004) reported null associations
between degree of circadian phase shift (PAD between t-min and sleep offset) across
treatment and antidepressant response to light treatment. However, direction of shift
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toward or away from PAD-3 across treatment accounted for a significant proportion of
variance (33.3%) in the antidepressant response.
These studies are yet to be replicated to provide more support for the role for
circadian phase shifts assessed via PAD in SAD versus controls. However, these
preliminary studies highlight that variability in PAD may relate to antidepressant
response to bright light therapy by SAD patients. Although 75% of SAD patients were
found to fall within the proximity of PAD-3 at post-treatment, 46% of patients had
exhibited a PAD near 3 hrs at baseline (Burgess et al., 2004). This finding highlights
possible variability in exhibited PAD and its possible relation to mood in SAD. Further,
Wright et al. (2005) reported natural inter-individual variation in PAD (DLMO-sleep
onset) in healthy individuals, related to inter-individual variation in the length of the
intrinsic period, such that a shorter intrinsic period was associated with longer PAD, and
a longer period with shorter PAD. The findings of Wright et al. (2005) further suggest
that inter-individual variation in intrinsic period also may account for normative variation
in PAD. The variability in PAD-6 (or PAD-3) within SAD patients, and as compared to
controls, has yet to be determined.
There is preliminary evidence to suggest unique effects of circadian
misalignments in nonseasonal depression. In a study of women with nonseasonal major
depressive disorder assessed as mildly to moderately depressed, a strong negative
correlation was found between PAD (DLMO-midsleep) and severity of depressed mood,
such that a shorter PAD (more delayed circadian phase relative to sleep) was associated
with greater depressive symptom severity as assessed by the Profile of Mood States-Brief
Form (Emens, Lewy, Kinzie, Arntz, & Rough, 2009). In comparison to nondepressed
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controls, nonseasonally depressed patients exhibited a greater t-min-midsleep PAD,
consistent with the shorter DLMO-sleep PAD reported in prior studies (Hasler, Buysse,
Kupfer, & Germain, 2010).
Additionally, there are a few studies to date that have supported a relation
between circadian phase shifts and mood in healthy populations. Emens, Lewy, Rough,
and Singer (2009) found PAD, assessed as DLMO to midpoint of sleep, was associated
with mood ratings in healthy medical students, such that shorter PAD was associated with
more depressed mood. This finding suggests a circadian misalignment to sleep may be a
correlate of normative variation in mood. Whether the association between PAD and
mood is stronger in SAD patients relative to controls has yet to be tested. Murray, Allen,
and Trinder (2003) examined seasonal changes in self-reported diurnal preference (i.e.,
Morningness-eveningness as an indirect measure of circadian phase) within a sample of
community sample of healthy adults in Melbourne, Australia. Murray et al. (2003) found
that the majority of individuals exhibited a winter shift towards eveningness, the
magnitude of which was associated with a lowering of mood from summer to winter
within individuals. These studies support the possibility that circadian phase and/or
diurnal preference may influence subtle mood shifts in healthy adults, as well, and
thereby may not be an exclusive phenomenon in SAD.
In summary, the PSH has been controversial as there have been mixed results
regarding the involvement of a circadian misalignment in SAD. However, many of these
studies have examined the phase shift in the clock time of circadian rhythms without
controlling for the effect of inter-individual variation in sleep. In an extension of the
PSH, Lewy et al. (1988) suggested SAD may involve a circadian misalignment relative to
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the sleep/wake cycle. Studies examining the effect of the temporal relation between
circadian rhythms and sleep (PAD) in SAD have shown that degree circadian
misalignment to an optimal entrained PAD has correlated with depression severity in
winter, and that degree of realignment of PAD after treatment with melatonin or bright
light has been associated with SAD symptom improvement (Burgess et al., 2004; Lewy
et al., 2003; 2006). Although circadian misalignment to sleep appears to be a correlate of
SAD, causation has not been established. Additionally, a misalignment in PAD does not
appear to fully account for the variance in SAD severity as not all patients exhibited
misalignments when depressed (Burgess et al., 2004; Lewy et al., 2006). Given the
limited number of studies examining PAD in SAD, important facets of the relation
remain unknown, such as whether individuals with SAD exhibit a different degree of
seasonal change in PAD than healthy, nondepressed individuals. More broadly, the
mechanism linking a misalignment in circadian rhythms to a disruption in mood has yet
to be elucidated as does the mechanism(s) of bright light treatment in symptom
improvement.
Mechanisms linking photoperiod to circadian rhythmicity. There are several
potential mechanisms to explain unique circadian responding to the short photoperiod of
winter in SAD: seasonal variation in light exposure, retinal subsensitivity to light, or
abnormal pathways in the circadian system (e.g., melanopsin photoreceptors, clock
genes).
Light exposure patterns. Studies examining time spent outdoors across seasons
as an indirect measure of light exposure found that SAD patients reported spending more
time outside in summer and less time outdoors in winter (Eastman, 1990). Additionally,
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patients spent significantly more time outdoors in summer than controls (Graw, Recker,
Sand, Krauchi, & Wirz-Justice, 1999). This pattern is consistent with, although not direct
evidence of, retinal subsensitivity to light in SAD suggesting SAD patients may require
greater light exposure to maintain a euthymic mood, for which SAD patients compensate
with greater time spent outdoors in summer, but are not able to do so in winter due to the
weather. Oren, Moul, Schwartz, and Brown (1994) tested whether SAD patients
exhibited unique light exposure patterns in winter as compared to controls. Actual
ambient light exposure as experienced by SAD patients and controls was measured
continuously via actigraphic wrist monitors. In this study, comparable light exposure
intensity was reported by patients and controls during the winter; however, a significant
correlation between depression severity and photoperiod was found for patients only,
where shortened photoperiod was associated with greater depression severity. This
finding suggests that SAD patients may exhibit a unique sensitivity to low light
availability in winter.
Retinal subsensitivity. Circadian responses to changes in photoperiod are
partially mediated through the retina. There is research to suggest aberrant functions of
the retinal photoreceptors (rods and/or cones) may contribute to the etiology of SAD and
the response to light therapy. A healthy retina responds to low light levels with increased
sensitivity to maintain visual acuity. There are two opposing theories of unique retinal
sensitivities in SAD. The first posits that SAD patients may have a retinal subsensitivity
or impaired retinal adaptation to low light levels, posing greater problems in winter when
environmental light availability is low due to short photoperiods (Remé, Terman, &
Wirz-Justice, 1990). The second theory suggests that SAD patients may experience a
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heightened sensitivity, or supersensitivity, to lower light levels, which may uniquely
affect circadian rhythms in SAD patients during winter (Beersma, 1990). Only a few
studies have examined retinal sensitivity across the seasons in SAD patients and
nondepressed controls. Ozaki, Rosenthal, Myers, Schwartz, and Oren (1995) measured
retinal sensitivity in summer and in winter in SAD patients and nondepressed controls via
the electrooculogram (EOG), an objective measure of retinal standing potential, with
higher ratios indicative of higher retinal sensitivity. Only controls were found to exhibit
an increased retinal sensitivity in winter, whereas SAD patients did not demonstrate a
seasonal difference in sensitivity, suggesting non-SAD individuals may be able to
compensate for low light conditions in winter whereas SAD patients are not (Ozaki et al.,
1995 A recent finding of diminished pupillary response in winter in SAD further supports
the retinal subsensitivity hypothesis (Roecklein et al., 2013). Specifically, SAD patients
had a smaller post illumination pupil response (PIPR; i.e., less pupil constriction
following a blue light stimulus) than controls in winter. The Roecklein et al. (2013)
study was cross-sectional with testing in winter only, so it remains unknown whether this
group difference persists at summer. Similarly, Lavoie et al. (2008) examined rod
sensitivity with electroretinogram (ERG) to light across seasons (summer and winter) in
SAD patients and controls and over four weeks of light treatment during winter in
patients. Only SAD patients demonstrated rod and cone retinal subsensitivity in winter
(at pre-treatment), as compared to their post-treatment levels when remitted with light
therapy. At summer, SAD patients were compared to controls, who did not exhibit
seasonal changes in retinal sensitivity. Hébert, Dumont, and LaChapelle (2006)
measured ERG in individuals with subsyndromal SAD (S-SAD) and healthy controls in
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summer and winter. A group difference was observed in winter only, with lower
sensitivity in the S-SAD group, for whom the magnitude of decrease in rod sensitivity
from summer to winter was positively correlated with seasonality, the degree of seasonal
variability in an individual’s mood and behavior. In contrast, Terman and Terman (1999)
found support for a retinal supersensitivity in SAD. SAD patients, but not controls,
exhibited a seasonal fluctuation in retinal sensitivity, with higher sensitivity in winter
relative to summer, and increased retinal sensitivity (faster rod recovery and lower cone
threshold) during a dark adaptation protocol in winter, as compared to controls. Given
the inconsistency of findings and multiple measures of retinal sensitivity utilized, more
research is needed to explicate whether SAD patients exhibit a heightened or impaired
retinal sensitivity and how retinal sensitivity aberrations may contribute to winter
depression severity (e.g., whether aberrant retinal function is tied to chronobiological or
psychological factors in SAD).
Melanopsin. Recently, a novel non-visual photopigment, melanopsin, has been
discovered in mammalian retinal ganglion cells (Provencio et al., 2000) and possibly
implicated in SAD (Roecklein et al., 2009). The photoreception detected by the nonvisual melanopsin system independently projects to the SCN via the retinohypothalamic
tract, supplementing the photic input from the ocular system (retinal rod and cone
receptors) in the regulation of circadian entrainment, melatonin production, sleep timing,
and pupillary response (Gooley, Lu, Chou, Scammell, & Saper, 2001; Gooley, Lu,
Fischer, & Saper, 2003). The melanopsin system has provided possible explanation as to
how circadian entrainment to the light/dark cycle is maintained in mammals without
visual light perception (Freedman et al., 1999; Provencio, Rollag, & Castrucci, 2002).
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The melanopsin pathway appears to be critical for circadian function, as evidenced by
impaired circadian phase-setting observed in a breed of melanopsin-knockout mice
(Panda et al., 2002). Thus, abnormalities in the melanopsin system could underlie unique
responding to photoperiod in SAD as proposed in the photoperiodic or phase-shift
hypotheses. The first study examining the role of melanopsin in SAD found a single
missense variant in the melanopsin OPN4 gene to be associated with increased risk for
SAD; specifically, individuals with the T/T genotype at P10L were 5.6 times more likely
to have SAD than were healthy controls (Roecklein et al., 2009). Given the low T/T
prevalence detected in this sample of SAD patients (N = 130, n = 7 or 5% of whom had
the T/T genotype), larger studies are needed to replicate results and clarify the role of
melanopsin deficiencies in SAD.
Clock genes. Genetic abnormalities in clock genes have been investigated as risk
factors for SAD. In a study comparing genotypes across SAD patients, controls, and
individuals high and low in seasonality; the Leu/Ser polymorphism in Npas2 was
associated with SAD, but not with high seasonality, but no other variants were associated
with SAD (Johannsson et al., 2003). However, Partonen et al. (2007) found singlenucleotide polymorphisms in three clock genes (Per2, Arntl, and Npas2) central to
pacemaker functioning had additive effects on SAD, suggestive of a genetic risk profile.
Psychological Vulnerability to SAD
Cognitive models of SAD. Although Lewy, Sack, Singer and White (1987)
initially acknowledged that a circadian misalignment as proposed in the PSH may not be
sufficient for the development of SAD, psychiatric research has exclusively examined the
role of biology in SAD (e.g., biological rhythms, genes, neurotransmitters) to the
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exclusion of psychological factors. Indirect evidence that cognitive and behavioral
vulnerabilities are also involved in SAD comes from a randomized clinical trial of a
cognitive-behavioral therapy (CBT) tailored to SAD (CBT-SAD). (CBT-SAD). CBTSAD is comparably efficacious to light therapy in acute reduction of SAD severity from
baseline to post-treatment (Rohan, Roecklein, et al., 2007; Rohan et al., 2015), and is
superior to light therapy in SAD recurrences and symptom severity at followups the next
winter (Rohan, Roecklein, Lacy & Vacek, 2009) and two winters later (Rohan et al.,
accepted). A recent wave of research conducted by clinical psychologists has revealed
that cognitive factors involved in nonseasonal depression are also implicated in SAD.
According to cognitive theories of depression, vulnerable individuals hold
negative cognitive processes (i.e., maladaptive thought patterns) that serve as underlying
vulnerabilities (i.e., diathesis), that when activated in periods of stress, contribute to
adverse emotional responses (i.e., depression). These studies have applied several
cognitive theories of depression to test whether specific cognitive vulnerabilities
implicated in nonseasonal depression also apply to SAD. In SAD, the occasion setter
(i.e., the stress) is operationalized as the onset of the winter season.
Rumination. The response styles theory (Nolen-Hoeksema & Morrow, 1991) of
depression proposes that an individual’s response style (i.e., rumination or distraction) to
sad mood affects the duration and intensity of the ensuing depression symptoms.
Rumination is defined as the tendency to react to dysphoric mood by repetitively
focusing on negative mood, its causes, and consequences, whereas distraction involves
thoughts or behaviors aimed to disengage from mood. Degree of endorsement of
brooding rumination, a natural tendency to ruminate when distressed, has been shown to
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predict prolonged duration of depression symptoms in clinically depressed patients, as
well as the development of depressive disorders (as reviewed by Nolen-Hoeksema,
Wisco, & Lyubomirsky, 2008).
Rohan, Sigmon, and Dorhofer (2003) published a study in which women with a
history of SAD and never-depressed age-matched controls were prospectively assessed in
fall, winter, and summer on several cognitive factors. Controlling for initial depression
severity in fall, rumination, but not distraction, in the fall was found to be a strong,
significant predictor of winter depression severity. Similarly, Young and Azam (2003)
reported that ruminative responses, but not distraction behaviors, as assessed via daily
diaries over a period of two weeks in the fall predicted winter depression severity after
controlling for initial levels of depression in SAD patients.
Treynor, Gonzalez, and Nolen-Hoeksema (2003) distinguished between subtypes
of the ruminative response style: reflective pondering, defined as a purposeful reflection
upon one’s situation problem-solving, and brooding rumination, defined as “moody
pondering” involving a passive comparison of one’s situation with some unachieved
standard. Brooding rumination is the maladaptive form of rumination, uniquely
associated with current and predictive of future depression (Moberly & Watkins, 2008;
Siegle, Moore, & Thase, 2004; Treynor, Gonzalez, & Nolen-Hoeksema, 2003) and other
psychopathology (Watkins, 2009). Consistent with this distinction, Enggasser and
Young (2007) found that only the brooding ruminative response style predicted winter
depression severity in a sample of individuals with SAD symptoms. According to
Kraemer, Kazdin, Offord, Kessler, Jensen, and Kupfers’ (1997) criteria for a risk factor, a
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brooding ruminative response style may constitute a cognitive risk factor for SAD
because it precedes episode onset and predicts symptom growth over time.
Cognitive reactivity. Beck’s cognitive model of depression (Beck, 1976)
proposes that dysfunctional attitudes stemming from maladaptive schemas constitute a
cognitive vulnerability to depression. Dysfunctional attitudes are learned maladaptive
attitudes or assumptions related to the negative cognitive triad. Rohan et al. (2003) found
that women with SAD endorsed more dysfunctional attitudes in fall and winter as
compared to themselves in summer when asymptomatic, whereas controls did not differ
across the seasons on dysfunctional attitudes. Of note, Rohan et al. (2003) did not detect
differences in the magnitude of endorsed dysfunctional attitudes between women with a
history of SAD (i.e., formerly depressed) and never-depressed controls in summer, when
patients are asymptomatic, suggesting a mood induction is needed to activate these
negative self-schemas in SAD patients. In a second longitudinal study examining
seasonal changes in dysfunctional attitudes in SAD patients and never-depressed
controls, SAD patients reported elevated dysfunctional attitudes in winter relative to
summer and endorsed more dysfunctional attitudes than controls in the winter (Golden,
Dalgleish, & Spinks, 2006). In a study comparing negative thought processes between
SAD patients, nonseasonally depressed individuals, and nondepressed controls in the
winter season, both patient groups endorsed greater dysfunctional attitudes than the
control group, with no significant differences between nonseasonally and seasonally
depressed patients (Hodges & Marks, 1998). Beck’s theory of depression also
emphasizes the mechanism by which the activation of dysfunctional attitudes may
contribute to future relapse and recurrence of depression. The theory posits negative self29

schemas, as indicated by dysfunctional attitude endorsement, are activated by life stress
and/or sad mood (Beck, 1976). However, the relative ease with which dysfunctional
attitudes are activated by depressed mood states is termed “cognitive reactivity.”
Cognitive reactivity can be assessed experimentally by inducing a sad mood when a
person is in a euthymic mood or is minimally symptomatic (e.g., during summer for SAD
patients) and measuring the change in dysfunctional attitudes before to after the mood
induction. The most commonly used dysphoric mood induction in tests of cognitive
reactivity involves reflecting on a personally-relevant sad memory while listening to a
piece of sad-suggestive orchestral music, Prokofiev’s “Russia under a Mongolian Yoke”
played at half-speed, a procedure shown to reliably induce a sad mood (Clark &
Teasdale, 1985). Cognitive reactivity is theorized to model the activation of negative
schemas in response to stress-induced negative affect and, therefore, it should predict
increased risk to relapse and recurrence of depression (Segal, Williams, Teasdale, &
Gemar, 1996). Cognitive reactivity to a negative mood induction has been shown to be
greater in formerly depressed patients than never depressed (Gemar, Segal, Sagrati, &
Kennedy, 2001). Additionally, residual cognitive reactivity after successful treatment
with antidepressant medications or cognitive therapy has been shown to predict
depression relapse (69%) over an 18-month period in nonseasonally depressed
individuals (Segal, Kennedy, Gemar, Hood, Pedersen, & Buis, 2006). To date, there has
been one study examining cognitive reactivity in SAD. Enggasser and Young (2007)
utilized a prospective, longitudinal design to examine the effect of cognitive reactivity on
annual recurrence of winter depression symptoms in individuals with either SAD or subsyndromal SAD. Contrary to the nonseasonal depression literature, Enggasser and Young
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(2007) did not find cognitive reactivity in response to a sad mood induction in the
summer to be predictive of depressive symptoms the following winter. However,
Enggasser and Young’s findings have yet to be replicated.
Season-specific cognitions. In the Cognitive-Behavioral Integrative Model of
SAD, Rohan (2008) proposes that individuals with SAD may hold rigid season-specific
cognitions regarding how the weather impacts their mood. These cognitions are
conceptualized as a domain-specific set of dysfunctional attitudes stemming from learned
associations between negative mood or depression and the winter season, and may
contribute to the maintenance of the annually recurrent seasonal pattern of depression
experienced by SAD patients. Prior SAD studies have utilized the Seasonal Attitudes
Scale (SAS; Sigmon, Rohan, Boulard, Whitcomb, & Dorhofer, 2000) as a measure of
trait-like emotional and behavioral responses to the changing seasons, as well as specific
attitudes about the seasons. The SAS has been shown to discriminate between individuals
with moderate seasonality of mood, and nondepressed, low-seasonality controls (Rohan,
Nillni, Mahon, Roecklein, Sitnikov, & Haaga, 2011). However, the SAS assesses an
individual’s attitudes about the changing seasons, as well as their typical emotional and
behavioral responses across the seasons (i.e., SAD symptoms). In this respect, the SAS
construct confounds seasonal attitudes with seasonality, measured by the SPAQ
(Rosenthal et al., 1987). Conversely, the Seasonal Beliefs Questionnaire (SBQ; Rohan,
Nillni, Lippy, Roecklein, & Hillhouse, 2007) was designed as a measure of seasonspecific cognitions that does not include items about symptoms. Rohan (2008)’s
Integrative Cognitive-Behavioral Model of SAD implicates season-specific cognitions as
a cognitive vulnerability of SAD.
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Behavioral models of SAD. According to Lewinsohn’s (1974) behavioral model
of depression (Lewinsohn, 1974), behavioral disengagement contributes to depression
onset and maintenance because reduced activity reduces the potential to derive positive
reinforcement from enjoyable activities. A diminished interest or pleasure in activities is
a diagnostic symptom of depression per the DSM-IV-TR (APA, 2000). There has only
been one study to date examining pleasant activity levels in SAD. In their longitudinal
investigation across the seasons, Rohan et al. (2003) found that women with SAD
engaged in significantly fewer pleasant activities in fall or winter relative to themselves
in summer, and were less active in winter relative to controls whose frequency of
engagement in pleasant activities did not differ across seasons. This study suggests that
behavioral disengagement correlates with the seasonal pattern in SAD; however,
clarification of the role of behavioral disengagement in the onset or annual recurrence of
SAD warrants further study.
Integrative Models of SAD
Given the evidence for both biological and psychological factors in SAD,
integrative etiological models propose that different types of vulnerabilities are mutually
involved in SAD onset and maintenance. There are several models proposing an
interplay of biological and psychological risk factors in SAD (Rohan, 2008; Young,
Watel, Lahmeyer, & Eastman, 1991; Young, 1999). In the initial integrative model,
Young (et al., 1991; 1999) proposed a dual vulnerability model of SAD, involving a
psychological vulnerability, as reflected by the vegetative symptoms (e.g., changes in
sleep, appetite, weight, and energy), and a separate psychological vulnerability, as
evidenced by the cognitive-affective symptoms (e.g., depressed mood, anhedonia, and
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low self-esteem). Young’s model proposes that the psychological vulnerability occurs
concomitantly or in response to the vegetative symptoms. Young’s dual vulnerability
model emphasizes how these two vulnerabilities interact to influence the onset of specific
SAD symptoms each fall/winter season.
Rohan’s integrative cognitive-behavioral model of SAD (Rohan et al., 2008;
Rohan, Rocklein, & Haaga, 2009) maintains Young’s concept of dual biological and
psychological vulnerabilities, yet elaborates the content of the psychological vulnerability
to include specific cognitive (e.g., dysfunctional attitudes, rumination) and behavioral
(e.g., behavioral disengagement) vulnerabilities to depression. See Figure 1 for Rohan’s
integrative cognitive-behavioral model of SAD. The model also postulates that SAD
individuals hold negative core beliefs specific to the winter season, weather, and low
light availability. The Seasonal Beliefs Questionnaire was developed to measure these
possible SAD-specific cognitions (Rohan, Nillni, et al., 2007). In contrast to Young’s
model, Rohan’s model does not tie the underlying vulnerabilities to specific symptom
profiles.
Limitations of Current SAD Literature
The majority of SAD studies have indirectly tested the PSH by assessing phase
shifts that accompany antidepressant response to light therapy. However, this type of
design does not test the PSH assumption that SAD involves a natural shift in circadian
rhythms across seasons. There have been two studies to date testing this effect
(Koorengevel et al., 2003; Wehr et al., 2001), both of which reported a nonsignificant
difference between summer and winter in SAD patients’ circadian rhythms. However,
methodological limitations confound the generalizability or certainty of these null
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findings. The latter study (Wehr et al., 2001) did not control for individual differences in
the timing of sleep, a necessary measure to isolate true seasonal effects on the melatonin
rhythm. The former study (Koorengevel et al., 2003) is the most stringent test of this
effect to date in that it used forced desynchrony procedures; however, the protocol
involved only 7 SAD patients due to the intensive and costly study procedures.
The greatest limitation of the current literature is the lack of empirical application
of the integrative models of SAD. Despite recent theories that integrate psychological
and biological vulnerabilities (Rohan, 2008; Young, 1991; 1999) and frequent
acknowledgments in both literatures of the other vulnerabilities likely implicated in SAD,
a major limitation of available research on SAD etiology is the examination of one
vulnerability in isolation (i.e., biological or psychological) as opposed to analysis of both
vulnerabilities within the same sample and statistical model. Studying one type of
vulnerability in isolation has not allowed for comparison of the relative contributions of
these vulnerabilities to SAD severity, controlling for effects of the other. This limitation
is likely due to the disciplinary division in the field, such that the chronobiological
research on SAD has been conducted by one “camp” (i.e., biological psychiatrists,
physiological psychologists, and circadian biologists) whereas the psychological research
has been conducted by a different “camp” (i.e., clinical psychologists with a cognitivebehavioral orientation) with little collaboration between them. Therefore, no study to
date has tested an integrative model, which is needed to elucidate the specific roles that
chronobiological and cognitive vulnerabilities play in the diathesis of SAD.
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CHAPTER 2: The Current Project
The proposed project is the first study to integrate expertise from leading
chronobiological and cognitive-behavioral SAD researchers to test an integrative model
of SAD (Rohan, 2008), see Figure 1. The project aimed to clarify the etiological
underpinnings of SAD by (1) comparing SAD patients and never-depressed controls on
chronobiological and cognitive vulnerabilities at both summer and winter, (2) utilizing a
prospective, longitudinal design to compare the relative contributions of the
chronobiological and cognitive vulnerabilities in predicting winter depression severity in
SAD patients versus controls.
The methodology of the current project improved upon the extant SAD literature
in several ways. First, this project was the first to utilize measures of both the proposed
cognitive and circadian correlates of SAD, such that relative contributions of these
factors on SAD severity can be assessed. Second, all measures were assessed in summer
and winter to accommodate longitudinal models of analyses. Third, the current study
involved a novel examination of PAD as a correlate of SAD, with the assessment of
variability in this relation across season and mood state. This provided a direct test of the
PSH defined as a circadian misalignment to sleep rather than to the light-dark cycle.
Study Aims and Hypotheses
Aim 1: To test whether SAD patients and controls differ in the seasonal change of
the chronobiological and cognitive vulnerabilities.
Hypothesis 1. SAD patients will show a greater degree of seasonal change in
PAD from summer to winter than controls, with a mean shortening of PAD in winter

35

relative to summer, indicative of a phase delay. This group effect would suggest a
seasonal circadian misalignment may be characteristic of SAD.
Hypothesis 2. SAD patients will exhibit comparable deviation from PAD-6 to
controls in summer, and greater deviation from PAD-6 than controls in winter. A greater
deviation from PAD-6 in winter among patients than controls would suggest a winter
circadian misalignment in SAD.
Hypothesis 3. SAD patients will endorse higher values of brooding rumination
than controls at both summer and winter assessments. This consistent group difference
across time would reflect a greater trait tendency to respond to sad mood with
maladaptive rumination in patients than controls.
Hypothesis 4. SAD patients will exhibit greater cognitive reactivity (i.e., an
increase in endorsed dysfunctional attitudes across a negative mood induction) in summer
than controls. Postulated as a maintenance mechanism of depression, this effect would
suggest SAD patients are more prone to respond to dysphoric mood with more negative
thought patterns.
Hypothesis 5. SAD patients will endorse more dysfunctional attitudes than
controls at winter, but the groups will not differ at summer. This finding would suggest
that SAD patients hold more rigid depressogenic attitudes than controls only when they
are depressed.
Hypothesis 6. SAD patients will endorse more rigid seasonal beliefs than controls
at both summer and winter assessments. This consistent group difference across time
would reflect a greater trait tendency for patients to endorse rigid beliefs about seasons
and light year-round, relative to controls.
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Aim 2: To test the predictive effects of these group differences in
chronobiological and cognitive vulnerabilities on seasonal change in depression severity.
Hypothesis 7. It is expected that the between-group effects of the vulnerabilities
will account for variance in depression severity, above and beyond the unique effects of
group, and the chronobiological and cognitive predictors.
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CHAPTER 3: Method
Participants
Participants were adults (aged 18 to 65) community residents recruited from
either the greater Burlington, Vermont or Pittsburgh, Pennsylvania areas. Specifically 31
individuals diagnosed with Major Depression Recurrent, with Seasonal Pattern (winter)
and 33 age- and sex- matched never-depressed control participants were recruited for this
study. General exclusion criteria for all participants included: 1) current psychological or
psychiatric treatment (i.e. psychotropic medications, psychotherapy, light therapy) or
plans to initiate treatment before study completion; 2) diagnosed sleep disorder (i.e.
Obstructive Sleep Apnea, Periodic Limb Movement Disorder, or Narcolepsy); and 3)
individuals with plans to travel outside New England within 2 weeks prior to a laboratory
visit, to control for latitude effects on depressed mood and time-zone travel effects on
circadian phase.
Study sites. Due to limited enrollment success in Burlington, VT (15.6% of
phone screens, and 45.8% of diagnostic screens), data were pooled across two funded
projects conducted simultaneously at the University of Vermont in Burlington, VT (44.5°
N) and the University of Pittsburgh in Pittsburgh, PA (40.4° N). Data were collected
concurrently from Pittsburgh and Burlington during the summer and winter seasons
during three consecutive years, 2012-2014 using comparable study enrollment criteria
and methods. Demographics and recruitment statistics are presented by site, below.
Criteria for the SAD patient group. At the time of initial in-person screening,
inclusion criteria for the SAD patient group are: DSM-IV-TR criteria for Major
Depression, Recurrent, with Seasonal Pattern for the past two winters as determined by
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the Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCIDCV; First et al., 1996). Exclusion criteria for the SAD patient group are: 1) a current
comorbid Axis I diagnosis, 2) Bipolar-type SAD, 3) summer-type SAD, and 4) acute or
serious suicidal intent. At the summer laboratory visit, an additional exclusion of not
having a full summer remission prior to lab visit 1 was applied (a score of ≥14 on the
Beck Depression Inventory-Second Edition), indicative of minimal persisting depressive
symptoms in summer. At the winter laboratory visit, an additional inclusion criterion of
prospectively meeting DSM-IV-TR criteria for a current Major Depressive Episode
(MDE) in the fall or winter months was applied. To do so, SAD patients were assessed
by phone biweekly (twice monthly) starting in fall for current MDE criteria on the SCIDCV, and scheduled for Time 2 once criteria are met. Calls were audio recorded for
reliability checks.
Criteria for the never-depressed control group. At the time of initial in-person
screening, inclusion criteria for controls included: (1) no current Axis I diagnosis as
ascertained by the SCID-CV, (2) no history of a Major Depressive Episode (MDE) on the
SCID-CV, and (3) seasonality scores that fall in the normal range on the Seasonal Pattern
Assessment Questionnaire (Rosenthal et al., 1984), indicating minimal seasonality and
the absence of sub-syndromal SAD. Additional inclusion criteria applied just prior to
each laboratory visit included: (4) DSM-IV criteria for a MDE on the SCID-CV and (2)
scoring ≤ 14 on the BDI-II.
Procedure
Screening procedure. Individuals who respond to advertisements were screened
for eligibility with a brief phone screen. Prior to study consent, the phone screen served
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to preliminarily assess the inclusion/exclusion criteria: depression history (SAD status
over past 2 winters for SAD patients, an absence of current depression or SAD history for
control participants); known psychological and/or sleep diagnoses; current psychiatric
treatment; interest and availability to participate in all study procedures. Eligible
individuals were invited to the in-person screening visit. Potential participants first
completed consent and HIPAA forms, then a diagnostic clinical interview, and lastly, the
SCID-CV was administered to assess eligibility criteria. If exclusionary psychiatric
diagnoses are met, the participant was informed and provided a referral list for
psychological services. Qualified participants were scheduled for the time 1 assessment
(May to September).
Ambulatory sleep schedule. Participants were asked to keep a consistent sleep
schedule of their choosing (with duration parameters of 8 hours +/- 30 minutes at
bedtime/waketime) for the 7 days prior to a laboratory visit to regulate sleep and
circadian phase. Sleep/wake patterns were objectively measured with wrist actigraphy
(Actiwatch 2, or Actiwatch Spectrum, Philips Respironics). Participants wore an
actigraph wrist device continuously on their non-dominant wrist for the 7 days of sleep
schedule leading up to the saliva collection time. Activity data were recorded in .5 min
epochs. Sleep onset and offset times were derived with Actiware scoring software. In the
event of watch malfunction (11%), sleep log times were substituted, as available. In order
to maximize natural circadian phase and sleep timing, participants were asked to abstain
from the use of melatonin and other sleep medications in the 2 weeks prior to a laboratory
visit, and the consumption of alcohol was limited to 1 drink per day, and caffeine to 2
cups of coffee or caffeine equivalent daily before noon.
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Saliva sample collection. Salivary melatonin has been shown to be a reliable,
noninvasive measure of circadian phase (Voultios, Kennaway, & Dawson, 1997). There
were two intended saliva collection days for each participant: one in late spring/summer
(May to August) and one in late fall/winter (November to February). Participants
completed serial (half-hourly) saliva collection for 6 hours (13 samples) on the 7th
evening of the sleep schedule week. Sampling times were tailored for each participant
based on their selected sleep schedule,, whereby the sampling window occurred 5.5 hours
before to .5 hours after their habitual bedtime. This was intended to optimize capture of
the DLMO, which typically occurs 2-5 hours prior to bedtime, yet which has been shown
to vary by diurnal preference and timing of sleep (Emens, Yuhas, et al., 2009).
Burlington, VT participants collected samples at home, whereas Pittsburgh, PA
participants collected samples in the laboratory. The sampling methods are described in
detail, below. All participants were instructed to brush their teeth, rinse their mouth, and
abstain from all food or beverages 10 minutes prior to each sample. Participants were
also asked to abstain from the following on the day of sampling: cranberry juice,
chocolate, bananas, caffeinated and decaffeinated coffee, tea, soda, Aspirin, Ibuprofen,
other non-steroidal anti-inflammatories, and toothpaste. All of these substances either
coat the mouth or otherwise contaminate the saliva.
Burlington participants collected saliva samples at home on the 7th evening of the
sleep schedule. At the laboratory visit, participants were provided sample materials [i.e.,
13 Salivettes® (Sarstedt, AG & Co.) labeled with intended administration times, sample
storage rack, saliva collection instructions, sunglasses, sample log and a toothbrush] and
guided through a sampling tutorial. To control for lighting conditions, participants were
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fitted with a set of dark-colored goggles (Julbo® spectron 4 lens sunglasses) for 95%
light filtration to wear for 7 hours during the evening of saliva collection to avoid the
suppressant effects of light on melatonin production during sample collection (Lewy et
al., 1980). The participants were informed that the importance of recording the exact
sampling time (e.g., 6:32 pm) is much greater than sampling exactly at the intended time
(e.g. at 6:30 pm), with an example chart of clean melatonin data. This instructional
technique has been associated with sampling precision comparable to collection by inpatient nursing staff (personal communication with Jonathan Emens, M.D., July 11,
2011).
Pittsburgh, PA participants collected 13 half-hourly saliva samples (Salivettes®;
Sarstedt, AG & Co.) starting from 5.5 hours before to 0.5 hour after their habitual
bedtime for the past week. Saliva samples were collected in the laboratory on the 7th
evening of the sleep schedule week, with the assistance of research staff. Participants
were allowed to ambulate and were not confined to constant postural conditions. Lighting
was controlled at ≤ 15 lux, as verified by spectrophotometer. Participants were provided
blue-light spectrum block glasses to wear if they needed to leave the unit during the
sample session. Samples were centrifuged and stored at 2-8°C upon collection, and
stored at -80°C within 2 days of collection until shipped for assay.
Melatonin assay. Saliva samples collected in Burlington, VT were assayed for
melatonin in the Neuroscience Center of Biomedical Research Excellence Core
Laboratory at the University of Vermont Medical School using the Bühlmann Direct
Saliva Melatonin ELISA kit (ALPCO Diagnostics, Salem, NH). Saliva samples were
immediately stored at 2-8°C upon collection, and placed at -80°C within 4 days of
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collection for storage until assay (up to 6 months). The Burlington assays averaged an
intra-assay precision of .31 and an inter-assay precision of CV = .10. The intra-assay
precision was higher than the acceptable window (.15), although the interassay precision
was within acceptable range. Limitations of the former are discussed, below. Saliva
samples collected in Pittsburgh, PA were assayed for melatonin by SolidPhase, Inc.
(Portland, ME, USA) using the Bühlmann Direct Saliva Melatonin Radioimmunoassay
kit (ALPCO Diagnostics, Windham, NH, USA). SolidPhase, Inc. (Portland, ME, USA)
did not include duplicates in the assay despite using the Bühlmann Direct Saliva
Melatonin Radioimmunoassay kit (ALPCO Diagnostics, Windham, NH, USA).
Therefore, the intra-assay sensitivity for the Pittsburgh DLMO data are non-applicable
and the measure of reliability of concentrations estimates is unavailable. The inter-assay
sensitivity for Solidphase was within acceptable range at CV: .12.
Measures
Structured Clinical Interview for the DSM-IV Axis I Disorders-Clinical
Version (SCID-CV). The SCID-CV (First et al., 1996) is a structured diagnostic
interview, which assesses DSM-IV criteria for Axis I Disorders. The SCID-CV was
utilized as a screening instrument to verify SAD patient or never-depressed control status
for inclusion in the study. The SCID-CV was administered by the P.I., or other clinical
psychology graduate students, who have been trained in SCID administration and have
experience administering the SCID-CV. Of the Burlington SCID interviews, a subset, n =
10 (25.6%), were rated by a second rater for inter-rater reliability of SAD diagnosis, with
100% congruence.
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Seasonal Pattern Assessment Questionnaire –SAD Version (SPAQ). The
SPAQ (Rosenthal et al., 1987) is a brief screening assessment for seasonality. Subjects
rate the degree to which they experience seasonal changes across 6 domains: sleep length,
social activity, mood, weight, appetite, and energy level rated on a scale of 0 “no change”
to 4 “extremely marked change.” A global score ≥ 11, with a minimum of moderate
impairment from seasonal symptoms, is consistent with a diagnosis of SAD. Due to low
sensitivity, the SPAQ is recommended as a supplemental instrument to clinical interview
for diagnosis of SAD (Mersch et al., 2004).
Structured Interview Guide for the Hamilton Rating Scale for Depression–
Seasonal Affective Disorder Version (SIGH-SAD). The SIGH-SAD (Williams et al.,
1992) is a semi-structured clinical interview including the 21-item Structured Interview
Guide for the Hamilton Rating Scale for Depression (HAM-D) and a supplementary 8item subscale to assess atypical depressive symptoms associated with winter SAD. A
SIGH-SAD was administered at the Time 1 summer visit, when relatively asymptomatic,
and at the Time 2 winter laboratory visit when in a major depressive episode. The SIGHSAD (i.e., 29 items) demonstrated acceptable internal consistency in summer (α = .63)
and excellent internal consistency when administered in winter (α = .91). Intraclass
correlations (ICC) were calculated to assess the inter-rater reliability between trained
raters for SIGH-SAD total scores at each assessment. All Burlington SIGH-SAD
interviews were rated by a second rate, with an ICC = .838 for summer, and ICC = .993
for winter, SIGH-SAD scores. A random selection (10%) of Pittsburgh SIGH-SAD
interviews were rated by a second rater, selected randomly across patient group and
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season. The Pittsburgh raters yielded an ICC = .941 for summer, and ICC = .998 for
winter.
Beck Depression Inventory–Second Edition (BDI-II). The BDI-II (Beck,
Steer, & Brown, 1996) is a 21-item measure of depressive symptom severity. The
questionnaire consists of 21 groups of statements for which the responder must select the
statement that best describes his/her experience in the past two weeks (e.g., for item 1,
sadness: “I do not feel sad”, “I feel sad much of the time”, “I am sad all the time”, or “I
am so sad or unhappy that I can’t stand it”). The BDI-II has demonstrated good testretest reliability and convergent validity (Beck et al., 1996). The BDI-II served as an
additional measure to verify depressive symptom severity at each laboratory visit. The
BDI-II demonstrated excellent internal consistency at both summer (α = .97) and winter
(α = .91).
Ruminative Response Scale (RRS). The RRS (Nolen-Hoeksema & Morrow,
1991) measures the tendency to ruminate in response to negative affect. The RRS
consists of 22 responses to sad mood focused on the self and the causes and
consequences of sad mood (e.g., “Go away by yourself and think about why you feel this
way”), rated on a scale of 1 (almost never respond in this way) to 4 (almost always
respond in this way). The RRS has three factor analytically-derived subscales:
depression, brooding, and reflective-pondering. The RRS demonstrates a test-retest
validity of .67 across 1 year, with good internal consistency for the reflective-pondering
and brooding subscales, respectively (α = .72, .77; Treynor et al., 2003).
Brooding rumination. The “brooding” subscale of the RRS has been particularly
associated with depression (Joorman, Dkane, & Gotlib, 2006; Siegle et al., 2004; Treynor
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et al., 2003) and SAD (Enggasser & Young, 2007), and constituted the rumination, and
primary cognitive vulnerability, measure in this study. The RRS (total score)
demonstrated excellent internal consistency in summer (α = .95) and winter (α = .97).
The brooding rumination subscale score also demonstrated good internal consistency at
both summer (α = .81) and winter (α = .89) assessments.
Cognitive reactivity. The Dysfunctional Attitudes Scale (DAS; Weissman &
Beck, 1978) is a 40-item measure of common cognitive assumptions endorsed by
individuals with depression, such as, “If I fail at my work, then I am a failure as a
person.” Ratings are given on a 7-point Likert scale with anchors of 7 = “totally agree”
to 1 = “totally disagree.” Per research on the cognitive vulnerability to depression,
cognitive reactivity is measured by change in DAS score from before to after a dysphoric
mood induction, and constituted the measure of cognitive reactivity in the current study.
In the summer when non-depressed, participants underwent a dysphoric mood induction
by reflecting upon a time when they felt sad, while listening to the orchestral introduction
to ‘Russia Under the Mongolian Yoke’ by Prokofiev, at half-speed, for 10 minutes (Clark
& Teasdale, 1985). This procedure has been shown to effectively activate the
dysfunctional attitudes in remitted depressed individuals (Gemar et al., 2001). To
determine whether the induction of a sad mood was successful, Visual Analog Scales
(VAS) were administered at pre- and post-mood induction. The VAS consisted of a 146
mm line, with positive mood defined as distance (mm) from the center mark to the right
(maximum = +73 mm) and negative mood defined as distance from the center to the left
(maximum = -73 mm). DAS form A was completed at pre-mood induction, and DAS
form B completed at post-mood induction. DAS B demonstrated excellent internal
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consistency (α = .94). DAS A also demonstrated excellent internal consistency, as
measured at both summer (α = .92), and winter (α = .93).
Seasonal Beliefs Questionnaire (SBQ). The SBQ (Rohan, Nillni, et al., 2007) is
a 26-item measure of season-specific cognitions in SAD (e.g. “I need sunshine to be
happy”). For each item, respondents rate their level of agreement on a 7-point Likert
scale from 7 “totally agree” to 1 “totally disagree.” Although the SBQ is a relatively new
measure, it is the only scale available to measure the SAD-specific cognitions proposed
in Rohan’s model. The SBQ has demonstrated high internal consistency (α = .98) and
test-retest reliability (r = .89; Rohan, Nillni, et al., 2007). The SBQ demonstrated
excellent internal consistency in the present study at both, summer (α = .94) and winter (α
= .93) assessments.
Morningness – Eveningness Questionnaire (MEQ). The MEQ (Horne &
Östberg, 1976) is a 19-item measure of diurnal preference, as a continuous scale of
preferred morningness or eveningness. Total MEQ scores range from 16-86, with lower
scores indicative of greater eveningness, and higher scores of greater morningness.
Middle scores are reflective of an intermediate, or neither, morning- nor evening-type.
The MEQ demonstrated relatively good internal consistency at both summer (α = .73)
and winter (α = .69) assessments.
Phase Angle Difference (PAD). PAD is a measure of the relation between
circadian phase and sleep, defined here as the difference in timing between the dim light
melatonin onset (DLMO) and the midpoint of sleep, see Figure 2. The DLMO is the
standard biomarker of circadian phase (Benloucif et al., 2012; Lewy et al., 1999)
measured via serial saliva collections under dim light conditions (< 30 lux) in the
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evening, defined as the interpolated time between the last saliva sample with a melatonin
concentration below 3pg/ml and the first sample above 3 pg/ml (Benloucif et al., 2008).
The actigraphic sleep midpoints were averaged over the week prior to saliva collection.
Deviation from PAD-6, proposed to be the “sweet spot” (Lewy et al., 2003; 2006),
constituted the chronobiological predictor, calculated as an absolute value difference (in
hours) from PAD of 6 hr. The absolute deviation was calculated to account for variation
in direction of phase shift, as prior findings indicate that a minority (i.e., 1/3) of SAD
patients exhibit a phase-advanced, whereas the majority exhibit a phase delayed,
circadian rhythm when depressed (Lewy et al., 2006).
Data Analytic Method
Aim 1. A series of Linear Mixed Models were conducted in SPSS to examine the
within- and between-subjects variation in the cognitive and chronobiological
vulnerabilities. Within-subject effects were tested across time, categorized by season (i.e.,
summer and winter). Between-subjects effects were tested across groups (i.e., SAD
patients and never-depressed controls). LMM offers several advantages over GLM for
longitudinal designs, such as allowance for correlated repeated data (i.e., violation of the
independence assumption of GLM), selection of flexible covariance matrices to allow
variability in error across time and group, inclusion of all available data rather than
requiring listwise deletion for repeated measures designs, as well as the allowance for
variable timing of data collection across individuals (Raudenbush & Bryk, 2002). All
vulnerability trajectories were presumed to be linear given the restriction of 2 waves of
data. The time variable, Season, was dummy coded (1, 2), such that 1 corresponded to the
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summer assessment as SAD remission (i.e., intercept) to preserve the baseline in a
prediction of the onset of SAD recurrence from summer to winter.
Prior to testing the hypothesized effects of within- and between-subjects effects, the
unconditional means model (i.e., intercept level) was examined for inter-individual
variability of the outcome as a measure of independence of observations. The Intraclass
Correlation (ICC) reflects the ratio of between-subject variance to the total variance,
absent of any additional fixed effects. As generally recommended, mixed modeling was
applied if the ICC was greater than .25, otherwise, GLM tests (e.g., regression or repeated
measures ANOVA) were applied, as appropriate. Next, the unconditional growth model
(i.e., intercept and time) was examined for random individual growth (i.e., random
variation in individual slopes). For all the mixed models, the unconditional growth model
did not converge, reflecting low random variation across time (i.e., restricted range of
individual slopes), indicating that an individual growth model is not a good fit to the data.
This result likely reflects restriction due to study design (i.e., selection of participants on
the dichotomous presence or absence of SAD), with a dichotomized range of captured
mood states across seasons (i.e., summer remission versus winter major depression in
SAD patients). The study was designed as a stringent test of potential correlates of SAD
recurrence. Due to the lack of random variation, the presented LMM results reflect
average growth (i.e., group means) across time points, whereby regression coefficients
indicate average degree of difference between summer and winter assessments, rather
than individual rates of change. Participant was included in the model as a random factor
to account for inter-individual variation in summer depression severity (i.e., intercept), as
well as individual variation in SAD vulnerabilities. All mixed models were built
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sequentially starting from the unconditional means model, adding fixed effects in a
stepped fashion across 4 additional models: Model 2 added the fixed main effect of
season to the unconditional means model, Model 3 added the fixed main effect of patient
status, and Model 4 added the interaction effect of patient status by season, entered as a
fixed effect. Various covariance structures were fitted to the models. In all cases, an
unstructured covariance matrix provided the best fit to the model, allowing covariances to
vary across summer and winter. In order to account for unexpected error variance due to
sample variability, factors shown to influence sample variability [e.g., study site, season
order (i.e., summer or winter as Time 1), diurnal preference, attrition, age, or sex] were
also tested for covariate effects on each vulnerability outcome measures. All significant
variables were included in the final model as fixed covariates. The inclusion of
significant covariates was intended to reduce error variance and associated Type I and
Type II error rates, and thereby increase power for detecting true effects by the variables
of interest. Prior to interpretation of model estimates, residuals were examined for
linearity, normality, and detection of outliers. If violation of assumptions was detected,
transformations of the dependent variable, and/or outlier diagnostics were applied. LMM
does not yield effect size estimates for fixed effects. Therefore, fixed effect estimates (2)
were calculated for Aim 1 analyses with GLM to facilitate interpretation of current and
prior findings. Effect size estimates should be interpreted with some caution given that
GLM estimates are not based on complete data due to listwise deletion.
Each cognitive vulnerability measure (i.e., Brooding Rumination subscale score,
Ruminative Response Scale score, Seasonal Beliefs Questionnaire total score,
Dysfunctional Attitudes Scale, and cognitive reactivity) was modeled as a linear function
50

of the fixed effects of season, patient status, and the interaction of patient status by
season, as well as any significant sample bias covariate, including study site, season
order, attrition, diurnal preference, or sex. The chronobiological vulnerabilities (DLMO,
PAD, and PAD – 6) were modeled in the same way, with additional tests for fixed
covariate effects of age and diurnal preference given established effects on circadian
phase and/or sleep (Duffy, Rimmer, & Czeisler, 2001; Yoon et al., 2003). Significant 2and 3-way interactions were explored graphically to determine the nature of the
interaction and to test simple slopes, per Aiken & West (1991).
Aim 2. A second series of Linear Mixed Modeling analyses was conducted to
explore the integrative model of SAD recurrence, testing depression severity (i.e., BDI-II
or SIGH-SAD total score) across seasons as a linear function of cognitive and
chronobiological vulnerability effects. In a series of fixed effects linear mixed models,
depression was tested as a linear function of participant (random effect) with season,
patient status, and the patient status by season interaction as fixed factors. These SIGHSAD and BDI-II models served as the base for comparison with subsequent models
testing solo covariate effects of cognitive (brooding rumination, RRS, SBQ, cognitive
reactivity, DAS) or chronobiological (PAD, PAD-6) vulnerability measures. The fixed
covariate effects of the vulnerabilities were each tested in a stepped fashion across 4
additional models to the SIGH-SAD and BDI-II base model. Model 1 added the main
effect of the vulnerability on depression. Model 2 added the 2-way interaction effect of
vulnerability by patient status. Model 3 added the 2-way interaction of vulnerability by
season. Model 4 added the 3-way interaction effect of vulnerability by patient status by
season. The 2-way interaction terms test whether the effect of season or patient status on
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depression depends on level of the vulnerability. The 3-way interaction term tests
whether the effect of patient status on average seasonal variation in depression severity
depends on the level of the vulnerability. Interactions were explored graphically with
planned simple slopes analyses and pairwise comparisons. Full maximum likelihood was
employed to estimate parameters based on likelihood of model fit. Full maximum
likelihood was selected over restricted maximum likelihood as the former provides more
accurate estimates for comparison of models varying by fixed effects (Singer & Willett,
2003). To compare whether the inclusion of the vulnerability improved model fit, and to
determine the best-fitting model, deviance chi-square tests were conducted between
consecutive models, per Snijders and Bosker (2012). Examination of residuals of the base
models revealed non-normality. Square-root transformations were found to correct the
normality violation with correction of influential outliers. Therefore, the results of the
transformed outcomes are presented, below.
The summer scores of RRS and brooding rumination were entered as trait
cognitive predictors because the integrative model posits that these underlying cognitive
vulnerabilities are stable across seasons in SAD, and contribute to depression via a
diathesis-stress mechanisms, in the context of winter. The summer score of cognitive
reactivity was also utilized as the negative mood induction was only administered in
summer. DAS scores were entered for both summer and winter, in accordance with
Beck’s cognitive theory and prior research in depression and SAD supporting
dysfunctional attitudes as mood state-dependent vulnerability that waxes and wanes with
depressive episodes (Young & Yap, 2010). Seasonal beliefs were tested with both
summer and winter scores due to the exploratory test of this proposed vulnerability.
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Similar to the DAS, the summer and winter scores of the chronobiological vulnerability
measures were entered to examine the effect of fluctuation of phase angle across mood
states and seasons on SAD severity. This approach is intended to test the Phase Shift
Hypothesis, which proposes that SAD patients may exhibit pathophysiologic shifting in
circadian rhythms when depressed in winter.
Prior to inclusion in the model, grand mean centering was applied to all predictors to
improve interpretability of intercepts, slopes, and interactions. Grand means were
calculated based on all time points included in the model per predictor (i.e., summer only
for RRS, brooding rumination, and cognitive reactivity). Grand mean centering of
predictors was selected over group mean centering given that the between-groups
differences in vulnerabilities are the effects of interest, rather than confounding effects.
The dichotomous, between-subjects level 2 predictor, patient status, was not centered in
order to retain interpretability, given that 0 is a meaningful value (i.e., absence of SAD).
SPSS does not estimate effect size for time-varying covariates, therefore effect size
estimates for Aim 2 predictors are not presented. Multiple imputation was applied to
estimate missing cases, intended to improve power for hypothesis testing of Aim 2 given
the number of parameters included in the models. Degrees of freedom in Aim 2 are based
on the number of observations (128) due to multiple imputation and maximum likelihood
estimation. Additionally, SPSS estimates degrees of freedom in LMM via the
Satterhwaite approximation, which results in decimal estimates.
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CHAPTER 4: Results
Participant Flow
Data were pooled across similar projects conducted simultaneously in Burlington,
Vermont and Pittsburgh, Pennsylvania during the summer and winter seasons, 2012 –
2014 in Burlington, Vermont and Pittsburgh, Pennsylvania.
Burlington, VT recruitment. A total of n = 373 individuals completed the phone
screen. After meeting phone screen criteria, 85 potential volunteers attended a screening
visit and signed a consent form. Of those who attended a screening visit, n = 26 were
excluded for the following reasons: n = 7 (8.2%) due to non-SAD axis I diagnosis, n = 13
(15.3%) due lack of fulfillment of DSM-IV criteria for SAD, and 2 (2.4.%) for
medications, and n =4 (4.7%) screened individuals were excluded as controls due to
history of depression. Of the 59 subjects deemed eligible based on the screening visit, n =
39 were successfully scheduled and provided data. Of these 39, n = 4 (10.2%) patients
were excluded from the analyses for not meeting SAD criteria at follow-up, defined as
either moderate depression in summer (i.e., BDI-II ≥ 14) or lack of SAD recurrence in
winter (i.e., never met full Major Depressive Episode per SCID criteria assessed
biweekly via telephone). A total of n = 35 (n = 21 SAD patients, n = 14 controls)
Burlington participants were included in analyses, comprising 59.3% of the pooled
sample.
Pittsburgh, PA recruitment. From a dataset of 58 prospective participants
enrolled after IRB approval and inclusion of the study measures, n = 22 patients (37.9%)
were excluded due to current treatment, and n = 7 (12.1 %) were excluded due to SAD or
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control exclusion criteria. A final sample of n = 29 (n = 10 SAD patients, n = 19 controls)
were included from the Pittsburgh site, comprising 40.7% of the total pooled sample.
Sample Characteristics
The final pooled sample (N = 64) included 31 SAD patients, and 33 control
participants, with 54.7% recruited in Burlington and 45.3% in Pittsburgh. The sample
was predominantly female (81.3%) and Caucasian (81.2%), with a mean age of 45.51
years (SD = 12.97). See Table 1 for sample demographics and descriptives.
The sample of SAD patients (n = 31) was 74.2% female, consistent with the
reported female gender ratio of 3:4 within the broader SAD patient population, and 71%
Caucasian. The sample of controls (n = 33) was also predominantly female (87.9%) and
Caucasian (90.9%). A significantly larger proportion of SAD patients than controls were
members of racial/ethnic minority groups, 29.0% vs. 9.1%, respectively, 2(1) = 4.2, p =
.041. The SAD patient sample was also significantly older in age (M = 49.0, SD = 11.2)
than the control group [M = 42.2, SD = 13.8), t (62) = 2.15, p = .036]. SAD patients had
a mean SPAQ global seasonality score (GSS) of 15.76 (SD = 4.72), indicating moderate
seasonality consistent with SPAQ criteria to estimate SAD diagnosis (GSS SAD cutoff
score ≥ 11; Kasper et al., 1989). Consistent with inclusion of never-depressed, lowseasonality controls, controls’ mean SPAQ GSS was 3.30 (SD = 2.36), indicating
minimal seasonality (Kasper et al., 1989). Diurnal preference varied across groups
whereby SAD patients endorsed more eveningness (M = 51.61, SD = 8.26) than controls,
who endorsed more morningness (M = 56.12, SD = 9.24), t (62) = -2.05, p = .044.
Sample retention and missing data. Patterns of attrition were not different
between patients and controls, 2(2) = 5.26, p = .072, with 42 participants (65.6%)
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providing data at both time points, n = 10 (15.6%) at summer only, and n =12 (18.8%) at
winter only. The degree of missing data varied by measure. The chronobiological data
presented the most logistical challenges, and therefore the most missing data. However,
patients and controls did not differ in the proportions with missing PAD data, 2(3) =
2.36, p = .502. Of the sample as a whole, a detectable DLMO and viable sleep data for
calculation of PAD was provided at both timepoints by n = 28 (43.8%), at the summer
assessment only by n = 5 (7.8%), and at the winter assessment only by n = 12 (18.8%),
however n = 19 (29.7%; n = 11 controls, n = 8 patients) did not provide valid PAD data at
either assessment due to cases with a missed DLMO at Time 1 and attrition prior to Time
2. See Table 2 for valid data (%) per measure.
Assessment timing. SAD patients and controls did not differ in timing of
assessments within season, as measured in absolute number of days between the SIGHSAD interview and the seasonal solstice, in either the summer (p = .312) or winter (p =
.178) assessments. The summer SIGH-SAD occurred an average of 49.64 (SD = 31.29)
days (absolute) from the summer solstice (i.e., late May to mid-September). Similarly,
the winter SIGH-SAD interview occurred an average of 47.07 (SD = 21.05) days
(absolute) from the winter solstice (i.e., early December to mid-March).
Season order. Season order of enrollment (i.e., summer or winter as Time 1) was
comparable across groups (p = .462), with n = 30 (46.9%; n =16 patients, n = 14 controls)
having completed Time 1 in summer, and n = 34 (53.1%; n =15 patients, n = 19 controls)
having completed Time 1 in winter.
Recruitment site. Sample demographics were compared across study sites to
assess compatibility of sub-samples. A larger proportion of SAD patients included in the
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analyses were recruited in Burlington (n = 21; 67.7%) than Pittsburgh (n = 10; 32.3%),
and, conversely, a larger proportion of controls included in the analyses were recruited in
Pittsburgh (n = 19; 57.6%) than Burlington (n = 14; 42.4%), [2(1) = 4.14, p = .042].
There were significantly fewer male SAD patients recruited in Pittsburgh (n = 2; 6.9%) as
compared to Burlington (n = 10; 28.6%), [2(1) = 4.89, p = .027]. There were no
between-site demographic differences within the patient or controls groups in age (p =
.419; p = .562), seasonality as indexed by SPAQ GSS (p = .268; p = .487), or diurnal
preference measured as MEQ score (p = .125; p = .843). Proportion of seasonal
enrollment order significantly varied by study site [2(1) = 7.92, p = .005], whereby the
majority of Burlington participants completed the summer assessment at Time 1 (62.9%),
however the majority of Pittsburgh participants completed the winter assessment at Time
1 (72.4%).
Depression severity. The validity of the following analyses was contingent upon
the accurate recruiting of SAD patients and low-seasonality, never-depressed controls
during contrasting mood states at winter. To verify validity of SAD patient vs. control
status (i.e., presence of SAD symptoms in patients and absence of depression in controls),
preliminary independent samples t-tests were conducted at summer and winter between
SAD patients and controls to examine levels of depression on the BDI-II. As expected,
SAD patients endorsed moderate depression severity on the BDI-II in winter (M = 26.52,
SD = 6.69), as compared to controls whose winter depression severity fell within the
minimal range of the BDI-II (M = 1.13, SD = 1.91), t (23.59) = 13.77, p < .001. Both
groups fell within the minimal depression severity range on the BDI-II in summer,
although SAD patients scores were slightly higher (M = 4.68, SD = 4.32) than controls
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(M = 1.32, SD = 2.14), t (40.84) = 3.70, p < .001. The full patterns of within- (i.e.,
season) and between-subjects (i.e., group) effects on seasonal change in depression were
examined within a linear mixed model for BDI-II and SIGH-SAD scores, as presented
under results for Aim 2 analyses. See Table 3 for depression scores across group and
season.
Aim 1: To test whether SAD patients and controls differ in cognitive or
chronobiological vulnerabilities across seasons
Chronobiological vulnerability results. Due to the related mechanisms of
sleep/wake cycle, correlations were examined between sleep and circadian factors prior
to testing within-and between-subjects factors in PAD or PAD-6. See Table 4 for the
estimated marginal means of sleep and chronobiological measures.
In order to properly interpret group and season effects on PAD, within- and
between-subjects variability in sleep (midsleep) and melatonin timing (DLMO) were
examined separately prior to analysis of PAD. In addition to examining season and
patient group effects, the chronobiological measures were also tested for the following
effects shown to be associated with variability in circadian function: age, diurnal
preference, and study site (i.e., proxy for latitudinal difference in photoperiod).
Additionally, chronobiological measures were also tested for sampling effects due to
completer status and season order.
The average clock time of midsleep, as occurring across the 7 days prior to
DLMO collection, was examined for individual-level variability to assess for fit to a
linear mixed model. The unconditional means model yielded an ICC of .87, indicating
87% of variance in midsleep is attributable to variation at the individual level. The
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unconditional growth model indicated a nonsignificant random variation across time (p =
.487). Therefore, a fixed effects linear mixed model was applied. The model was built in
a stepped fashion from the intercept, including significant effects. Initial tests of potential
covariates revealed that midsleep times were not influenced by season order (p = .646), or
completer status (p = .188). These factors were dropped from the model. However, there
were significant fixed effects of age (p < .001), study site (p = .033), and MEQ (p =
.024), and sex (p < .001) on midsleep timing. There were no significant interaction effects
between the covariates and patient status or season. To reduce unknown error, age, study
site, MEQ, and sex were jointly included in the final model as fixed covariates. The final
model tested midsleep as a linear function of season with participant entered as a random
effect; season, patient status, and the interaction of patient status by season entered as
fixed factors; and with age, study site, MEQ, and sex included as fixed covariates. The
effects of MEQ and sex became nonsignificant in the final model (p = .826; p = .059,
respectively). There was a significant fixed covariate main effect of age [F(1, 56.36) =
23.05, p < .001, 2 = .434], whereby older age was associated with earlier midsleep times
(b = -.04, SE = -.01). The effect of study site also remained significant, [F(1, 53.69) =
9.76, p = .003, 2 = .108], indicating that Burlington participants averaged later midsleep
clock times (M = 3.10, SD = 1.02) than Pittsburgh participants (M = 2.48, SD = 0.80).
Average midsleep occurred at M = 2.92 (SD = 1.00). Of note, there were no significant
interactions of age or site by patient status or season. The model did not yield significant
effects of interest for season (p = .426), patient status (p = .813), or the interaction of
patient status by season (p = .769), reflecting comparable timing in midsleep between
patients and controls at summer, at winter, as well as comparable degrees of seasonal
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variation in midsleep across groups. See Table 4 for the estimated marginal means by
group and season, as adjusted for the effects of age and site.
An unconditional model for DLMO clock time was also examined for fit to the
linear mixed model, which yielded an ICC of .58, indicating 58% of the variance in
DLMO occurs at the individual level. The unconditional growth model yielded a
nonsignificant random variation by season, which implicated application of a fixed
effects model. A linear mixed model was built sequentially testing effects of season,
patient status, and the patient status by season interaction, and influences by confounding
factors related to circadian rhythms (e.g., study site, age, diurnal preference as MEQ
score) or sample variability (e.g., completer status and season order). There were no
effects of season order (p = .138), completer status (p = .463), or sex (p = .080), or MEQ
(p = .364). There were significant effects of study site (p = .023), and age by season (p =
.006). There were no significant interactions of site or age by patient status. Site, age, and
age by season were included in the model. An unstructured covariance structure was
selected for the final model. The model tested DLMO as a linear function of participant
(random effect), with season, patient status, and patient status by season included as fixed
factors, and study site, age, and age by season included as fixed covariates. The model
did not reveal significant differences across seasons (p = .080) or patient status (p =
.095), or an interaction of patient status by season (p = .450), indicating similarity in
DLMO timing across groups and stability across seasonal assessments. The main effect
of site remained significant, [F(1, 47.50) = 4.26, p = .044, 2 =.081], indicating later
DLMO times in the Pittsburgh sample (b = .73 hrs, SE = .36), with the average
Burlington DLMO occurred at 20:22 (SD = 1.29), and the average Pittsburgh DLMO
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occurred at 21:05 (SD = 1.50), as averaged across seasons. There was not a significant
site difference by season. However, descriptively, the Pittsburgh DLMOs occurred an
average of 36.96 minutes later than Burlington in summer, and an average of 49.63
minutes later than Burlington in winter. The direction of site variability in summer
DLMO difference was consistent with documented difference between laboratory and athome saliva collection. Prior research has found that laboratory DLMOs occur an average
of 37 (+/- 19) minutes later than at-home collection in the same participants (Pullman,
Roepke, & Duffy, 2012). The DLMO difference across sites, which was larger in winter,
may reflect the compound effects of sampling method differences and the shorter winter
photoperiod in Vermont. There was also a significant effect of age by season [F(1, 37.80)
= 4.51, p = .040, 2 = .105] on DLMO clock times. The simple slopes analysis revealed
that older participants averaged later DLMO times (i.e., 45 minutes) in winter than older
participants in summer [(b = .75), t = 2.06, p = .045], whereas younger participants did
not exhibit significant seasonal variation (p = .670). See Table 4 for the estimated
marginal means for DLMO by group and season, adjusted for effects of age and site.
Hypothesis 1: PAD. The unconditional model for PAD yielded an ICC of .54,
indicating 54% of the variance in PAD is attributable to inter-individual variation. The
unconditional growth model revealed a nonsignificant effect of season, indicating a fixed
effects model is appropriate. Therefore, a fixed effects linear model was applied to
examine the within- and between-subjects patterns of PAD. The model was built in a
stepped fashion adding the effects of season, patient status, patient status by season, and
potential covariates sequentially. Study site, age, MEQ, season order, and completer
status were all examined as covariates for potential inclusion in the model. The model
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building yielded nonsignificant effects for age (p = .567), sex (p = .785), MEQ (p = .674),
season order (p = .160), and completer status (p = .786). Consistent with the site
differences in DLMO, there was a significant fixed effect for study site (p = .001) on
PAD. Therefore, site was included in the final model as a fixed covariate. An
unstructured covariance structure was applied to the model to allow maximum flexibility
across observations. The final model tested PAD as a linear function of participant
(random effect), with season, patient status, and the patient status by time interaction term
as fixed factors, and study site included as a fixed covariate. Contrary to the hypothesized
effects, the model yielded nonsignificant effects for season (p = .836) and patient status
(p = .161), and patient status by season (p = .836), indicating comparable PAD across
seasons and group, with a sample average PAD of M = 6.32 hours (SD = 1.27). There
was a significant fixed effect of site [F(1, 49.18) = 13.61, p = .001, 2 = .086], whereby
Burlington participants exhibited longer PAD collapsing across seasons (M = 6.63, SD =
0.94) than Pittsburgh participants (M = 5.57, SD = 1.64), (b = -1.27, SE = 0.36). The
longer PAD in Vermont appears to be due to both earlier occurring DLMO and later
occurring midsleep times, relative to the Pittsburgh sample. Of note, the effect of patient
status was nonsignificant (p = .638) prior to adding study site to the model, which
suggests that the effect of site is not masking an effect of patient status. Examination of
the model residuals revealed one influential outlier (z = -3.51), a control participant who
exhibited a uniquely short PAD in winter (PAD = 2.47 hr) relative to the other control
participants, M = 6.73 (SD = 1.29). A square root transformation did not correct for nonnormality associated with the outlier due to the degree of departure from the mean.
Removal of this outlier corrected the normality of residuals. The outlier was removed to
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improve precision of the group mean for the sample, given the lack of individual growth
resolution in the current statistical model. However, the outlier is deemed a valid data
point to be noted as variability within the control population. The reduced model revealed
a significant main effect for season [F(1, 30.50) = 7.04, p = 013, 2 = .001], whereby
winter PADs averaged longer (M = 6.61, SE = .16) than summer PADs (M = 6.24, SE =
.15)., with winter PADs averaging 25 minutes longer than summer PADs (b = -0.41, SE
= .20). There was also a main effect of patient status [F(1, 43.19) = 4.51, p = 039, 2
=.016] whereby controls exhibited longer PADs, collapsing across seasons, (M = 6.73,
SE = .20) than patients (M = 6.12, SE = .20), with control PADs averaging 38 minutes
longer than patient PADs (b = -.64, SE = .32). There was not a significant interaction of
patient status by season (p = .811). The aforementioned effect of site remained significant
in the reduced model [F(1, 45.91) = 13.86, p = .001, 2 =.163]. There were not
interaction effects of site by season or patient status. See Table 4 for estimated marginal
means of PAD by group and season after removal of the outlier.
Hypothesis 2: PAD-6. The unconditional model yielded an ICC of .25, indicating
that 25% of the variance in PAD-6 is attributable to variability at the individual level. The
unconditional growth model yielded a nonsignificant effect of season, implicating a fixed
effects model. A fixed effects linear model was utilized to test within- and betweensubjects effects of PAD-6. There were no significant effects of site (p = .204), completer
status (p = .338), season order (p = .684), sex (p = 227), or age (p = .246). PAD-6 was
modeled as a linear function of patient status, season, and the interaction. Examination of
residuals revealed outlier influence by the same case as identified in the PAD analysis (z
= 1.88). Contrary to the PAD analysis, a square-root transformation performed on the
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PAD-6 outcome measure corrected non-normality of residuals for retention of the outlier.
MEQ remained the only significant covariate, and was included in the final model.
Testing for MEQ confounding effects is of particular importance when comparing
patterns of PAD and PAD-6 given that chronotype is associated with inter-individual
variation in intrinsic period and natural phase angle of entrainment to light (Duffy, Djik,
Hall, & Czeisler, 1999; Duffy, Rimmer, & Czeisler, 2001; Emens et al., 2009). The
inclusion of MEQ significantly improved model fit. An unstructured covariance structure
was fitted to the model given that PAD-6 was expected to vary differently by season for
patients and controls. The final model tested PAD-6 (absolute deviation) as a linear
function of participant (random effect), with season, patient status, and patient status by
season entered as fixed factors, and with MEQ included as a fixed covariate. The Linear
Mixed Model results revealed nonsignificant effects of season (p = .135), and season by
patient status (p = .233). The effect of patient status remained significant, yet diminished
with the addition of MEQ, [F(1, 40.46) = 4.09, p = .039, 2 =.166], whereby controls
exhibited greater deviation from PAD-6 (M = .99 hrs, SE = .06) than patients (M = .80
hrs, SE = 06) collapsing across seasons. The significant covariate main effect for MEQ
[F(1, 51.36) = 4.67, p = .035, 2 =.122] revealed that greater morningness was associated
with greater deviation from PAD-6 (b = .01, SE = .01), whereby a 1 point increase in
morningness was associated with a 1-minute increase in deviation from PAD-6. The
patterns of significant results do not support the hypothesis for greater deviation from
PAD-6 in SAD patients than controls. See Table 4 for estimated marginal means of PAD6, adjusting for the covariate effect of MEQ, and Figure 6 for illustration of PAD-6 by
patient status and season.
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Cognitive Vulnerability Results. See Table 5 for descriptive statistics for the
cognitive vulnerabilities by patient status and season.
Hypothesis 3: Brooding rumination. It was hypothesized that SAD patients
would endorse greater brooding rumination relative to controls. An effect of season was
not expected, as rumination has been conceptualized and previously examined as a trait
tendency to ruminate (and in this case, brood) in response to sad mood. Rumination in
the fall has been shown to be predictive of depression severity the following winter in
SAD (Rohan, Sigmon, & Dorhofer, 2003; Young & Azam, 2003), and this finding has
been replicated for brooding rumination, specifically (Enggasser & Young, 2007). The
unconditional means model for the brooding rumination subscale score of the RRS
(Treynor et al., 2003) yielded an ICC of r = .69 at the participant level, indicating 69% of
the variance in brooding rumination is attributable to inter-individual variation. The
unconditional growth model yielded a nonsignificant random effect of season (p = .202)
indicating that a fixed effects model is warranted over a random effects model. A fixed
effects linear model was applied to test the effects of season, patient status, and the
interaction of patient status by season on brooding rumination subscale score.
Prior to finalizing the model, season order (i.e., season of Time 1) and completer
status (i.e., attrition) were separately tested as possible fixed effects to determine whether
these factors should be included as fixed covariates in the model. These models did not
yield significant effects for study site (p = .172), completer status (p = .622), or sex (p =
.065). There was a significant covariate effect of season order by patient status (p = .007),
indicating variability in the effect of patient status by season order. This effect was
included as a covariate in the final model, which included participant entered as a random
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effect, with season, patient status, and the interaction, patient status by season, entered as
fixed factors, and season order and season order by patient status as fixed covariates. An
unstructured covariance structure was selected given the expectation for covariances to
differ between SAD patients and controls across seasons. Examination of residuals
revealed significant non-normality (i.e., leptokurtosis) with two outliers, a patient in
winter with extreme low (z = -6.21; raw score: 0) and a patient in winter with extreme
high (z = 6.87; raw score: 13). Normality was not corrected by transformation of the
outcome, so the raw values were examined. The outliers were retained in the model as
their removal did not change the pattern of results and the points were deemed valid.
However, the exact estimates of the model should therefore be regarded with some
caution, due to violation of normality. There was a significant fixed covariate interaction
of season order x patient status [F(1, 61.93) = 9.61, p = .003, 2 = .102. A simple slopes
analysis revealed that participants enrolled in winter as Time 1 endorsed greater mean
levels of brooding rumination than participants enrolled initially in summer. The effect
was significant within both the patient [b = 7.74, t = 10.96, p < .001] and control groups
[b = 4.68, t = 2.98, p = .004], however the interaction effect indicates that the effect was
stronger in patients. There were also significant main effects of season, [F(1, 48.29) =
17.68, p < .001, 2 = .150], and patient status [F(1, 63.56) = 34.10, p < .001, 2 =.578],
and a significant interaction effect of patient status by season, [F(1, 48.29) = 17.68, p <
.001, 2 = .174], indicating differential average patterns of brooding rumination across
seasons between patients and controls. The interaction was explored graphically and via
paired comparisons to determine the nature of the effects. The simple slopes analysis
revealed significant seasonal variation in brooding rumination across summer and winter
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(i.e., significantly different from zero) for patients, [b = 3.01 (SE = .53), p < .001], but not
controls, p = 1.00. Paired contrasts revealed that SAD patients endorsed greater brooding
rumination than controls at summer [b = 3.33 (SE = .60), p < .001], and winter [b = 5.88
(SE = .68), p < .001]. Taken together, these results indicate that SAD patients endorse a
greater tendency to engage in brooding rumination in response to sad mood year-round
relative to controls, and also exhibit unique, significant seasonal variation across seasons,
with greater tendency to brood in winter, when depressed. These results support the
hypothesis that SAD patients would report more tendency to brood, which supports
brooding rumination as a cognitive risk factor in SAD. This finding is novel in
documenting the trait elevation of brooding rumination in SAD patients, relative to a
never-depressed control group, as well as by observing the significant seasonal elevation
of brooding rumination in winter in patients. See Table 5 for estimated marginal means of
brooding rumination adjusted for season order, and Figure 7 for a graphical
representation of brooding rumination estimated marginal means by patient status and
season.
For direct comparison to the extant literature, the total score of the RRS (Treynor
et al., 2003) was also examined for patterns occurring across season and patient status, as
the full RRS scale been the most widely used within the SAD literature to date, with
replicated support for the predictive effect of general rumination on winter depression
severity. The same model, as for brooding, was run with the RRS total score. The
unconditional model of the total score revealed yielded an ICC of .64 at the participant
level, indicating 64% of the variance in RRS is attributable to inter-individual variation.
The individual growth curve model yielded a nonsignificant random effect of time on
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individual growth trajectories (p = .197), implicating a fixed effects linear model. Prior to
finalizing the model, study site, completer status, and season order were tested as possible
covariates due to variability in the sample. There were not significant effects for
completer status (p = .423) or sex (p = .721). There were initial significant effects of
study site (p = .012) and season order (p = .021). There was an additional effect of season
order by patient status (p = .018). Therefore, site, season order, and season order by
patient status were jointly included as fixed covariates in the final model. The final model
tested RRS as a linear function with participant entered as a random effect; and season,
patient status, and the interaction of patient status by season entered as fixed factors, and
with site, season order and season order by patient status included as fixed covariates. An
unstructured covariance structure was fitted to the model. Including the covariates in the
final model improved model fit per the AIC and BIC indices. Examination of residuals
revealed significant violation of normality, as well as numerous outliers. A square-root
transformation corrected normality and outlier bias, and retained the same pattern of
results, and was therefore considered the final RRS model. The square-root RRS model
revealed significant covariate effects of site [F(1, 66.69) = 7.77, p = .007, 2 = .015],
whereby Burlington participants averaged greater rumination than Pittsburgh participants
(b = -.76, SE = .27). There was also a significant interaction effect of season order by
patient status [F(1, 64.49) = 6.03, p = .017, 2 = .044]. A simple slopes analysis revealed
that participants enrolled in winter as Time 1 endorsed greater mean levels of rumination
than participants enrolled in summer. The effect was significant for patients (b = 4.37, t =
12.26, p < .001), as well as controls (b = 3.61, t = 4.06, p < .001), with the interaction
indicating a stronger effect within the patient group. Regarding the hypothesized effects,
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there was a significant fixed effect of season [F(1, 47.10) = 32.55, p < .001, 2 = .262],
and a large effect of patient status [F(1, 65.02) = 37.02, p < .001, 2 = .892]. There was
also a significant patient status by season interaction [F(1, 47.28) = 26.43, p < .001, 2 =
.224], indicating differential rates of seasonal variation in RRS by patient status. The
nature of the interaction was explored graphically. A simple slopes analysis revealed that
SAD patients averaged significantly greater RRS scores in winter relative to summer (p <
.001), in contrast to the control group, which did not exhibit significant seasonal variation
(p = .675). Further, SAD patients averaged greater RRS than controls at both summer and
winter, with respective differences as M = 2.14, SE = .31, p < .001; M = 3.74, SE = .27, p
< .001. This supports the broad construct of rumination in SAD as depressed mood statedependent, as was observed for brooding-specific rumination. See Table 5 for the RRS
estimated marginal means, adjusted for covariate effects. Figure 8 illustrates average
group means by season.
Hypothesis 4: Cognitive reactivity. It was hypothesized that SAD patients would
exhibit greater cognitive reactivity (i.e., an increase in endorsed dysfunctional attitudes
across a negative mood induction) in summer than controls.
Prior to examining model effects, a manipulation check was conducted to confirm
that the dysphoric mood induction was successful in producing a negative mood, as
measured by the Visual Analog Scale (VAS). On average, the sample endorsed a mean
positive mood (i.e., defined as above the midpoint mark) at pre-induction (M = 99.81, SD
= 14.78), and a mean negative mood (i.e., defined as below the midpoint mark) at postinduction (M = 51.11, SD = 23.13). All participants evidenced an increase in VAS from
pre- to post-mood induction with a mean change in VAS of 50.00 mm (SD = 27.74).
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Accordingly, a GLM 2 by 2 Mixed ANOVA (n = 35) revealed a significant effect of
time, whereby post-induction VAS scores were significantly lower (i.e., more negative)
than pre-induction VAS scores. There was not a significant main effect of patient status
(p = .405) or a significant interaction of patient status by mood induction timepoint (preand post-induction; p = .717), indicating that the mood induction procedure was
comparably effective at inducing a negative mood for both groups.
The degree of mood reactive negative thinking (i.e., cognitive reactivity; change
in DAS score from pre- to post-mood induction) across SAD patients and controls was
examined with a linear mixed model analysis. Mood induction (pre- to post-induction)
constituted the time variable. LMM was employed due to non-independence of the
observations across time. The unconditional means model revealed an ICC of .26,
indicating that 26% of the variability in cognitive reactivity was accounted for by interindividual variability. Similar to the other analyses examining change across season, the
unconditional growth model did not converge; therefore, a fixed effects model was
applied. There were no significant covariate effects of completer status, season order, sex,
or site. Therefore, the final model tested cognitive reactivity as a linear function of
participant (random effect) by patient status and mood induction (i.e., time), with the
interaction of patient status by mood induction, included as fixed factors. Examination of
residuals revealed violation of the linearity assumption with the identification of three
outliers, all SAD patients with extreme (high or low) reactivity. Transformations did not
correct linearity. Joint removal of the outliers resulted in correction of the model, as
indicated by improvement in model fit and visual inspection of residual plots. The
reduced model revealed a significant effect of mood induction [F(1, 32.66) = 11.98, p =
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.002, 2 = .146], and a significant main effect of patient status [F(1, 49.86) = 9.77, p <
.001, 2 =164]. There was also a significant interaction of patient status by mood
induction [F(1, 32.66) = 4.77, p = .003, 2 = .059]. The interaction was explored with a
simple slopes analysis to examine the average degree of change in DAS from pre- to
post-induction between patients and controls. The simple slopes analysis revealed that
SAD patients exhibited significant cognitive reactivity in response to the negative mood
induction [b = 27.68 (SE = 5.72), p < .001], whereas the effect was not observed in
controls (p = .437). Patients showed higher DAS scores relative to controls at postinduction only [b = 34. 58, SE = 10.94, p = 003]. Regarding the removal of outliers,
inclusion of one patient with an extreme low cognitive reactivity score (raw score = -29; z
= -80.36) masked the mean interaction effect represented by the sample. Two other
outliers exhibited extreme cognitive reactivity (raw scores of 248, 186, and residuals of z
= 108.64, z = 75.31, respectively). Although inclusion of these cases did not change the
pattern of results, these cases were found to significantly skew mean estimates of change.
These cases were not included in the model due to disproportionate influence on group
change estimates; however, the data are deemed valid, and these outliers highlight likely
important variability in cognitive reactivity within the SAD patient population.
Hypothesis 5: Dysfunctional attitudes. It was hypothesized that SAD patients
would endorse more dysfunctional attitudes than controls at winter, but the groups will
not differ at summer. This finding would suggest that SAD patients hold more rigid
depressogenic attitudes than controls only when they are depressed. The DAS measured
in summer (prior to the mood induction) and winter was also examined for within- and
between-subjects effects, as a measure of cognitive vulnerability across the seasons in
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SAD. The unconditional means model was tested for cross-level variation at the
individual level, and revealed an ICC of .69, indicating 69% of variance in DAS scores is
attributable to variation at the individual level (level 2). The unconditional growth model
yielded a nonsignificant random effect of season, indicating that a fixed effects model is
implicated. There were no significant effects of completer status (p = .760), season order
(p = .529), or study site (p = .564), therefore, these factors were dropped from subsequent
models. An unstructured covariance structure provided the best fit to the model. The final
model tested DAS as a linear function of participant (random effect), with season, patient
status, and the interaction of patient status by season (fixed factors). Examination of
residuals met model assumptions. The final model revealed significant fixed effects of
season [F(1, 44.34) = .18, p = .004, 2 = .144], and patient status [F(1, 61.76) = 12.18, p
= .001, 2 = .314]. There was also a significant interaction of season by patient status
[F(1, 44.31) = 9.58, p = .003, 2 = .157], indicating that degree of seasonal variation in
DAS depended upon level of patient or control status. The interaction was examined
graphically with a simple slopes analysis to further test whether one or both slopes were
each significantly different from zero. As hypothesized, the interaction indicated
significantly greater seasonal variation in DAS across seasons unique to the patient status
[b = 18.55 (SE = 6.14), t = 4.14, p < .001], whereby SAD patients endorsed more rigid
dysfunctional attitudes in winter (M = 127.48, SE = 4.89) than summer (M = 109.13, SE =
4.94). However, control participants did not exhibit significant variation in dysfunctional
attitudes across seasons (p = .964). SAD patients and controls significantly differed in
DAS scores across seasons, with greater mean discrepancy in winter [b = 26.30, SE =
5.89, p = .002] than in summer [b = 11.69, SE = 5.67, p = .004]. See Table 5 for the DAS
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estimated marginal means by patient status and season. Figure 10 provides a graphical
representation of this interaction effect. This finding supports the hypothesis that SAD
patients would more strongly endorse dysfunctional attitudes in winter, within the context
of depression, supporting Beck’s cognitive theory and DAS as a correlate of SAD.
Hypothesis 6: Seasonal beliefs. It was hypothesized that SAD patients would
endorse more rigid seasonal beliefs than controls at both summer and winter assessments.
This consistent group difference across time would reflect a greater trait tendency for
patients to endorse rigid beliefs about seasons and light year-round, relative to controls.
The unconditional means model was initially tested for repeated measures variation at the
individual level (level 2). The unconditional means model yielded an ICC of r = .94 at the
participant level, indicating 94% of the variance in Seasonal Beliefs Questionnaire (SBQ)
score is attributable to inter-individual variation. The unconditional growth model yielded
a nonsignificant random effect of time on individual trajectories, indicating that a fixed
effects model is warranted. Therefore, a fixed effect linear model was utilized to examine
the within- and between-subject patterns of seasonal beliefs. Prior to finalizing the model,
study site, completer status, and season order were tested as possible covariates due to
variability in the sample. There were no significant effects for study site (p = .626),
season order (p = .086), sex (p = .815), or MEQ (p = .094). There was a significant
covariate effect of completer status (p = .002), which was then included in the final
model to account for sampling bias. An unstructured covariance structure was applied to
the model due to expected varying covariance across season. The final model tested SBQ
as a linear function of participant (random effect), with season, patient status, and patient
status by season as fixed factors, and completer status as a fixed covariate. The effect of
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completer status was retained in the model [F(1,60.89) = 10.103, p = .002], whereby
participants who completed the study averaged greater seasonal beliefs (M = 101.61, SD
= 35.95) than non-completers (M = 108.68, SD = 34.24), b = 14.24 (SE = 4.60). Of the
primary variables of interest, there was a significant main effect of season [F(1, 44.78) =
18.82, p < .001, 2 = .059], with higher SBQ scores in winter (M = 111.95, SE = 2.38)
than in summer (M = 105.22, SE = 2.17). There was also a large significant main effect
of patient status [F(1, 60.38) = 206.63, p < .001, 2 = .834], whereby SAD patients
endorsed more seasonal beliefs (M = 138.74, SE = 3.08) than controls (M = 78.3, SE =
2.91), collapsing across seasons. There was not a significant interaction of patient status
by season (p = .382) indicating comparable patterns of change in SBQ in patients and
controls. See Table 5 for estimated marginal means of SBQ by patient status and season.
See Figure 11 for a graphical depiction of the main effects of season and patient status.
Aim 2: To test the respective, predictive effects of cognitive and chronobiological
vulnerabilities on SAD depression severity across seasons.
Hypothesis 7: Between-group effects of the vulnerabilities on depression
severity. It was hypothesized that the between-group effects of the vulnerabilities would
account for variance in depression severity, above and beyond the unique effects of
patient status (SAD patient vs. control) and the main effects of the chronobiological and
cognitive predictors.
Base models were examined for the SIGH-SAD and BDI-II separately, examining
the effects of season, patient status, the interaction of patient status by season, as well as
potential confounding covariate effects due to sampling variability. The unconditional
means and growth models were examined initially. Nonsignificant random variation in
74

depression severity for the SIGH-SAD and BDI-II indicated a fixed effects model would
provide the best fit to the data. Prior to analysis of the data, residuals were examined for
model assumptions. The base model residuals for both the SIGH-SAD and BDI-II raw
scores exhibited significant non-normality. Square-root transformations on the outcome
measures corrected the normality violation of the residuals. See Table 3 for SIGH-SAD
and BDI-II depression severity mean scores (raw and transformed) by group and season
for the imputed data, with means of the original data for comparison.
To determine the effects of potential confounding factors due to the sample
variability in: study site, season order, attrition, age, sex, and diurnal preference (MEQ);
zero-order correlations were examined between these factors and the depression severity
outcome measures (SIGH-SAD and BDI-II SQRT scores); see Table 6 for correlation
coefficients. If significant, these factors were tested as fixed covariates in the last step of
base model testing. Any significant fixed covariate was included in the base model for
subsequent analyses. The SIGH-SAD SQRT scores were correlated with MEQ, such that
less morningness (i.e., more eveningness) was associated with greater depression per the
SIGH-SAD (r = -.18, p = .043). The BDI-II was significantly correlated with study site (r
= -.18, p = .047), sex (r = -.20, p = .023), and age (r = .19, p = .037). These factors were
each tested as fixed effects, separately and combined.
SIGH-SAD. The imputed unconditional means models of the SIGH-SAD total
scores yielded an average ICC of .21, estimating 21% of the variance in SIGH-SAD was
due to variability between individuals. Although the ICC below the recommended
threshold for application of LMM over GLM (ICC = .25), LMM was deemed a better fit
to the structure of the data due to nested and non-independent observations. The
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unconditional growth model with season added as a Random effect did not converge,
indicating that a fixed effects LMM was appropriate. The base SIGH-SAD model was
built over a series of steps, incrementally adding one fixed effect parameter of season,
patient status, and the interaction of patient status by season. When included as a fixed
covariate, MEQ did not significantly predict SIGH-SAD scores, nor were there
significant interactions of MEQ by patient status, or season. Therefore the final model
included participant as a random effect, with season, patient status and the interaction as
fixed factors. An unstructured covariance matrix provided the best model fit.
The SIGH-SAD base model revealed a significant main effect of season [F(1,
67.37) = 69.41, p < .001, 2 = .374], and a significant main effect of patient status [F(1,
67.37) = 141.81, p < .001, 2 = .678]. As expected, there was a also a significant patient
status by season interaction, indicating differential seasonal variation in depression
severity for patients and controls [F(1, 67.37) = 48.17, p < .001, 2 = .260]. A simple
slopes analysis was conducted to examine the nature of the interaction, and revealed that
only SAD patients exhibited significant seasonal variation between summer and winter [b
= 2.22 (SE = .23) p < .001], whereas controls did not (p = .348). Paired comparisons
further revealed that SAD patients averaged greater SIGH-SAD scores than controls at
both summer [b = 0.98, (SE = 0.15), p < .001] and winter [b = 3.01 (SE = 0.16), p <
.001]. However, the degree of depression endorsed by patients on the SIGH-SAD in the
summer was within the normal range of mood (i.e., SIGH-SAD ≥ 20 has been used as a
cutpoint for a major depressive episode). Figure 12 provides a graphical display of
averaged SIGH-SAD SQRT patterns across seasons between groups. This effect
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corroborates successful capture of seasonal depression in SAD patients, and the absence
of depression in controls, per the SIGH-SAD.
BDI-II. The patterns of the BDI-II were congruent with those exhibited by the
SIGH-SAD. The imputed unconditional means models of the BDI-II total scores (SQRT)
yielded an average ICC of .20, indicating 20% of the variance in BDI-II is due to
variability between individuals. Convergence was not met with the unconditional growth
model, when season was entered as a random effect, indicating that slopes between
individuals did not significantly randomly vary. Therefore, a fixed effect model was
employed in which season was identified as a repeated effect for model structure,
whereby the effect of time on BDI-II was tested as a fixed effect. Participant was entered
as a random effect. Therefore, BDI-II scores were tested as a linear function of season,
patient status, and patient status by season (fixed effects), participant (random effect), and
sex, site, or age (fixed covariates). Tests for significant confounds did not reveal
significant covariates effects for site, sex, or age, ns. There were also no significant
interactions of these potential covariates by patient status or season. Therefore these
factors were dropped from subsequent models.
The base model for the BDI-II included participant entered as a random factor,
with patient status, season, and the interaction of patient status by season entered as fixed
factors. An unstructured covariance matrix provided the best model fit, The BDI-II base
model revealed a significant main effect of season [F(1, 64) = 73.55, p < .001, 2 = .330],
a significant main effect for patient status [F(1, 64) = 135.35, p < .001,2 = .678], and a
significant patient status by season interaction, indicating differential seasonal variation
in average depression severity across season by group [F(1,64,) = 83.99, p < .001, 2 =
77

.378]. A simple slopes analysis was conducted to examine the nature of the interaction.
The degree of depression difference between summer to winter was significantly
different from zero for patients only b = 2.87 (SE = 0.23), p < .001, not for controls (p =
.666). Pairwise comparisons also revealed that SAD patients averaged higher BDI-II
scores than controls at both summer [b = 0.92 (SE = 0.26), p = .002] and winter [b = 3.89
(SE = .27), p < .001]. Summer BDI-II scores for SAD patients were within the normal
(euthymic mood range), with a cutpoint of BDI-II ≥ 13 used to define mild depressive
symptoms (Beck et al., 1996). See Figure 13 for a graphical illustration of the BDI-II
patterns by patient status and season. This further corroborates successful capture of
seasonal depression in SAD patients and the absence of SAD in controls per the BDI-II.
Zero-order correlations. Prior to hypothesis testing the effects of vulnerabilities
on depression, zero-order correlations were computed among independent vulnerability
variables and outcome depression variables (SIGH-SAD and BDI-II SQRT scores), see
Tables 7 and 8 for correlations between chronobiological and cognitive predictor
variables with depression outcome measures, respectively. The cognitive vulnerability
measures that remain elevated across season were all positively correlated with
depression severity (i.e., BDI-II and SIGH-SAD SQRT scores) at summer and winter at p
< .01. The state-like cognitive vulnerabilities (e.g., DAS scores) were consistently
positively correlated with depression at winter (p < .01), although cognitive reactivity
was not significantly correlated with BDI-II or SIGH-SAD at summer or winter, ns. The
chronobiological measures were less consistently related to depression outcomes.
Average midsleep clock time, DLMO clock time, and PAD were not correlated with
either BDI-II or SIGH-SAD SQRT scores in summer or winter. Absolute deviation from
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PAD-6 in winter was significantly negatively correlated with winter scores on both the
BDI-II and SIGH-SAD (p < .01).
Cognitive Vulnerability Models. The Linear Mixed Modeling results examining
effects of vulnerabilities on depression severity are presented below, by each
vulnerability measure, with results for SIGH-SAD and BDI-II (SQRT) presented in
succession. The model coefficients reflect the effect of grand-mean centered predictors
on square root-transformed outcomes. All models retained significant effects of patient
status, season, and the interaction of patient status by season. Reported below, are
findings for the additional effects of the respective vulnerabilities.
Brooding rumination. The effects of trait brooding rumination (i.e., summer
score) on SIGH-SAD (SQRT) severity was tested across a series of 4 models. Model 1
significantly improved the fit to the data beyond the base SIGH-SAD model [2(1) =
2518.80, p < .001]. Model 1 yielded a significant main effect of brooding rumination in
summer on SIGH-SAD severity, collapsing across group and season [F(1, 64) = 5.33, p =
.033], whereby greater brooding rumination predicted greater SIGH-SAD depression
severity (b = .83, SE = .04). See Table 9 for the LMM results of trait brooding rumination
(i.e., summer score) on SIGH-SAD (SQRT).
Of the BDI-II analyses with summer brooding scores, Model 1 provided the best
fit, with significantly improved fit from the BDI-II base model [2(1) = 47.10, p < .001].
Model 1 yielded a nonsignificant effect for brooding rumination summer score (p = .271).
There were no significant interaction effects for trait brooding rumination by patient
status or season on BDI-II scores. See Tables 9 and 10 for LMM results for the effect of
trait (i.e., summer) brooding rumination on SIGH-SAD, and BDI-II scores, respectively.
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Due to the significant seasonal variation in brooding rumination in SAD patients
in Aim 1 analyses, reported above, a follow-up analysis examined whether there were
differential effects when including brooding rumination scores at both summer and
winter, thereby testing the effects of concurrent brooding rumination (i.e., state brooding
rumination) on depression severity. The follow-up analysis conducted the same series of
LMM, modeling SIGH-SAD and BDI-II (SQRT) as linear functions of brooding, entered
with both summer and winter scores. Of the SIGH-SAD models, Model 1 provided the
best fit, with significantly improved fit beyond the base model, [2(1) = 32.09, p < .001].
Model 1 revealed a significant main effect for brooding rumination [F(1, 114.92) =
19.48, p < .001], whereby greater brooding predicted higher SIGH-SAD (SQRT) scores
(b = .14, SE = .03). See Table 11 for state brooding rumination effects on SIGH-SAD
(SQRT).
Brooding rumination summer and winter scores were also tested for predictive
effects on BDI-II (SQRT). Similar to the SIGH-SAD results, Model 1 was the best fitting
model for the BDI-II, whereby the inclusion of the main effect of brooding rumination
significantly improved model fit beyond the BDI-II (SQRT) base model, [2(1) = 30.29,
p < .001]. There was a significant main effect of brooding rumination on BDI-II (SQRT)
as well, [F(1, 112.13) = 24.72, p < .001]. Models 2 also yielded a significant interaction
effect of state brooding rumination by patient status [F(1, 120.92) = 11.12, p = .008]. The
interaction remained significant across Models 1-4. There was a trend toward an
interaction effect with state brooding rumination by season (p = .054) at Model 3,
although there was not a significant three-way interaction of brooding rumination by
season by patient status (p = .577) at Model 4. The effect of state brooding rumination by
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patient status was examined graphically with a simple slopes analysis as an exploratory
analysis. The analysis revealed significant slopes for both patients [b = 0.70, t = 4.05, p <
.001] and controls [b = 0.41, t = 4.87, p < .001], whereby higher state brooding
rumination predicted greater levels of concurrent depression in both groups. Contrary to
the hypothesized effect, controls evidenced a significantly steeper slope (b = 0.29, SE =
.09) than patients, indicating increased potency for brooding rumination for controls
relative to SAD patients, within the minimal range of depression endorsed by the control
sample. Implications for SAD vulnerabilities are discussed, below. See Figure 14 for a
graphical representation of the interaction. See Table 12 for LMM results for state
brooding rumination on average BDI-II (SQRT) scores.
Ruminative Response Scale (RRS). The series of SIGH-SAD models examining
trait rumination included the summer score of the RRS as a predictor of depression. The
SIGH-SAD analyses significantly improved model fit at Model 1, [2(1) = 16.90, p <
.001]. However, there were no significant effects of trait rumination on SIGH-SAD
severity (p = .089, Model 1). See Table 13 for the LMM estimates for trait rumination
(i.e., RRS, summer score) on SIGH-SAD severity across models.
The BDI-II LMM analyses testing the summer RRS score as a covariate of
depression also failed to yield a significant effect for RRS. The inclusion of RRS in the
model significantly improved model fit with Model 1 [2(1) = 1-.50, p < .001].
Congruent with the SIGH-SAD findings, there were no significant effects of trait
rumination on BDI-II scores, ns. See Table 14 for trait rumination (i.e., RRS, summer
score) effects on BDI-II SQRT scores. Taken together, these findings do not provide
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support for trait rumination, or trait brooding rumination, as a contributing vulnerabilities
to SAD severity, as measured by either the SIGH-SAD or the BDI-II.
As an exploratory aim to test the role of concurrent (i.e., state) ruminative
responding with current depression severity, a series of LMM was conducted with RRS
scores including both summer and winter scores on SIGH-SAD and BDI-II SQRT scores.
Model 1 of the SIGH-SAD analyses provided significant better fit than the base model,
and the best fitting model, [2(1) =36.75, p < .001]. There was also a significant main
effect for RRS [F(1, 118.68) = 26.00 p < .001], indicating that endorsed tendency to
ruminate was associated with concurrent mood (b = .04, SE = .01), for both patients and
controls. There were no significant interactions of state rumination by patient status or
season on SIGH-SAD scores. See Table 15 for the LMM results of state rumination on
SIGH-SAD (SQRT) scores.
Model 3 of the BDI-II analyses yielded the best fit, [2(1) = 5.98, p = .032].
Model 3 also revealed a significant main effect of RRS [F(1, 125.60) = 42.80, p < .001],
as well as significant interaction effects of rumination by patient status [F(1, 121.92) =
11.73, p = 004], and rumination by season [F(1, 84.82) = 8.53, p = .006]. There was not a
significant 3-way interaction between rumination, patient status, and season in Model 4
(p = .572), therefore the 2-way interactions were examined with simple slopes analyses.
Regarding the effect of rumination by patient status, the simple slopes analysis revealed
that rumination had a stronger association with depression severity (BDI-II SQRT scores)
in patients, yet the effect was significant in patients [b = 0.2, t = 4.36, p < .001] and
controls [b = 0.1, t = 5.52, p < .001]. The evidence for association of rumination with
depression in both patients and controls may indicate that rumination is related to
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depression severity, regardless of threshold (i.e., severe or minimal). Given, that this
analysis included both summer and winter scores of depression and rumination, this
effect is likely masking variability in SAD severity across seasons, as well. See Figure 15
for the interaction of state rumination and patient status on BDI-II depression severity
(SQRT). The significant interaction of rumination by season indicated that the effect of
RRS on BDI-II scores varied by season. The simple slopes analysis revealed that
rumination significantly predicted greater depression severity in winter [b = 0.07, SE
=0.01, t = 7.18, p < .001], with only a trend toward a similar effect in summer (p = .051).
Figure 16 illustrates of the seasonal variation in the magnitude of effect of rumination on
BDI-II depression. Table 16 presents for the LMM effects for state rumination on BDI-II
(SQRT).
Cognitive reactivity. Cognitive reactivity was added to the base models for
SIGH-SAD and BDI-II. The inclusion of cognitive reactivity significantly improved
model fit at Model 1 for both SIGHSAD [2(1) = 14.23, p < .001] and BDI-II [2(1) =
10.56, p < .001]. However, neither the SIGH-SAD, nor the BDI-II, series revealed
significant covariate effects of cognitive reactivity at Model 1 or across the models, ns.
See Tables 17 and 18 for LMM results for cognitive reactivity.
Dysfunctional Attitudes Scale (DAS). Inclusion of the DAS as a covariate to the
SIGH-SAD model significantly improved model fit at Model 1, [2(1) = 24.47, p < .001].
Model 1 revealed a significant main effect for DAS [F(1, 101.19) = 11.52, p = .001],
indicating that higher DAS scores were predictive of higher depression scores overall (b
= 0.01, SE = 0.03), collapsing across group and season. The main effect was maintained
across Models 1-4. However, the SIGH-SAD models did not yield significant interaction
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effects of DAS by patient status or season. See Table 19 for LMM results of DAS on
SIGH-SAD (SQRT).
The inclusion of DAS as a covariate significantly improved model fit, with Model
1 providing the best fit to the data [2(1) = 18.60, p < .001]. There was a significant main
effect of DAS [F(1, 108.25) = 9.94, p = .002]. Model 2 also yielded a significant
interaction for DAS by patient status [F(1,114.38) = 6.04, p = .015. This effect was
retained in Models 2-3. Model 4 revealed a significant 3-way interaction of DAS by
patient status and season [F(1, 84.99) = 5.15, p = .028]. Because model fit estimates may
be influenced by power, the 3-way interaction in Model 4 was explored. The nature of the
3-way interaction was explored graphically and probed with a simple slopes analysis. The
interaction revealed that the effect of dysfunctional attitudes on depression significantly
varied across season in patients (p = .006), but not in controls, ns. For patients,
dysfunctional attitudes significantly predicted greater depression in winter [b = 4.38, SE
= .20, t = 21.66, p < .001], but not summer (p = .236). In contrast, dysfunctional attitudes
were significantly predictive of greater depression severity in controls year-round, i.e., in
both summer (b = 0.02, SE = .01, t = 2.75, p = .010] and winter [b = 0.97, SE = .18, t =
5.38, p < .001]. The interaction of DAS by patient status by season is displayed in Figure
17. Additionally, see Table 20 for LMM results of DAS on BDI-II (SQRT) scores.
Seasonal Beliefs Questionnaire (SBQ). The SIGH-SAD analyses for the SBQ
revealed significantly improved model fit at Model 3 relative to Model 2 [2(1) = 28.59,
p < .001]. Model 3 yielded a significant main effect of seasonal beliefs on SIGH-SAD
[F(1, 123.18) = 21.58, p < .001, a significant interaction of SBQ by season [F(1, 91.73) =
11.82, p = .002], and Model 4 revealed a significant 3-way interaction of seasonal beliefs
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by patient status [F(1, 94.63) = 4.93, p = .043]. The 3-way interaction was interpreted
despite best fit in Model 3 due to possible power confounds. The interaction indicated
differential seasonal variation in the effect of SBQ on depression between patients and
controls. The simple slopes analysis revealed that SBQ was a significant predictor of
BDI-II score for patients, in winter [b = .03, SE = .01), t = 5.00, p < .001], but not
summer (p = .162). The pattern was reversed for controls, for which there was a
significant effect of SBQ on BDI-II in summer only [b = .03, SE = .01, t = 2.81, p <
.001], but not winter (p = .070). Pairwise comparisons of slopes indicated that the
difference between summer and winter slopes was significant for patients [b = -.04, SE =
.01, p = .001], but not controls (p = .548). Figure 18 presents a graphical display of the
interaction effect. See Table 21 for LMM results of SBQ on SIGH-SAD (SQRT).
The BDI-II models for the SBQ yielded a significantly improved model fit at
Model 1 [2(1) = 28.59, p < .001]. Model 1 yielded a significant main effect of SBQ
[F(1, 124.96) = 22.17, p < .001], indicating that greater endorsement of rigid seasonal
beliefs predicted greater levels of depression per the BDI-II, collapsing across groups and
seasons (b = .02, SE = .004). See Table 22 for the LMM results of SBQ on BDI-II
(SQRT).
Chronobiological Vulnerability Models.
PAD. The LMM analyses examining the effects of PAD on SIGH-SAD (SQRT)
yielded an improved fit with Model 1 [2(1) = 14.81, p < .001]. However, there were not
significant effects of PAD on SIGH-SAD detected across the models, ns.
The BDI-II model series for PAD retained the significant effects for season and
the interaction of patient status by season. Model 1 significantly improved model fit
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beyond the BDI-II (SQRT) base model, [2(1) = 11.93, p = .002]. However, PAD was not
a significant predictor of BDI-II scores, as evidenced by nonsignificant effects across all
models. See Table 24 for LMM results for PAD on BDI (SQRT).
PAD-6. The SIGH-SAD analysis for PAD-6 revealed significant improved fit at
Model 1 [2(1) = 16.10, p < .001]. The models did not reveal significant effects for PAD6 as a predictor of SIGH-SAD scores, ns. See Table 25 for the LMM results of PAD-6
on SIGH-SAD.
Of the BDI-II analyses for PAD-6, Model 1 yielded the best fit relative to the base
model [2(1) = 12.20, p = .001]. However, none of the models yielded significant main
effects of PAD-6, or interactions of PAD-6 by patient status or season on BDI-II scores.
Table 26 presents the LMM results for PAD-6 on BDI-II (SQRT). Taken together, these
null findings do not support the role of season variation in PAD or PAD-6 as predictive
of SAD severity. Limitations and implications are addressed, below.
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CHAPTER 5: Discussion
The current study aimed to extend the current literature in the field of SAD by
investigating the presence and prominence of proposed chronobiological and cognitive
vulnerabilities to inform a more comprehensive understanding of seasonal depression.
The state of the current literature presents a paucity of direct evidence implicating
chronobiological vulnerabilities in SAD. The majority of available evidence indirectly
infers a chronobiological mechanism based on the efficacy of light therapy as a SAD
treatment. A greater limitation of the literature, and one that this study intended to
address, is the disparateness of studies examining chronobiological and cognitive
vulnerabilities despite evidence implicating both vulnerabilities in SAD. In favor of
integrating evidence across the disciplines of clinical psychology and chronobiology, the
current project aimed to compare patterns of chronobiological and cognitive
vulnerabilities across the summer and winter between SAD patients and never-depressed
controls to determine the distinct effects in SAD. A secondary aim was to examine the
respective effects of these vulnerabilities in prediction of seasonal depression. To achieve
these aims, the project enrolled a group of SAD patients and never-depressed controls to
complete cognitive vulnerability questionnaires and collect saliva data to test
chronobiological biomarkers once during summer, when SAD patients are
characteristically euthymic, and once during winter, when SAD patients are significantly
depressed. The timing of assessments were confined to summer and winter to capture the
presence and absence of a depressive episode in the SAD group. The study design served
as a stringent test of the between-groups differences in vulnerabilities and the within-
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subjects change in vulnerability across the change in seasons (i.e., a proxy for mood state
in SAD).
Aim 1: To test whether SAD patients and controls differ in the seasonal change of
the chronobiological and cognitive vulnerabilities.
Hypothesis 1: SAD patients will show a greater degree of seasonal change in
PAD from summer to winter than controls, with a mean shortening of PAD in winter
relative to summer, indicative of a phase delay. This group effect would suggest a
seasonal circadian misalignment may be characteristic of SAD.
Prior to examining PAD, the timing of midsleep and DLMO were examined.
Regarding midsleep times, the model did not reveal significant difference in midsleep
timing across seasons, or significant variation in midsleep between groups. Midsleep
timing in the sample was significantly influenced by age, with older age associated with
earlier midsleep times. This effect is consistently supported in the literature and is
regarded as established, as recently reviewed by Adan et al. (2012). Of note, age-related
advances in sleep timing (i.e., sleep/wake cycle) are not reflective of shifts in circadian
functioning or diurnal preference (Duffy & Czeisler, 2002). In the current sample,
Burlington participants exhibited later midsleep times than Pittsburgh participants.
Similarly, the Burlington sample yielded earlier DLMOs in both summer and winter. The
summer DLMOs collected in Burlington were an average of 36.5 minutes earlier than
those collected in Pittsburgh, a difference on par with the documented difference (37
minutes) between laboratory (i.e., Pittsburgh) and at-home (i.e., Burlington) salivary
DLMO collection methods (Pullman, Roepke, & Duffy, 2012). DLMOs collected in
winter were even more discrepant by site in timing, with an average difference of 49.5
88

minutes. The increased magnitude of the site difference in DLMO at winter is likely due
to the combined effects of these sampling method differences as well as shorter winter
photoperiod in Vermont. Later midsleep and earlier DLMO timing in Vermont resulted in
longer observed PAD in the Burlington sample relative to Pittsburgh, collapsing across
seasons. This direction is consistent with the expected effects of latitude and sampling
method.
The findings of the current study do not support distinct circadian misalignment in
PAD as proposed by the Phase Shift Hypothesis (PSH). Even after removal of an
influential outlier masking significant main effects of season and patient status, the
effects were inconsistent with the PSH. As a whole, the sample exhibited an average
lengthening of PAD in winter relative to summer, with an average difference of 25
minutes longer PAD in winter. Further, the main effect of patient status revealed that
controls in the current sample averaged longer PADs than patients, with an average PAD
difference of 38 minutes longer in controls. Rather, n = 19 (61.3%) of SAD patients
exhibited a phase advance in winter relative to summer. This is near opposite that
reported in the literature, whereby an estimated minority 1/3 of SAD patients were
predicted to phase advance, rather than delay, in winter (Lewy et al., 2006). The control
group exhibited a more balanced directions of shift, with n = 18 (54.5%) exhibiting a
phase advance. It should be noted that although the PSH posits that phase delays are more
common in SAD, comparison of mean seasonal shift in PAD across individuals is not an
ideal measure to examine abnormality of circadian functioning due to the inter-individual
individual variability in intrinsic period length (i.e., cancelling out abnormal phase
advances and delays), as exhibited by opposing directions of shift. However, these effects
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were tested to examine whether the SAD patients averaged more delay than controls in
winter regardless of some variability. This sample exhibited more variability in direction
of seasonal shift in patients than has been documented in the prior literature, highlighting
important variability within the SAD population. The current findings did not support the
PSH, as patients did not exhibit unique phase delays in winter, relative to summer. In
contrast, patients and controls did not differ on PAD in either season. Although this data
cannot determine whether a pathophysiologic phase delay possibly occurs for SAD
patients outside of this sample. As the first test of seasonal shift in PAD in SAD, the
effects ought to be retested. However, the proposed PSH winter delay was not observed
within this sample of SAD patients.
Hypothesis 2: SAD patients will exhibit comparable deviation from PAD-6 to
controls in summer, and greater deviation from PAD-6 than controls in winter. A greater
deviation from PAD-6 in winter among patients than controls would suggest a circadian
misalignment in winter in SAD.
As a more robust test of the PSH, the absolute deviation from PAD-6 (hrs.) was
calculated for PAD in summer and winter. PAD-6 has been associated with near 24-hour
circadian oscillation and a naturally entrained circadian phase, as well maximum
response to light therapy in winter in SAD (Burgess et al., 2004; Duffy et al., 2001; Lewy
et al., 2006). Contrary to the hypothesized effects, the results did not yield significant
effects of season, or an interaction of season and group. There was a significant effect of
patient status in the opposite direction of the PSH, whereby controls exhibited greater
mean deviation from PAD-6 than patients. This finding is inconsistent with SAD theory
positing closer proximity to PAD-6 as related to antidepressant response to light therapy
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in SAD, as well as prior theory and findings that PAD-6 is associated with stable
circadian entrainment (Duffy et al., 2001). In the current sample, there was also a
significant covariate effect of MEQ, whereby morningness was related to increased
deviation from PAD-6. This sample of SAD patients averaged intermediate chronotype,
or “neither type,” rather than the typical “evening type” (Murray, Allen, & Trinder,
2003), whereas the controls averaged moderate morning type. The between-groups
discrepancies in morningness-eveningness and deviation from PAD-6 are consistent with
the literature that associates more extreme chronotypes with greater degrees of phase shift
due to intrinsic periods that are longer or shorter than 24 hrs (Duffy & Czeisler, 2002;
Emens et al., 2009; Wright et al., 2005). Thus, in this sample, a greater degree of
deviation from PAD-6 in controls may reflect a greater departure from a 24 hr circadian
period, as indicated by their moderate morningness. Given that prior reports of SAD
patients show significant departures from PAD-6 in winter (Burgess et al., 2004; Lewy et
al., 2006), the present finding of greater deviation in controls, may be confounded by
group differences in chronotype. The current inverse finding also brings to light the
importance of matching controls and patients on chronotype for an accurate comparison
of true circadian misalignment, by controlling for inter-individual variability in phase
angle due to individual variation in intrinsic period length. Targeted recruitment of SAD
patients who identify as evening-types may ensure enrollment of patients with longer
intrinsic periods, which is consistent with delayed sleep phase syndrome in SAD (Lee,
Rex, Nievergelt, Kelsoe, & Kripke, 2011). These patients may be more prone to exhibit
significant phase delays from summer to winter, and may be the desired sample to
examine whether abnormal seasonal phase delays are associated with greater depression
91

for some SAD patients. Similarly, enrolling patients with more extreme morningness may
also allow more adequate testing of whether significant seasonal circadian phase
advances are truly associated with SAD in a minority subset of SAD patients, as
proposed by Lewy et al. (2006). Additionally, the current sample supports the variability
of PAD-6 within the SAD group (i.e., the minimal deviation of PAD-6 during winter
depression, at least in some SAD patients), as consistent with the Burgess et al. (2004)
finding that 46% of the SAD patient sample exhibited a healthy phase angle at baseline of
light therapy, during a full Major Depressive Episode. Taken together, these findings
indicate that significant circadian misalignment is not a necessary condition for SAD
recurrence.
Hypothesis 3: SAD patients will endorse higher brooding rumination than
controls at both summer and winter assessments.
The current study tested whether brooding rumination, a maladaptive subtype of
rumination closely linked to depression severity and relapse, was also a correlate of SAD.
To date, there has been one prior study examining brooding rumination in SAD.
Enggasser and Young (2007) reported that trait brooding rumination endorsed during
summer remission was prospectively predictive of depression severity the following
winter. However, no published study to date had yet examined whether SAD patients
endorsed a distinctive tendency to brood in response to sad mood relative to neverdepressed controls. This was Aim 1 of the current study. The hypothesized effect was that
SAD patients would endorse higher brooding rumination than controls at both summer
and winter assessments, indicating a trait tendency to ruminate, and specifically, brood
(i.e., dwell on the causes, consequences, and symptoms associated with sad mood) when
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sad. The results of the current study support the hypothesis that brooding rumination is
distinct in SAD, as patients endorsed elevated brooding rumination in summer and winter
as compared to controls. The residual elevation in brooding rumination in SAD during
remission may reflect habitual learning, based on their history of depression and the
strengthening of brooding rumination as habit over the course of depressive episodes
(e.g., more opportunities to brood with more frequent depressive symptoms). Contrary to
the hypothesis, SAD patients also endorsed significant seasonal variation in brooding
rumination, with an greater endorsed tendency to brood in response to sad mood during
depression in winter, relative to remission in summer. This effect was not observed in
controls. The Response Styles Theory posits rumination as a trait tendency to ruminate in
response to sad mood (Nolen Hoeksema & Morrow, 1991), with documented stability of
rumination over time (Smith & Alloy, 2009). This trait tendency has been characterized
by a tendency to engage in rumination in the presence of, or after exposure to, a traumatic
or psychosocial stressor, whereby rumination is considered a reactive response. In
addition to demonstrating that brooding rumination magnitude is distinct in SAD, the
current study provided preliminary evidence highlighting that SAD patients exhibit
significant seasonal fluctuation of brooding rumination relative to controls.
Within the current sample, the same pattern of results was found for the broader
construct of ruminative response style (Nolen-Hoeksema & Morrow, 1991), as measured
by the total Rumination subscale score on the Ruminative Response Scale (RRS).
Patients did not endorse the expected stability of a ruminative tendency across time, but
endorsed increased tendency to ruminate in response to sad mood, when feeling sad in
winter, relative to summer. Taken together, the findings of brooding rumination and more
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general rumination, may indicate that a tendency to ruminate or brood in response to sad
mood remains a latent vulnerability year-round in SAD, but that it is the fluctuation that
occurs within the context of seasonal depression that most strongly predicts concurrent
depression severity. These findings support the implication that these styles of
maladaptive coping (i.e., brooding and rumination) may intensify with SAD episodes and
remain activated to a lesser degree year-round in SAD. The extensive literature on
brooding rumination in nonseasonal depression has found brooding rumination to be
associated with increased depression and related vulnerabilities (i.e., rejection sensitivity,
intrapersonal submissiveness, and increased suicidal ideation; Moberly & Watkins, 2008;
Pearson, Watkins, Mullan, & Moberly, 2010; Siegle, Moore, & Thase, 2004; Treynor,
Gonzalez, & Nolen-Hoeksema, 2003). Whether these vulnerabilities are associated with
brooding among SAD patients remains unknown.
Hypothesis 4: SAD patients will exhibit greater cognitive reactivity (i.e., an
increase in endorsed dysfunctional attitudes across a negative mood induction) in summer
than controls.
In Beck’s cognitive theory, sad mood induction replicates stress, under which
activation of negative core schema and negative core beliefs are activated. Beck’s
cognitive theory has been supported by the findings that remitted non-seasonally
depressed individuals exhibit greater cognitive reactivity than never-depressed controls
(Gemar, Segal, Sagrati, & Kennedy, 2001), and cognitive reactivity has also been found
to mediate the relationship between neuroticism and depression severity in nonseasonally
depressed patients (Barnhofer & Chittka, 2009; Segal, Kennedy, Gemar, Hood, Pedersen,
& Buis, 2006). To date, only one published study had examined cognitive reactivity in
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SAD (Enggasser and Young, 2007), and found evidence for significant cognitive
reactivity in SAD. The current study was the first study to compare SAD patients and
controls on cognitive reactivity and found SAD patients to exhibit a distinct increase in
dysfunctional attitudes in response to a negative mood induction. In contrast, neverdepressed controls did not exhibit significant cognitive reactivity, despite endorsing
increased sad mood to the mood induction.
Hypothesis 5: SAD patients will endorse more dysfunctional attitudes than
controls at winter, but the groups will not differ at summer. This finding would suggest
that SAD patients hold more rigid depressive attitudes than controls only when they are
depressed.
The current study replicated this effect in SAD. SAD patients in the current study
endorsed higher dysfunctional attitudes in winter relative to summer. Additionally,
patients endorsed greater dysfunctional attitudes relative to controls in both summer,
when remitted, and in winter when depressed, although the between-groups difference
was greater in winter. These findings indicate significant seasonal variation in DAS, as
consistent with Beck’s cognitive theory proposing that increased activation of negative
self-schema in response to depression is a vulnerability of recurrent depression. Taken
together with prior literature, this pattern of mood suggests state-dependent endorsement
of dysfunctional attitudes are distinct in SAD relative to never-depressed controls
(Golden, Dalgleish, & Spinks, 2006; Hodges & Marks, 1998; Rohan et al., 2003), and
that DAS scores wax and wane with SAD episodes (Hodges & Marks, 1998). Of
importance, the current findings also highlight residual elevation of dysfunctional
attitudes during remission in summer between SAD episodes indicating that the
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vulnerability is not entirely latent in nature. These findings further support dysfunctional
attitudes as a cognitive vulnerability to nonseasonal depression appears to generalize to
seasonal depression.
Hypothesis 6. SAD patients will endorse more rigid seasonal beliefs than controls
at both summer and winter assessments. This consistent group difference across time
would reflect a greater trait tendency for patients to endorse rigid beliefs about seasons
and light year-round, relative to controls.
As a potentially SAD-specific cognitive vulnerability, the study provided a novel
test of the Seasonal Beliefs Questionnaire (SBQ) between patients and controls. Relative
to other cognitive measures designed for SAD such as the Seasonal Attitudes Scale, the
SBQ was designed as a measure of rigid beliefs about the seasons and light that is less
confounded with SAD symptoms (Rohan, Nillni, Lippy, Roecklein, & Hillhouse, 2007).
In support of the hypothesis, the current study found a significant effect of patient status,
whereby SAD patients endorsed significantly greater seasonal beliefs across both seasons
than controls. Both patients and controls endorsed higher SBQ scores in the winter than
in the summer, suggesting that seasonal beliefs may be more activated within the
environmental conditions of winter for humans living at latitudes with significant
seasonal climate fluctuations. Unlike the DAS which waxes and wanes with episodes
nonseasonal depression as well as SAD (i.e., mood state-like), seasonal beliefs assessed
by the SBQ were proposed to be trait-like across the seasons. The seasonal variation
indicates that these beliefs are not entirely static across seasons; yet SAD patients
maintained consistently higher levels of seasonal beliefs year-round relative to controls,
indicating some chronicity in the vulnerability across the year. The sustained elevation of
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seasonal beliefs in patients relative to controls may be reflective of reinforcement of these
beliefs both in and out of a SAD episode. SBQ items reflect the assumptions that mood is
contingent on season and lighting conditions, and that the likelihood of reinforcement
depends on current context of seasonal conditions. For example, the SBQ belief, “I need
sunshine to be happy,” is likely reinforced for patients during the longer photoperiod in
summer, when euthymic, albeit not as much, as well as during the shorter photoperiod of
winter, when depressed. In contrast, it makes intuitive sense that endorsement of DAS
items such as, “If I do not do well all the time, people will not respect me” and “If others
dislike you, you cannot be happy” would escalate within the context of depression, but
return to normative levels when euthymic. Given the large effect size between patients
and controls in the endorsement of SBQ beliefs, these findings further support the SBQ
as a valid measure for SAD-specific rigid beliefs about the seasons and light, which are
specifically targeted in CBT for SAD.
Aim 2: To test the predictive effects of these group differences in cognitive and
chronobiological vulnerabilities on seasonal change in depression severity.
Hypothesis 7: the between-group effects of the vulnerabilities will account for
variance in depression severity, above and beyond the unique effects of group and the
chronobiological and cognitive predictors.
Chronobiological Vulnerabilities. Contrary to expectation, the current study did
not find predictive effects of PAD or deviation from PAD-6 on BDI-II or SIGH-SAD
scores. The current study examined whether PAD, or absolute deviation from PAD-6,
was associated with mood state across seasons in patients. PAD did not yield significant
correlations or predictive relations to depression severity per the BDI-II or SIGH-SAD at
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summer or winter. Due to the variability in direction of circadian shift in the measure of
PAD, absolute deviation from PAD-6 was examined as a fixed factor on depression
severity. PAD-6 has been proposed as the optimal PAD (i.e., DLMO to midsleep) in
humans, based on evidence that PAD-6 is associated with an intrinsic period close to 24
hrs and natural entrainment in healthy adults (Duffy, Rimmer, & Czeisler, 2001).
Additionally, two SAD studies to date have provided indirect evidence implicating
deviation from PAD-6 (or equivalent) as a vulnerability in SAD (Burgess et al., 2004;
Lewy et al., 2006) based on the observation that reduced deviation from PAD-6 after
light therapy was associated with better treatment response in 75% of patients. In the
current study, PAD-6 was inversely correlated with BDI-II depression severity in winter,
indicating greater PAD-6 deviation in controls. This evidence is in opposition of the
hypothesis and suggests that deviation from PAD-6 is not exclusive to SAD. The minimal
observed deviation from PAD-6 in the SAD group also highlights variability within the
SAD population regarding this proposed vulnerability. This is consistent, however, with
the prior report by Burgess et al. (2004) that a significant minority (46%) had exhibited
healthy phase angles (within 1 SD of PAD-6) at pretreatment, when clinically depressed.
Taken together, the results from the current study suggest that deviation from PAD-6 is
not a necessary or exclusive condition of SAD. Given the limited number of studies
examining PAD and PAD-6 in SAD, it remains unknown whether these samples of
patients are representative of the broader SAD population. One interesting finding is that
the SAD patients did not exhibit the distinct eveningness characteristic of SAD. PAD-6
was associated with morningness, as consistent with prior reports that morningness is
associated with longer phase angles (Emens et al., 2009). Consistent with the effect of
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chronotype on phase shift, phase delays would be expected by individuals with more
evening-type chronotype. Therefore, the effect may not have been applicable in this
sample of patients with intermediate chronotype. The question remains whether the
influence of circadian misalignment in SAD varies by chronotype. To explore this effect,
future studies ought to aim to recruit patients and controls, matched across a broad range
of chronotype in order to clarify potential circadian variability and vulnerability in SAD.
Cognitive Vulnerabilities. The current study examined whether the betweengroups effects of the cognitive vulnerabilities, as documented in Aim 1, significantly
predicted between-groups differences in seasonal depression severity. The current study
yielded a significant effect for dysfunctional attitudes, which revealed that more rigid
dysfunctional attitudes were predictive of depression severity by patients in winter, but
not in summer. Conversely, controls did not exhibit seasonal variation in the effect of
dysfunctional attitudes, although dysfunctional attitudes were predictive of depression,
albeit to a lesser degree, in controls year-round. The differential findings in the effect of
dysfunctional attitudes on depression severity in patients and controls are consistent with
the observed seasonal variation in endorsement of dysfunctional attitudes by patients
only, as well as with Beck’s cognitive theory which proposes that activation of negative
automatic thoughts and negative core schemas within the context of stressful experience
precipitates, and ultimately maintains depression severity and duration (Beck et al.,
1979). For SAD patients, winter constitutes a recurrent, external stressful context.
Contrary to the hypothesis and Beck’s cognitive theory, the current study did not provide
significant results for cognitive reactivity to a SAD mood induction as predictive of
depression severity in winter despite unique cognitive reactivity exhibited by the SAD
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group. This is the second study, to date, to test an association between cognitive
reactivity and winter depression severity in SAD. The first test of cognitive reactivity in
SAD, Enggasser and Young (2007) also failed to find support for cognitive reactivity as
predictive of SAD severity in individuals with SAD and subsyndromal SAD. Therefore,
the current finding serves as replication of the prior report by Enggasser & Young (2007).
However, Enggasser and Young (2007) were also the first to test brooding
subtype of rumination as predictive of SAD severity. They reported a significant effect of
trait brooding (i.e., summer score) on winter depression, but a nonsignificant finding for
reflective pondering, or broader rumination. Contrary to the prior report, the current
study did not yield significant effects for trait brooding or rumination scores. Rather, the
inclusion of the summer and winter scores, as the examination of the covariation in
brooding tendency with concurrent mood state, revealed a significant main effect of
brooding rumination and general ruminative response style. These findings highlight the
importance of examining the magnitude of the current ruminative response, in this case,
by self-report, as a vulnerability measure for current depression. Although SAD patients
exhibited an elevated baseline in brooding rumination relative to controls, the seasonal
variation – as additional fluctuation in rumination – was the significant predictor of
depression in the current sample.
The current findings also highlight the role of specific dysfunctional attitudes
regarding seasonal beliefs and depression severity. This theme of rigid negative attitudes
was endorsed to a greater degree in SAD patients, relative to controls, in both summer
and winter, yet both groups endorsed increased rigid seasonal beliefs in winter, within the
context of the shortened photoperiod. Consistent with the hypothesis, seasonal beliefs
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uniquely predicted depression for patients in winter. The finding of residual elevation of
seasonal beliefs in summer may reflect reinforcement of rigid seasonal beliefs in summer
and winter, as they experience recurrent pairing of summer with remission and winter
with depression over the annual course of SAD recurrence. These thoughts are currently
the targets of CBT-SAD, as they are considered to maintain seasonal patterns of
experiential avoidance, behavioral disengagement, and depression in winter. The latter
association is supported by the current study, although future research should further
examine the possible influence of seasonal cognitions on behaviors across seasons in
SAD, as well.
In summary, the current study found further evidence for rumination and
dysfunctional attitudes as predictive of depression severity. Novel findings included the
documentation of elevated brooding rumination in SAD patients, relative to controls, as
well as the contribution of state brooding rumination and rumination to depression
severity. Seasonal beliefs, as measured by the SBQ, were also significantly predictive of
depression severity, indicating these beliefs are important contributors to depression in
SAD. The between-groups differences in the cognitive vulnerabilities complicated
testing the hypothesis that between-groups differences (i.e., interactions of vulnerability
by patient status) would explain additional variance in depression severity above and
beyond the main effect of patient status, or the effect of patient status and season in the
linear mixed model. It is possible that Aim 2 main effects reported above (i.e., brooding
rumination, RRS, or DAS on SIGH-SAD; or SBQ on BDI-II,) in part reflect the betweengroups differences in vulnerability across patient status groups., although this needs to be
retested in a larger sample. As a whole, the present study provides further support for
101

cognitive vulnerabilities are significant contributing factors to depression severity, and in
this instance, SAD.
Of additional note is that rumination and brooding rumination were also
predictive of depression in controls. Despite reported elevated levels of brooding relative
to controls, brooding rumination was more predictive of depression in controls. This
finding is contrary to the hypothesized effects, and may indicate that these vulnerabilities
may be more potent for minimal levels of depression, as endorsed by the current control
group. Additionally, dysfunctional attitudes were predictive of depression within the
control group, to a lesser degree, year-round. These effects within the control group
indicate that although cognitive vulnerabilities may be distinct in seasonal variation and
potency of influence on depression in winter in SAD, non-clinically depressed
individuals are not immune to the influence of cognitive vulnerabilities on mood.
Study Limitations
The current sample presented a number of noteworthy limitations. First, the
absence of a third (i.e., fall) assessment precluded the examination of true individual
growth curve analysis. All effects were assumed to be linear, but it is possible that the
slope of change in depression or corresponding vulnerabilities may vary nonlinearly
across season depending on internal (i.e., psychological) and/or external (i.e.,
environmental) cues for seasonal mood changes.
Second, the inclusion of Pittsburgh data was intended to increase sample size and
generalizability across locations/latitude. However, the introduction of another site for the
purposes of increased power introduced unbalanced sample variability. Although there
were no between-site differences in age, sex, or ethnicity for the entire sample, or within
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either the patient or control groups, a greater number of controls were recruited in
Pittsburgh, and a greater number of patients were recruited in Burlington. Pooling of data
and condensed seasonal enrollment compromised feasibility of enrolling a truly matched
sample. The current study attempted to control for sample variability within each
analysis, although this does not replace true matching for the purposes of comparing
magnitude of vulnerabilities.
There were significant site differences in DLMO collection methods. Pittsburgh
participants completed salivary laboratory DLMO collections, whereas Burlington
participants collected salivary melatonin samples at-home. Recent research suggests
relative compatibility of laboratory and at-home sampling methods, yet with some
difference in DLMO. The study with methods most comparable to the current study
compared at-home and laboratory DLMO as collected on consecutive nights in a small
sample (n = 18) of healthy adults with sleep complaints (Pullman, Roepke, & Duffy,
2012). Comparable to the current study, participants were provided a set of dark goggles
and instructed to remain in dim light conditions from 7 hours prior, to 1 hour after, their
typical bedtime. The study revealed successful detection of DLMOs using the 3 pg/ml
threshold in 62% of individuals at-home, yet less than the 88% detected with laboratory
collection. The DLMO times significantly correlated between laboratory and at-home
collection (r = 0.85, p = .0001), yet the collection methods yielded an average difference
in DLMO timing of 37 minutes (+/- 19 minutes). The success rate of at-home DLMO
detection in the current study (i.e., 83.6 % in the Burlington sample) was comparable to
those reported in prior studies (i.e., 76% in Keijzer, Smits, Peeters, Looman, Endenburg,
Klein, 2011 and 62.5% in Pullman, Roepke, & Duffy, 2012). Laboratory DLMO
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detection in the Pittsburgh sample (83.8%) was comparable to the at-home DLMO
detection in the Burlington sample. Newly published research has revealed the
development of a salivary collection kit with an object time stamp compliance measure
for dim light and half-hourly saliva collection, which has yielded improved at-home
DLMO results, with DLMO times comparable (p < .05) to laboratory collection (Burgess,
Wyatt, Park, & Fogg, 2015). This new procedure provides promise in preserving the
reliability of circadian phase detection when collected at-home. This can affect the
validity of the saliva data, and may have compromised the validity of the saliva data in
Burlington and/or further confounded comparison of the DLMO results. Further, the
intra-assay sensitivity in the Burlington sample was below the acceptable threshold (CV:
.31) indicating variability between original and duplicate samples likely due to low
precision laboratory technique by study staff. This may have compromised the validity
and the observance of effects in the Burlington sample. Additionally, assays conducted
by SolidPhase, Inc. (Portland, ME, USA) did not include duplicates despite using the
Bühlmann Direct Saliva Melatonin Radioimmunoassay kit (ALPCO Diagnostics,
Windham, NH, USA). Therefore, the intra-assay sensitivity for the Pittsburgh DLMO
data are unknown.
Initial study procedures for Time 1 assessment in summer and Time 2 assessment
in winter were relaxed for recruitment feasibility by allowing initial enrollment of
subjects in either summer or winter, introducing further sample variability in direction of
observed SAD episode (i.e., summer 1st measuring SAD recurrence onset, and winter 1st
measuring SAD recurrence offset). The models tested for effects of season order on
patterns of vulnerabilities and depression. Of note, there were no detected effects of
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season order on the magnitude of seasonal depression, on the cognitive or
chronobiological vulnerabilities, or on the effects of the vulnerabilities on depression
severity.
Lastly, the lack of broader variation in seasonal mood precluded examination of
individual growth across seasons. Future studies ought to include broader range of
variability in SAD, by perhaps including a subsyndromal-SAD (i.e., high seasonality,
lower depression group), or a nonseasonally depression comparison (i.e., low seasonality,
higher depression group) to examine the moderation of these vulnerabilities across
depression and SAD. Further, the current sample size likely further restricted resolution
of detected effects due to the number of parameters included in Aim 2 analyses. For
example, controlling for the large effects of patient status, and moderate effects of patient
status by season on depression severity is expected to have diminished power for
detection of effects by the vulnerability covariates.
Future Directions
Cognitive Vulnerabilities. Aim 1 results replicated support for cognitive
vulnerabilities to depression in SAD, for rumination on the RRS, seasonal beliefs on the
SBQ, and dysfunctional attitudes on the DAS. The study provided further evidence for
unique endorsement of brooding-type rumination, specifically in SAD versus controls,
and new evidence for the effect of mood-state concurrent brooding and ruminative
responses that predict depression severity. Future studies ought to further examine the
possible role of cognitive vulnerabilities in SAD, as well as to replicate the findings of
brooding rumination and seasonal beliefs in SAD. Additionally, the evidence for state
rumination supports the notion of examining current ruminative behaviors, perhaps in
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response to seasonal or darkness cues, to further the theory and evidence for cognitive
vulnerabilities specific to SAD. These efforts further refine our understanding of the
maladaptive cognitive processes specific to SAD, and thereby identify potentially
important targets to address in treatments, such as CBT-SAD.
For example, given the prominence of rumination in prediction of SAD
recurrence, targeting rumination in treatment may further bolster the treatment response.
Evans et al. (2013) found that SAD treatment (LT or CBT) was associated with acute
reductions in negative automatic thought frequency and intensity, and ruminative
tendency. However, only the reductions in the content (negative automatic thoughts)
were prescriptive of reduction in SAD severity the following winter (Evans, et al., 2013).
One possible explanation may be that ruminative process is not targeted directly by CBT
mechanisms, whereby the reduction in rumination over the course of CBT-SAD may be a
consequence, rather than a cause, of the reduction in depressive severity. Mindfulnessbased cognitive therapy (MBCT) has been shown to reduce relapse in nonseasonally
depressed patients with a history of 3+ major depressive episodes (Teasdale, Segal,
Williams, Ridgeway, Soulsby, & Lau, 2000); and a recently published review of the
mechanisms for MBCT (van der Velden et al., 2015) revealed some evidence that
reduction in rumination mediated the effect of MBCT on depressive relapse. One study to
date (Fleer et al., 2014) has recently pilot-tested MBCT for SAD with treatment delivered
during summer remission consistent with MBCT for nonseasonal depression (Segal et al.,
2012). The SAD trial did not find significant effects between MBCT and wait-list control
(Fleer et al., 2014). However, it remains to be tested whether the application of
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mindfulness component to CBT-SAD delivered in winter, and targeted at rumination in
response to seasonal cues may further buffer SAD recurrence.
Chronobiological Vulnerabilities. The most important implication of these
findings for future studies examining chronobiological vulnerabilities between SAD
patients and controls is the demonstrated need to control for diurnal preference, or
intrinsic period, when comparing phase angle difference or deviation from PAD-6 across
SAD patients and controls. There is extensive evidence linking diurnal preference, and
intrinsic period, to phase angle of entrainment. Morningness, or shorter intrinsic periods
are associated with longer phase angle differences (i.e., a longer interval between
melatonin release and sleep; Duffy, Dijk, Hall, & Czeisler, 1999; Duffy, Rimmer, &
Czeisler, 2001; Mongrain, Lavoie, Selmaoui, Paquet, & Dumont, 2004). Controlling for
either intrinsic period, or the related behavioral trait, diurnal preference, by group
matching would improve accuracy of the between-groups comparison to determine
whether abnormal phase angle entrainment is truly indicative of SAD, rather than
confounded by natural individual variability in intrinsic period. Given that the current
sample was uniquely morning-type relative to other SAD samples (Lee, Rex, Nievergelt,
Kelsoe, & Kripke, 2011), it remains unclear whether SAD patients who endorse greater
eveningness, and more intrinsic circadian delays, may also exhibit abnormal deviation
from PAD-6.
A second implication, in the context of null findings for PAD abnormalities in
SAD, is the need to include multiple markers of possible chronobiological vulnerabilities
to balance the model that includes multiple measures of cognitive vulnerability. This
study served as a further step in refining the proposed vulnerabilities; however, the field
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is still in the exploratory phase in determining potential circadian biomarkers of SAD.
For example, there is recent research supporting aberrant pupillary response in SAD, as
assessed by the post illumination pupil response (PIPR; Roecklein, et al., 2013). This
study provided preliminary evidence to suggest that SAD may involve deficient retinal
response to low light levels in winter, as observed in SAD patients, but not in neverdepressed controls. These findings suggest that some SAD patients may have low light
intake in winter, which may affect the circadian photoentrainment and melatonin release
in winter. However, the influence of these effects on annual SAD recurrence remains
unknown.
Integrative Chronobiological-Cognitive Model. Future research should also test
the integrative model of SAD with a larger sample to adequately power examination of
the relative, and possible interactive, effects of chronobiological and cognitive
vulnerabilities in SAD within one model to further our understanding of the maintenance
mechanisms in SAD. Ultimately, this research could explore the possible heterogeneity in
profiles of chronobiological and cognitive risk factors in SAD (i.e., whether some load
higher on one type of vulnerability over another, versus the combination). Doing so may
improve precision of SAD assessment, and treatment referral for appropriate treatment
(i.e., light therapy vs. CBT- SAD) matched to prominent underlying vulnerabilities (e.g.,
light therapy for pronounced circadian misalignment; CBT-SAD for prominent cognitive
vulnerability), consistent with personalized medicine.
Conclusions
The current study served as a first test of the chronobiological and cognitive
components in the integrative chronobioloigcal-cognitive model of SAD. Findings
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supported that SAD patients could be distinguished from controls on the basis of several
cognitive vulnerabilities (ruminative response style, brooding, seasonal beliefs, cognitive
reactivity, and dysfunctional attitudes). The reported effects replicate prior findings on
rumination and dysfunctional attitudes, and newly implicate brooding rumination,
cognitive reactivity, and seasonal beliefs as characteristic of SAD relative to controls.
Vulnerabilities that vary across seasons (i.e., rumination, dysfunctional attitudes, and
seasonal beliefs) were more strongly related to depression severity than proposed latent
(i.e., cognitive reactivity), or trait (i.e., residual ruminative tendency during summer
remission) vulnerabilities. The patterns of effects in the current study highlight the
importance of measuring concurrent vulnerabilities with the seasonal variation in SAD
severity to fully capture the resolution of season-varying vulnerability effects.
Understanding the dynamic interplay between vulnerabilities and depression severity
across seasons in SAD may ultimately improve SAD assessment and treatment. The
current findings suggest that these maladaptive cognitive constructs and processes vary in
magnitude and potency for SAD over the annual course of seasonal change.
Contrary to the hypothesized effects, and despite the observed distinct cognitive
reactivity in SAD patients, cognitive reactivity did not predict SAD severity in the current
sample. This is the second study to date to report a null relationship between cognitive
reactivity to an induced negative mood and seasonal depression. Additionally, the current
results were inconclusive regarding a seasonal circadian phase misalignment as a
vulnerability for SAD. The variability in the sample regarding chronotype and assay
sensitivity limited the generalizability of these findings. Although the present results did
not support the phase shift hypothesis, more stringent tests are needed. Of importance, the
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current sample further indicates the importance of controlling for confounding influence
of chronotype when investigating the presence of abnormal circadian functioning in SAD
versus healthy controls.
As the chronobiological and cognitive vulnerabilities continue to be refined,
subsequent tests of an integrative chronobiological- or physiological-cognitive model for
SAD should continue to be explored. Furthered understanding of the interplay between
cognitive-behavioral and chronobiological vulnerabilities to SAD may lead allow better
informed treatment referrals (i.e., light therapy or CBT-SAD) based on the prominent
underlying vulnerabilities of the SAD patient, and ultimately improve treatment for SAD.
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APPENDIX A
Subject ID # _______

Date_____________

Ruminative Response Scale
People think and do many different things when they feel depressed. Please read each of the
items below and indicate whether you never, sometimes, often, or always think or do each one
when you feel down, sad, or depressed. Please indicate what you generally do, not what you
think you should do.
0
Almost Never

1
Sometimes

2
Often

3
Almost Always

_____ 1. Think about how alone you feel.
_____ 2. Think “I won’t be able to do my job/work if I don’t snap out of this.”
_____ 3. Think about your feelings of fatigue and achiness.
_____ 4. Think about how hard it is to concentrate.
_____ 5. Think “What am I doing to deserve this.”
_____ 6. Think about how passive and unmotivated you feel.
_____ 7. Analyze recent events to try to understand why you are depressed.
_____ 8. Think about how you don’t seem to feel anything anymore.
_____ 9. Think “Why can’t I get going.”
_____ 10. Think “Why do I always react this way.”
_____ 11. Go away by yourself and think about why you feel this way.
_____ 12. Write down what you are thinking and analyze it.
_____ 13. Think about a recent situation, wishing it had gone better.
_____ 14. Think “I won’t be able to concentrate if I keep feeling this way.”
_____ 15. Think “Why do I have problems other people don’t have?”
_____ 16. Think “Why can’t I handle things better?”
_____ 17. Think about how sad you feel.
_____ 18. Think about all your shortcomings, failings, faults, mistakes.
_____ 19. Think about how you don’t feel up to doing anything.
_____ 20. Analyze your personality to try to understand why you are depressed
____ 21. Go someplace alone to think about your feelings.
_____ 22. Think about how angry you are with yourself.

126

APPENDIX B
DAS – Form A
Subject ID # _______

Date ___________

This inventory lists different attitudes or beliefs which people sometimes hold.
Read EACH statement carefully and decide how much you agree or disagree
with the statement.
For each of the attitudes, show your answer by placing a checkmark under the
column that BEST DESCRIBES HOW YOU THINK. Be sure to choose only one
answer for each attitude. Because people are different, there is no right answer
or wrong answer to these statements.
To decide whether a given attitude is typical of your way of looking at things,
simply keep in mind what you are like MOST OF THE TIME.

1. It is difficult to be happy unless one
is good looking, intelligent, rich,
and creative.
2. Happiness is more a matter of my
attitude towards myself than the
way other people feel about me.
3. People will probably think less of
me if I make a mistake.
4. If I do not do well all the time,
people will not respect me.
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TOTALLY
DISAGREE

DISAGREE VERY
MUCH

DISAGREE
SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY
MUCH

ATTITUDES

TOTALLY AGREE

Remember that your answers should describe the way you think MOST OF THE
TIME.

5. Taking even a small risk is foolish
because the loss is likely to be a
disaster.
6. It is possible to gain another
person’s respect without being
especially talented at anything.
7. I cannot be happy unless most
people I know admire me.
8. If a person asks for help, it is a sign
of weakness.
9. If I do not do as well as other
people, it means I am an inferior
person.
10. If I fail at my work, then I am a
failure as a person.
11. If you cannot do something well,
there is little point in doing it at all.
12. Making mistakes is fine because I
can learn from them.
13. If someone disagrees with me, it
probably indicates that he does
not like me.
14. If I fail partly, it is as bad as being
a complete failure.
15. If other people know what you are
really like they will think less of
you.

128

TOTALLY
DISAGREE

DISAGREE VERY
MUCH

DISAGREE
SLIGHTLY

NEUTRAL

AGREE
SLIGHTLY

AGREE VERY
MUCH

TOTALLY AGREE

ATTITUDES

16. I am nothing if a person I love
doesn’t love me.
17. One can get pleasure from an
activity regardless of the end result.
18. People should have a reasonable
likelihood of success before
undertaking anything.
19. My value depends greatly on what
others think of me.
20. If I don’t set the highest standards
for myself, I am likely to end up a
second rate person.
21. If I am to be a worthwhile person, I
must be truly outstanding in one
major respect.
22. People who have good ideas are
more worthy than those who do
not.
23. I should be upset if I make a
mistake.
24. My own opinions of myself are
more important than others’
opinions of me.

129

TOTALLY
DISAGREE

DISAGREE
VERY MUCH

DISAGREE
SLIGHTLY

NEUTRAL

AGREE
SLIGHTLY

AGREE VERY
MUCH

TOTALLY
AGREE

ATTITUDES

25. To be a good, moral, worthwhile
person, I must help everyone who
needs it.
26. If I ask a question, it makes me
look inferior.
27. It is awful to be disapproved of by
people important to you.
28. If you don’t have other people to
lean on, you are bound to be sad.
29. I can reach important goals
without slave driving myself.
30. It is possible for a person to be
scolded and not get upset.
31. I cannot trust other people
because they might be cruel to
me.
32. If others dislike you, you cannot be
happy.
33. It is best to give up your own
interests in order to please people.
34. My happiness depends more on
other people than it does on me.
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TOTALLY DISAGREE

DISAGREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

36. If a person avoids problems, the
problem tends to go away.
37. I can be happy even if I miss out
on many of the good things in life.
38. What other people think about me
is important.
39. Being isolated from others is
bound to lead to unhappiness.
40. I can find happiness without being
loved by another person.
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TOTALLY DISAGREE

DISAGREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

DAS – Form B
Subject ID # _______

Date _____________

This inventory lists different attitudes or beliefs which people sometimes hold.
Read EACH statement carefully and decide how much you agree or disagree
with the statement.
For each of the attitudes, show your answer by placing a checkmark under the
column that BEST DESCRIBES HOW YOU THINK. Be sure to choose only one
answer for each attitude. Because people are different, there is no right answer
or wrong answer to these statements.
To decide whether a given attitude is typical of your way of looking at things,
simply keep in mind what you are like MOST OF THE TIME.

1. You can be a happy person without
going out of your way in order to
please other people.
2. I have to impress new acquaintances
with my charm, intelligence, or wit or
they won’t like me.
3. If I put other people’s needs before
my own, they should help me when I
want them to do something for me.
4. It is shameful for a person to display
his weaknesses.
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TOTALLY
DISAGREE

DISAGREE VERY
MUCH

DISAGREE
SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY
MUCH

ATTITUDES

TOTALLY AGREE

Remember that your answers should describe the way you think MOST OF THE
TIME.

5. People will like me even if I am not
successful.
6. People who have the marks of
success (good looks, fame, wealth)
are bound to be happier than people
who do not.
7. I should try to impress other people if I
want them to like me.
8. If a person I love does not love me, it
means I am unlovable.
9. I ought to be able to solve my
problems quickly and without a great
deal of effort.
10. If a person is indifferent to mean, it
means he does not like me.
11. I should be able to please
everybody.
12. Others can care for me even if they
know all my weaknesses.
13. If people whom I care about do not
care for me, it is awful.
14. Criticism need not upset the person
who receives the criticism.
15. My life is wasted unless I am a
success.
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TTALLY DISAGREE

DISAREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

16. People should prepare for the worst
or they will be disappointed.
17. I must be a useful, productive,
creative person or life has no
purpose.
18. A person should think less of himself
if other people do not accept him.
19. I do not need other people’s
approval for me to be happy.
20. I can enjoy myself even when others
do not like me.
21. My value as a person depends
greatly on what others think of me.
22. If I make a foolish statement it
means I am a foolish person.
23. If a person has to be alone for a long
period of time, it follows that he has
to feel lonely.
24. A person should be able to control
what happens to him.
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TOTALLY DISAGREE

DISAGREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

25. If a person is not a success, then his
life is meaningless.
26. A person doesn’t need to be well
liked in order to be happy.
26. A person doesn’t need to be well
liked in order to be happy.
27. If someone performs a selfish act,
this means he is a selfish person.
28. I should always have complete
control over my feelings.
29. I should be happy all the time.
30. If people consider me unattractive it
need not upset me.
31. Whenever I take a chance or risk I
am only looking for trouble.
32. A person cannot change his
emotional reactions even if he
knows they are harmful to him.
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TOTALLY DISAGREE

DISAGREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

33. I may be able to influence other
people’s behaviour but I cannot
control it.
34. People will reject you if they know
your weaknesses.
35. People should be criticized for their
mistakes.
36. One should look for a practical
solution to problems rather than a
perfect solution.
37. If I do well, it is probably due to
chance; if I do badly, it is probably
my own fault.
38. The way to get people to like you is
to impress them with your
personality.
39. Turning to someone else for advice
or help is an admission of
weakness.
40. A person should do well at
everything he undertakes.
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TOTALLY DISAGREE

DISAGREE VERY MUCH

DISAGREE SLIGHTLY

NEUTRAL

AGREE SLIGHTLY

AGREE VERY MUCH

TOTALLY AGREE

ATTITUDES

APPENDIX C
Seasonal Beliefs Questionnaire
Subject ID # _______

Date_____________

Directions: Below is a list of thoughts, attitudes, and beliefs about the seasons that people might have.
Please read each statement carefully and decide how much you agree or disagree with it. For each item,
write the number that corresponds to how much you agree or disagree with that statement in the blank
space in front of it. Answer each statement based on HOW YOU GENERALLY THINK.
1
Totally
Disagre

2
Disagree
Very Much

3
Disagree
Slightly

4
Neutral

___ 1. Winter is the best season of the year.
___ 2. I can’t be productive on dark, dreary days.
___ 3. Dark, gloomy days are depressing.
___ 4. I look forward to winter.
___ 5. Everything is easier in the summertime.
___ 6. I don’t pay much attention to the changing seasons.
___ 7. Spring is no better than any other season.
___ 8. It’s difficult to feel good on dark, dreary days.
___ 9. I’m in a fog all winter long.
___ 10. It’s hard to get up in the dark.
___ 11. I love winter.
___ 12. Sunlight doesn’t affect my mood.
___ 13. There’s something wrong with me in the winter.
___ 14. All is well if the sun is shining.
___ 15. I don’t expect much of myself in the winter.
___ 16. Dark, dreary days exhaust me.
___ 17. I can’t seem to get going on dark, dreary mornings.
___ 18. I’m a failure in the winter.
___ 19. I welcome cold winter days.
___ 20. I’m stuck in a rut in the winter.
___ 21. How I feel is irrelevant to the weather.
___ 22. I am going to have the winter blues every year.
___ 23. I’m not a winter person.
___ 24. I’m always happier when it’s warmer.
___ 25. I can’t snap out of my winter funk.
___ 26. I’m ineffective in the winter.
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5
Agree
Slightly

6
Agree
Very Much

7
Totally
Agree

APPENDIX D
Daily Diary Form
Subject ID # _______

Date __________

Instructions: Complete one diary per day, start a new form each morning.

Date:

Day of the Week:

Morning questions (complete first time upon awakening):
1. What time did you fall asleep last night?
(Note: this may be different from the time you got into bed)
2. What time did you wake up this morning?
(Note: this may be different from the time you got out of bed)
3. Please rate the quality of last night’s sleep on a scale of one to ten,
with one being defined as restless and ten being very sound.
4. How rested do you feel? Please rate this on a scale of one to ten,
with one being exhausted and ten being very refreshed.
Evening questions:
1. On a scale of one to ten, how did you feel during the day with one
defined as extremely tired and ten being rested and full of energy.
2. How many naps did you take today?

3. If so, what time did you take the naps?

4. What was the total amount of time you were asleep during those naps?

5. How much caffeine and alcohol did you have today?
6. What medications did you take today?
Medication

Dose
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Time(s) Taken

APPENDIX E
Beck Depression Inventory-II
Subject ID # _______

Date_____________

Instructions: This questionnaire consists of 21 groups of statements. Please read each group
of statements carefully, and then pick out the one statement in each group that best describes
the way you have been feeling during the past two weeks, including today. Circle the number
beside the statement you have picked. If several statements in the group seem to apply equally
well, circle the highest number for that group. Be sure that you do not choose more than one
statement for any group, including Item 16 (Changes in Sleeping Pattern) or Item 18 (Changes in
Appetite)
1. Sadness
0 I do not feel sad.
1 I feel sad much of the time.
2 I am sad all the time.
3 I am so sad or unhappy that I can't
stand it.

6. Punishment Feelings
0 I don't feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7. Self-Dislike
0 I feel the same about myself as ever.
1 I have lost confidence in myself.
2 I am disappointed in myself.
3 I dislike myself.

2. Pessimism
0 I am not discouraged about my future.
1 I feel more discouraged about my future
than I used to be.
2 I do not expect things to work out for me.
3 I feel my future is hopeless and will only
get worse.

8. Self-Criticalness
0 I don't criticize or blame myself more than
usual
1 I am more critical of myself than I used to
be.
2 I criticize myself for all of my faults.
3 I blame myself for everything bad that
happens.

3. Past Failure
0 I do not feel like a failure.
1 I have failed more than I should have.
2 As I look back, I see a lot of failures.
3 I feel I am a total failure as a person.
4. Loss of Pleasure
0 I get as much pleasure as I ever did
from the things I enjoy.
1 I don't enjoy things as much as I used to.
2 I get very little pleasure from the things I
used to enjoy.
3 I can't get any pleasure from the things I
used to enjoy.
5. Guilty Feelings
0 I don't feel particularly guilty.
1 I feel guilty over many things I have
done or should have done.
2 I feel quite guilty most of the time.
3 I feel guilty all of the time.

9. Suicidal Thoughts or Wishes
0 I don't have any thoughts of killing
myself.
1 I have thoughts of killing myself, but I
would not carry them out.
2 I would like to kill myself.
3 I would kill myself if I had the chance.
10.
0
1
2
3

11.
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Crying
I don't cry anymore than I used to.
I cry more than I used to.
I cry over every little thing.
I feel like crying, but I can't.

11. Agitation
0 I am no more restless or would up than
usual.
1 I feel more restless or wound up than
usual.
2 I am so restless or agitated that it's hard
to stay still.
3 I am so restless or agitated that I have
to keep moving or doing something.

`

17.
0
1
2
3

Irritability
I am no more irritable than usual.
I am more irritable than usual.
I am much more irritable than usual.
I am irritable all the time.

18. Changes in Appetite
0 I have not experienced any change in
my appetite.
1a My appetite is somewhat less than
usual.
1b My appetite is somewhat greater than
usual.
2a My appetite is much less than before.
2b My appetite is much greater than usual.
3a I have no appetite at all.
3b I crave food all the time.

12. Loss of Interest
0 I have not lost interest in other people or
activities.
1 I am less interested in other people or
things than before.
2 I have lost most of my interest in other
people or things.
3 It's hard to get interested in anything.

19.
0
1
3

Concentration Difficulty
I can concentrate as well as ever.
I can't concentrate as well as usual.
It's hard to keep my mind on anything
for very long.
4 I find I can't concentrate on anything.

13. Indecisiveness
0 I make decisions about as well as ever
1 I find it more difficult to make
decisions than usual.
2 I have much greater difficulty in making
decisions than I used to.
3 I have trouble making any decisions.

20. Tiredness or Fatigue
0 I am no more tired or fatigued than
usual.
1 I get more tired or fatigued more easily
than usual.
2 I am too tired or fatigued to do a lot of
the things I used to do.
3 I am too tired or fatigued to do most of
the things I used to do.

14. Worthlessness
0 I do not feel I am worthless.
1 I don't consider myself as worthwhile and
useful as I used to.
2 I feel more worthless as compared to
other people.
3 I feel utterly worthless.
15.
0
1
2

Loss of Energy
I have as much energy as ever.
I have less energy than I used to have.
I don't have enough energy to do very
much
3 I don't have enough energy to do
anything.

21. Loss of Interest in Sex
0 I have not noticed any recent change in
my interest in sex.
1 I am less interested in sex than I used
to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely

16. Changes in Sleeping Pattern
0 I have not experienced any change in
my sleeping pattern.
1a I sleep somewhat more than usual.
1b I sleep somewhat less than usual.
2a I sleep a lot more than usual.
2b I sleep a lot less than usual
3a I sleep most of the day.
3b I wake up 1-2 hours early and can't get
back to sleep.
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APPENDIX F
Structured Interview for the Hamilton Depression Rating Scale—
Seasonal Affective Disorder Version (SIGH-SAD)
Subject ID # _______ Date_____________

Have you been physically sick or ill over the last week?
YES

NO

If yes, explain:
____________________________________________________________
Have you taken any trips outside of the area since you were last here in the lab?
YES

NO

If yes, where did you go?:
____________________________________________________
What dates were you there?
__________________________________________________
Is the climate of (that location) tropical or summer-like this time of year?
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YES

NO

OVERVIEW: I’d like to ask you some questions about the past week, since last
(DAY OF WEEK). How have you been feeling since then?
H1.

What’s your mood been like this past week
(compared to when you feel OK)?

DEPRESSED MOOD (sadness,
Hopeless, helpless, worthless):

Have you been feeling down or depressed?

0 = absent
1 = indicated only on questioning
2 = spontaneously reported verbally
3 = communicated non-verbally, i.e.
facial expression, posture, voice
tendency to weep
4 = VIRTUALLY ONLY; this in
spontaneous verbal and
non-verbal communication

Sad? Hopeless? Helpless? Worthless?
In the last week, how often have you
felt (OWN EQUIVALENT)? Every day?
All day?

Have you been crying at all?

IF SCORED 1-4 ABOVE, ASK: How long have you been feeling this way?

H2.

IF OUTPATIENT: Have you been working
this week (in or out of the home)?
IF NOT: Why not?
IF WORKING: Have you been able to get
as much (work) done as you usually do
(when you’re feeling OK)?
How have you been spending your time
this past week (when not at work)?
Have you felt interested in doing (THOSE
THINGS), or do you feel you have to push
yourself to do them?
Have you stopped doing anything you used
to do? IF YES: Why?
Is there anything you look forward to?
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WORK AND ACTIVITIES:
0 = no difficulty
1 = thoughts and feelings of incapacity,
fatigue or weakness related to
activities, work or hobbies
2 = loss of interest in activity, hobbies or
work – by direct report of the patient
or indirect in listlessness, indecision
And vacillation (feels he has to push
self to do work or activities)
3 = decrease in actual time spent in
activities or decrease in
productivity. In hospital,
patient spends less than 3
hours/day in activities (hospital job
or hobbies) exclusive of ward
chores
4 = stopped working because of present
illness. In hospital, no activities
except ward chores, or fails to
perform ward chores unassisted

A1.

H3.

In the last week, have you been as
social as when you feel well?
IF NO: Tell me which fits you best.
(READ DOWN ANCHOR DESCRIPTIONS
AND RATE ACCORDINGLY.)

*SOCIAL WITHDRAWAL:

This week, how has your interest in sex

GENITAL SYMPTOMS (such as loss of

been? (I’m not asking about actual
sexual activity, but about your interest
in sex – how much you think about it.)

libido, menstrual disturbances):

Has there been any change in your interest
in sex (from when you were not depressed)?

0 = interacts with other people as usual
1 = less interested in socializing with
others but continues to do so
2 = interacting less with other people in
social (optional) situations
3 = interacting less with other people in
work or family situations (i.e., where
it is necessary)
4 = marked withdrawal from others in
family or work situations

0 = absent
1 = mild
2 = severe

Is it something you’ve thought much about?
IF NO: Is that unusual for you compared to
when you feel well? (Is it a little less or a
lot less?)
H4.

How has your appetite been this past
week? (What about compared to your
usual appetite?)

SOMATIC SYMPTOMS GASTROINTESTINAL:
0 = none
1 = loss of appetite but eating without
encouragement
2 = difficulty eating without urging:
requests or requires laxatives or
medication for G.I. symptoms

Have you had to force yourself to eat?
Have other people had to urge you to
eat? (Have you skipped meals?)
Have you had any stomach or intestinal
problems? (Have you needed to take
anything for that?)
H5.

Have you lost any weight since you
started feeling depressed or down?
IF YES: Did you lose any weight this
last week? (Was it because of feeling
depressed?) How much did you lose?

LOSS OF WEIGHT (Rate either A or B):
A. When rating by history:
0 = no weight loss
1 = probable weight loss due to current
depression
2 = definite (according to patient) weight
loss due to depression
3 = not assessed

IF NOT SURE: Do you think your
clothes are any looser on you?

B. When actual weight changes are measured:
0 = less than 1 pound loss in week
1 = greater than 1 pound loss in week
2 = greater than 2 pounds loss in week
3 = not assessed

143

A2.

A3.

A4.

A5.

Have you gained any weight in the
last week? IF YES: Was it because
of feeling depressed or down? How
much did you gain?

*WEIGHT GAIN:

In the past week, has your appetite
been greater than when you feel well
or OK? IF YES: Do you want to eat a
little more, somewhat more, or much
more than when you feel well or OK?

*APPETITE INCREASE:

In the past week, have you actually
been eating more than when you feel
well or OK? IF YES: A little more,
somewhat more, or much more than
when you feel well or OK?

*INCREASED EATING

In the last week, have you been
craving or eating more starches or
sugars?
IF YES: Have you been eating
or craving starches or sugars more
than when you feel well or OK, much
more, or has it been irresistible?

*CARBOHYDRATE CRAVING OR
EATING (in relation to total amount of
food desired or eaten)

Has it been mainly starches or mainly
sweets? Which specific foods have you
been craving?
LIST:

CIRCLE ONE
OR BOTH:

Mainly
starches

Mainly Both
sweets

CIRCLE ONE
OR BOTH:

Craving

Eating Both

0 = no weight gain
1 = probable weight gain due to current
depression
2 = definite (according to patient) weight
gain due to depression

0 = no increase in appetite
1 = wants to eat a little more than usual
2 = wants to eat somewhat more than
normal
3 = wants to eat much more than usual

0 = is not eating more than usual
1 = is eating a little more than usual
2 = is eating somewhat more than usual
3 = is eating much more than normal

0 = no change in food preference or
consumption
1 = craving or eating more
carbohydrates (starches or sugars)
than before
2 = craving or eating much more
carbohydrates than before
3 = irresistible craving or eating of
sweets or starches

Have you actually been eating more
starches or sweets, or just craving them?

USUAL TIME OF CRAVING OR EATING:
Has the (CRAVING OR EATING)
occurred at any particular time of day?
(__________o’clock)

0 = it comes and goes at various times
1 = usually morning
2 = usually afternoon or evening
3 = virtually all the time
RATER NOTE: IF BOTH CRAVING
AND EATING, RATE TIME OF EATING.
DO NOT COUNT ABOVE SCORE IN
TOTALS.
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H6.

I’d like to ask you now about your
sleeping during the past week.

INSOMNIA EARLY (INITIAL INSOMNIA):
0 = no difficulty falling asleep
1 = complains of occasional difficulty
falling asleep – i.e., more than ½
hour
2 = complains of nightly difficulty falling
asleep

Have you had any trouble falling
asleep at the beginning of the night?
(Right after you go to bed, how long
has it been taking you to fall asleep?)
How many nights this week have you
had trouble falling asleep?

H7.

During the past week, have you been
waking up in the middle of the night?
IF YES: Do you get out of bed? What
do you do? (Only go to the bathroom?)
When you get back in bed, are you able
able to fall right back asleep?

INSOMNIA MIDDLE:
0 = no difficulty
1 = complains of being restless and
disturbed during the night
2 = waking during the night – any
getting out of bed (except to void)

Have you felt your sleeping has been
restless or disturbed some nights?
H8.

What time have you been waking up in
the morning for the last time, this past
week?
IF EARLY: Is that with an alarm clock,
or do you just wake up yourself?

INSOMNIA LATE (TERMINAL
INSOMNIA):
0 = no difficulty
1 = waking in early hours of morning but
goes back to sleep
2 = unable to fall asleep again if gets
out of bed

What time do you usually wake up
(that is, when you feel well)?
A6.

Have you been sleeping more than
usual this past week?
IF YES: How much more?
IF NO: What about weekends?

*HYPERSOMNIA (Compare sleep
length to euthymic and NOT to
hypomanic sleep length. (If this cannot
be established, use 8 hours):

(What time have you been falling asleep?
Have you been taking naps? That means
you’ve been sleeping about ___ hours a day
altogether? How much time do you usually
sleep when you feel well?)

0 = no increase in sleep length
1 = at least 1 hour increase in sleep
length
2 = 2+ hour increase
3 = 3+ hour increase
4 = 4+ hour increase
Sleep length used (circle one):
euthymic (___ hrs)
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8-hour

H9.

How has your energy been this past
week?

SOMATIC SYMPTOMS GENERAL:

IF LOW ENERGY: Have you felt tired?
(How much of the time? How bad has
it been?)

0 = none
1 = heaviness in limbs, back or head.
Backaches, headaches, muscle
aches. Loss of energy and
fatigability.
2 = any clear-cut symptom

This week, have you had any aches or
pains? (What about backaches,
headaches, or muscle aches?
Have you felt any heaviness in your
limbs, back or head?
A7.

IF ACKNOWLEDGED FEELING TIRED ON
PREVIOUS ITEM: How much of the time
have you felt tired? (Every day? How much
of each day?)

0 = does not feel more fatigued than
usual
1 = feels more fatigued than usual but
this has not impaired function
significantly; less frequent than in (2)
2 = more fatigued than usual; at least
one hour a day; at least three days a week
3 = fatigued much of the time most days
4 = fatigued almost all the time

Very tired, or just a little?

H10.

*FATIGABILITY (or low energy, or
feelings of being heavy, leaden,
weighed down);

Have you been putting yourself down,
this past week, feeling you’ve done
things wrong, or let others down?
If Yes: What have your thoughts been?
Have you been feeling guilty about
anything that you’ve done or not done?
What about things that happened a long
time ago?
Have you thought that you’ve brought
(THIS DEPRESSION) on yourself in
some way?

FEELINGS OF GUILT:

0 = absent
1 = self-reproach, feels he/she has let
people down
2 = ideas of guilt or rumination over
past errors or sinful deeds
3 = present illness is a punishment:
delusions of guilt
4 = hears accusatory or denunciatory
voices and/or experiences
threatening visual hallucinations

Do you feel your being sick is a
punishment?
H11.

This past week, have you had any
thoughts that life is not worth living?
IF YES: What about thinking you’d
be better off dead? Have you had
thoughts of hurting or killing yourself?

SUICIDE:

IF YES: What have you thought about?
Have you actually done anything to hurt
yourself?
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0 = absent
1 = feels life is not worth living
2 = wishes he were dead or any
thoughts of possible death
to self
3 = suicidal ideas or gesture
4 = attempts at suicide

H12.

Have you been feeling especially tense
or irritable this past week? IF YES: Is
this more than when you are not
depressed or down?
Have you been unusually argumentative
or impatient?

ANXIETY PSYCHIC:
0 = no difficulty
1 = subjective tension and irritability
2 = worrying about minor matters
3 = apprehensive attitude apparent in
face or speech
4 = fears expressed without questioning

Have you been worrying a lot about
little things, things you don’t ordinarily
worry about? IF YES: Like what, for example?
H13.

In this past week, have you had any
of the following physical symptoms?
(READ LIST, PAUSING AFTER EACH
SX FOR REPLY. CIRCLE POSITIVE SXS.)
Have you had these only while you’ve
been feeling depressed or down?
IF YES: How much have these things
been bothering you this past week?
(How bad have they gotten? How much
of the time, or how often, have you had
them?)
Do you have any physical illness or are
you taking any medication that could be
causing these symptoms? (IF YES,
RECORD PHYSICAL ILLNESS OR
MEDICATION, BUT RATE SYMPTOMS
ANYWAY:________________________)

H14.

In the last week, how much have your
thoughts been focused on your physical
health or how your body is working
(compared to your normal thinking)?
(Have you worried a lot about being or
becoming physically ill? Have you really
been preoccupied with this?)

ANXIETY SOMATIC (physiologic
Concomitants of anxiety, such as
GI – dry mouth, indigestion, gas,
diarrhea, stomach cramps,belching
C-V – heart palpitations, headaches
Resp – hyperventilating, sighing,
having to urinate frequently,
sweating:
0 = absent
1 = mild
2 = moderate
3 = severe
4 = incapacitating

HYPOCHONDRIASIS:
0 = not present
1 = self-absorption (bodily)
2 = preoccupation with health
3 = frequent complaints, requests for
help, etc.
4 = hypochondriacal delusions

Do you complain much about how you
feel physically?
Have you found yourself asking for help
with things you could really do yourself?
IF YES: Like what, for example? How
often has that happened?
H15.

RATING BASED ON OBSERVATION
DURING INTERVIEW.

INSIGHT:
0 = acknowledges being depressed and
ill OR not currently depressed
1 = acknowledges illness but attributes
cause to bad food, overwork, virus,
need for rest, etc.
2 = denies being ill at all
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H16.

RATING BASED ON OBSERVATION
DURING INTERVIEW

RETARDATION (slowness of thought
and speech; impaired ability to
concentrate; decreased motor activity):

IF TELEPHONE INTERVIEW: Do you
feel that your speech or physical movements are sluggish? Has anyone
actually commented on this?

H17.

RATING BASED ON OBSERVATION
INTERVIEW.

0 = normal speech and thought
1 = slight retardation at interview
2 = obvious retardation at interview
3 = interview difficult
4 = complete stupor
AGITATION:

IF TELEPHONE INTERVIEW: As we
talk, are you fidgeting at all, or having
trouble sitting still? For instance, are
you doing anything like playing with your
hands or your hair, or tapping your foot?
Do others notice that you are restless?
17-ITEM TOTAL SCORE HAMILTON DEPRESSION

0 = none
1 = fidgetiness
2 = playing with hands, hair, etc.
3 = moving about, can’t sit still
4 = hand- wringing, nail biting, hairpulling, biting of lips

_______

_______

Over the past week, in the first few hours
after waking up have you been feeling
better or worse or no different from before
you go to sleep?

DIURNAL VARIATION TYPE A:

H18.

IF VARIATION: How much worse do you
feel in the (MORNING OR EVENING)?
IF UNSURE: A little bit worse or a
lot worse?

B. When present, mark the severity of
the variation:
0 = none
1 = mild
2 = severe

A8.

This week, have you regularly had a
slump in your mood or energy in the
afternoon or evening?

*DIURNAL VARIATION TYPE B:

A. Note whether symptoms are worse
After awakening or before
sleeping. If NO diurnal variation,
mark none:
0 = no variation OR not currently
depressed
1 = worse after awakening
2 = worse before going to sleep
RATER NOTE: DO NOT COUNT ABOVE SCORE IN SCALE TOTALS.

IF YES: Is it mostly in your mood or your
energy? Does it occur every day? At what
time has the slump usually begun?
(_____o’clock). When has it ended? Has
that been at least an hour before you go to
sleep? How big a slump do you have –
would you say it’s generally mild, moderate,
or severe?
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0 = no
1 = yes, of mild intensity
2 = yes, of moderate intensity
3 = yes, of severe intensity
CIRCLE ONE
OR BOTH:

Mood
Slump

Energy
Slump

NOTE: RATE ONLY SLUMPS THAT
ARE FOLLOWED BY AT LEAST AN
HOUR OF RECOVERED MOOD OR
ENERGY BEFORE SLEEP.

H19.

In the past week, have you ever suddenly

DEPERSONALIZATION AND

had the sensation that everything is
DEREALIZATION
unreal, or you’re in a dream, or cut off from
(such as feelings of unreality and from
other people in some strange way? Any spacey Nihilistic ideas):
feelings?

H20.

IF YES: Tell me about it. How bad has
that been? How often this week has that
happened?

0 = absent
1 = mild
2 = moderate
3 = severe
4 = incapacitating

This past week, have you thought that
anyone was trying to give you a hard
time or hurt you?

PARANOID SYMPTOMS:
0 = none
1 = suspicious
2 = ideas of reference
3 = delusions of reference and
persecution

What about talking about you behind
your back?
IF YES: Tell me about that.

H21.

In the past week, have there been
things you’ve had to do over and over
again, like checking the locks on the
doors several times, or washing your
hands? IF YES: Can you give me
an example?

OBSESSIONAL AND COMPULSIVE
SYMPTOMS:
0 = absent
1 = mild
2 = severe

Have you had any thoughts that don’t
make any sense to you, but that keep
running over and over in your mind?
IF YES: Can you give me an example?

21-ITEM TOTAL SCORE HAMILTON DEPRESSION
(without starred items):

_____ _____

TOTAL 8-ITEM ATYPICAL SCORE (starred items
only):

_____ _____

TOTAL 29-ITEM SIGH-SAD SCORE

_____ _____

ATYPICAL BALANCE SCORE (total 8-item
atypical score divided by total 29-item SIGHSAD score, multiplied by 100):

_____ _____ . _____

NOTE: If patient is not depressed and score is derived primarily from symptoms of hypomania
(e.g., items H4, H5, H6, H7, H8, H12, H17), administer HIGH-SAD and report both scores.
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APPENDIX G
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APPENDIX H
The Morningness-Eveningness Questionnaire
Instructions: There will be 19 questions about your daily sleep-wake habits and the times
of day you prefer certain activities. Answering should take only about 5-10 minutes. For
each question, circle the answer choice that best describes you. Base your judgments on
how you have felt in recent weeks.
Approximately what time would you get up if you were entirely free to plan your day?
1) 5:00-6:30 a.m.
2) 6:30-7:45 a.m.
1
3) 7:45-9:45 a.m.
4) 9:45-11:00 a.m.
5) 11:00 a.m. - 12:00 noon
6) 12:00 noon – 5:00 a.m.
Approximately what time would you go to bed if you were entirely free to plan your
evening?
1) 8:00-9:00 p.m.
2 2) 9:00-10:15 p.m.
3) 10:15-12:30 a.m.
4) 12:30-1:45 a.m.
5) 1:45-3:00 a.m.
6) 3:00 a.m. – 8:00 p.m.
If you usually have to get up at a specific time in the morning, how much do you
depend on an alarm clock?
3 1) Not at all
2) Slightly
3) Somewhat
4) Very much
How easy do you find it to get up in the morning (when you are not awakened
unexpectedly)?
4

1) Very difficult
2) Somewhat difficult
3) Fairly easy
4) Very easy
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How alert do you feel during the first half hour after you wake up in the morning?
1) Not at all alert
5 2) Slightly alert
3) Fairly alert
4) Very alert
How hungry do you feel during the first half hour after you wake up?
1) Not at all hungry
6 2) Slightly hungry
3) Fairly hungry
4) Very hungry
During the first half hour after you wake up in the morning, how do you feel?
1) Very tired
7 2) Fairly tired
3) Fairly refreshed
4) Very refreshed
If you had no commitments the next day, what time would you go to bed compared to
your usual bedtime?
1) Seldom or never later
8 2) Less than 1 hour later
3) 1-2 hours later
4) More than 2 hours later
You have decided to do physical exercise. A friend suggests that you do this for one
hour twice a week, and the best time for him is between 7-8 a.m. Bearing in mind
nothing but your own internal "clock," how do you think you would perform?
9 1) Would be in good form
2) Would be in reasonable form
3) Would find it difficult
4) Would find it very difficult
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At approximately what time in the evening do you feel tired, and, as a result,
in need of sleep?
10

1) 8-9 p.m.
2) 9-10:15 p.m.
3) 10:15 p.m. – 12:45 a.m.
4) 12:45-2:00 a.m.
5) 2-3 a.m.
You want to be at your peak performance for a test that you know is going
to be mentally exhausting and will last two hours. You are entirely free to
plan your day. Considering only your internal "clock," which one of the four
testing times would you choose?

11
1) 8-10 a.m.
2) 11a.m. – 1 p.m.
3) 3-5 p.m.
4) 7-9 p.m.
If you got into bed at 11 p.m., how tired would you be?
12

1) Not at all tired
2) A little tired
3) Fairly tired
4) Very tired
For some reason you have gone to bed several hours later than usual, but
there is no need to get up at any particular time the next morning. Which one
of the following are you most likely to do?

13

1) Will wake up at usual time, but will not fall back asleep
2) Will wake up at usual time and will doze thereafter
3) Will wake up at usual time, but will fall asleep again
4) Will not wake up until later than usual
One night you have to remain awake between 4-6 a.m. in order to carry out
a night watch. You have no time commitments the next day. Which one of
the alternatives would suit you best?

14 1) Would not go to bed until the watch was over
2) Would take a nap before and sleep after
3) Would take a good sleep before and nap after
4) Would sleep only before the watch
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You have to do two hours of hard physical work. You are entirely free to plan your
day. Considering only your internal "clock," which one of the following times
would you choose?
15

1) 8-10 a.m.
2) 11 a.m.- 1 p.m.
3) 3-5 p.m.
4) 7-9 p.m.
You have decided to do physical exercise. A friend suggests that you do this for one
hour twice a week. The best time for her is between 10-11 p.m. Bearing in mind
only your own internal "clock," how well do think you would perform?

16

1) Would be in good form
2) Would be in reasonable form
3) Would find it difficult
4) Would find it very difficult
Suppose you can choose your own work hours. Assume that you work a five-hour
day (including breaks), your job is interesting and you are paid based on your
performance. At approximately what time would you choose to begin?

17 1) 5 hours starting between 4 a.m. and 8 a.m.
2) 5 hours starting between 8 a.m. and 9 a.m.
3) 5 hours starting between 9 a.m. and 2 p.m.
4) 5 hours starting between 2 p.m. and 5 p.m.
5) 5 hours starting between 5 p.m. and 4 a.m.
At approximately what time of day do you usually feel your best?
1) 5-8 a.m.
18 2) 8-10 a.m.
3) 10 a.m. – 5 p.m.
4) 5-10 p.m.
5) 10 p.m. – 5 a.m.
One hears about "morning types" and "evening types." Which one of these types do
you consider yourself to be?
19

1) Definitely a morning type
2) Rather more a morning type than an evening type
3) Rather more an evening type than a morning type
4) Definitely an evening type
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Figure 1
Rohan’s Integrative Cognitive-Behavioral Model of SAD

Psychological
Appraisal/Expectation
s (anticipation of
winter)

Environmental Cues
(light, season,
weather)

Psychological Vulnerability
 Cognitive
Brooding rumination;
Dysfunctional attitudes;
Negative cognitions
regarding seasons and light
 Behavioral
behavioral disengagement,
reactivity to light and
seasonal cues

Physiological Vulnerability
 Chronobiological
Circadian misalignment;
 Expanded melatonin
release duration
 Retinal sub-sensitivity

SAD Episode
(winter depression severity)
Figure 1. An illustration of the effects tested by this project, adapted from Rohan’s
integrative cognitive-behavioral model of SAD.
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Figure 2
Temporal Relation between DLMO and Sleep

Figure 2. PAD = Phase Angle Difference (Hr); DLMO = Dim Light Melatonin Onset.
Illustration of the temporal relation between sleep/wake and circadian oscillators
during stable phase entrainment. Adapted from Lewy etl al., 2006.
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Figure 3
Average Midsleep Clock Time by Patient Status and Season

Figure 3. Midsleep = Midpoint of sleep episode. Midsleep clock times by patients
and controls across season. No significant differences were found between SAD
patients and controls, or as across summer or winter. Error bars represent standard
errors.
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Figure 4
DLMO Clock Time by Patient Status and Season

Figure 4. DLMO = Dim Light Melatonin Onset. Salivary DLMO (3 pg/ml) means
depicted by patient status and season exhibit no significant differences were found in
the timing of DLMO between patients and controls, or across summer or winter.
Error bars represent standard errors.
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Figure 5
PAD by Patient Status and Season

Figure 5. PAD = Phase Angle Difference (hr). There was a main effect of season,
whereby PAD was longer in winter, collapsing across patients and control status.
Error bars represent standard errors.
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Figure 6
PAD-6 (SQRT) by Patient Status and Season

Figure 6. PAD-6 = Absolute Deviation in Phase Angle Difference from 6 (hr). The
linear model revealed that controls exhibited greater deviation from PAD-6, than
patients, collapsing across seasons.. Morningness was a significant covariate,
whereby greater morningness predicted greater deviation from PAD-6, collapsing
across patient status and season. Error bars represented standard errors.
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Figure 7
Brooding Rumination by Patient Status and Season

Figure 7. Brooding subscale of Ruminative Response Scale (Treynor et al., 2003).
Brooding rumination total subscale score estimated marginal means depicted by
patient status and group. SAD patients exhibited a unique seasonal variation in
brooding rumination, endorsing a significantly greater tendency to brood in response
to sad mood when depressed. As expected, SAD patients endorsed significantly
greater tendency to brood than controls, across seasons.
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Figure 8
Ruminative Response Scale by Patient Status and Season

Figure 8. RRS = Ruminative Response Scale Total Score SQRT (Nolen-Hoeksema &
Morrow, 1991). Estimated marginal means by patient status and season. SAD patients
exhibited significant seasonal variation, endorsing greater RRS in winter relative to
summer, and greater RRS than controls at both time points.
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Figure 9
Cognitive Reactivity by Patient Status across a Negative Mood Induction

Figure 9. Cognitive Reactivity = DAS change from pre- to post- negative mood
induction. DAS = Dysfunctional Attitudes Scale, Form A (Weissman & Beck,1978).
Cognitive reactivity in response to a negative mood induction, as illustrated by patient
status. SAD patients exhibited a unique increase in dysfunctional attitudes (i.e.,
cognitive reactivity) from pre- to post- negative mood induction. SAD patients also
endorsed a significantly greater mean level of cognitive reactivity at post-induction
only, relative to controls.
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Figure 10
Dysfunctional Attitudes Scale by Patient Status and Season

Figure 10. DAS = Dysfunctional Attitude Scale (Weissman & Beck,1978). Estimated
marginal mean DAS scores by patient status and season, indicating that SAD patients
exhibit unique seasonal variation in dysfunctional attitudes. Winter scores were
significantly different from summer scores for patients only. Patients endorsed
significantly greater levels than controls in both summer and winter, with a greater
between-group difference in winter.
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Figure 11
Seasonal Beliefs Questionnaire by Patient Status and Season

Figure 11. SBQ = Seasonal Beliefs Questionnaire (Rohan, Nillni, Lippy, Roecklein, &
Hillhouse, 2007) estimated marginal means by patient status and season, depicting that
SAD patients endorse greater seasonal beliefs than controls, collapsing across seasons.
Additionally, there was significant seasonal variation, as both patients and controls
endorsed greater SBQ scores in winter, relative to summer.
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Figure 12
SIGH-SAD (SQRT) Estimated Marginal Means by Patient Status and Season

Figure 12. SIGH-SAD = Structured Interview Guide for the Hamilton Depression
Rating Scale, Seasonal Affective Disorder Version (Williams et al., 1992). Square-root
transformed SIGH-SAD estimated marginal means depicting unique seasonal variation
by SAD patient relative to controls, with averaged patient scores significantly greater in
winter, yet comparable in summer, as characteristic of SAD. Error bars represent
standard errors.
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Figure 13
BDI-II (SQRT) Estimated Marginal Means by Patient Status and Season

Figure 13. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996).
BDI-II square root transformed estimated marginal means display a unique seasonal
variation in BDI-II core by SAD patients, with significant greater depression in winter,
as characteristic of SAD. Error bars represent standard errors.
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Figure 14
BDI-II (SQRT) by State Brooding Rumination and Patient status

Figure 14. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996);
Brooding subscale of Ruminative Response Scale (Treynor et al., 2003). BDI-II square
root transformed estimated marginal means display variation in BDI-II (SQRT) score
by state brooding rumination, whereby higher levels of brooding were significantly
associated with greater levels of rumination, for both patients and controls. Contrary to
the hypothesized effects, state brooding rumination was more strongly associated with
depression severity within controls. Error bars represent standard errors.
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Figure 15
BDI-II (SQRT) by State Rumination and Patient Status

Figure 15. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996);
Ruminative Response Scale Total Score (Nolen-Hoeksema & Morrow, 1991). BDI-II
square root transformed estimated marginal means display variation in BDI-II
(SQRT) score by state rumination, whereby higher levels of brooding were
significantly associated with greater levels of rumination, for both patients and
controls, with a stronger effect within the patient group.
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Figure 16
BDI-II (SQRT) by State Rumination and Season

Figure 16. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996);
Ruminative Response Scale Total Score SQRT (Nolen-Hoeksema & Morrow, 1991).
A 2-way interaction of state rumination by season on BDI-II (SQRT) revealed that
rumination significantly predicted greater depression scores in winter only, with a
trend toward significance in summer.
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Figure 17
BDI-II (SQRT) by Dysfunctional Attitudes, Patient Status, and Season

Figure 17. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996);
DAS = Dysfunctional Attitudes Scale (Weissman & Beck, 1978). BDI-II square root
transformed estimated marginal means display a 3-way interaction, whereby the
effect of DAS on BDI-II varied by patient status and season. DAS significantly
predicts BDI-II severity for patients in winter, but not summer, whereas DAS predicts
minimal BDI-II severity in controls year-round.
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Figure 18
SIGH-SAD (SQRT) by Seasonal Beliefs, Patient Status, and Season

Figure 18. SIGH-SAD: Structured Interview Guide for the Hamilton Depression
Rating Scale, Seasonal Affective Disorder Version (Williams et al., 1992); SBQ =
Seasonal Beliefs Questionnaire (Rohan, Nillni, Lippy, Roecklein, & Hillhouse, 2007).
SIGH-SAD (SQRT) as predicted by SBQ by patient and season. SBQ was a
significant predictor of depression for patients in winter, but not summer.
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Table 1
Sample Characteristics
Total Sample
SAD
Controls
2
Characteristic
(N = 64)
(n = 31)
(n = 33)
t/c df
p
________________________________________________________________________
Age, Mean (SD)
Sex, Number (%)
Female
Male

45.5 (13.0)

52 (81.3)
12 (18.8)

49.0 (11.2)

23 (74.2)
8 (25.8)

42.2 (13.9)

2.2 61

.034

2.0

1

.161

4.2* 1

.041

12.9 40
-2.0 62

.000
.044

29 (87.9)
4 (12.1)

Race, Number (%)
Caucasian
African American
American Indian
Asian
Hispanic

52 (81.3)
5 (7.8)
4 (6.3)
2 (3.1)
1 (1.6)

22
3
4
1
1

(71.0)
(9.7)
(12.9)
(3.2)
(3.2)

30 (90.9)
2 (6.1)

SPAQ, Mean (SD)
MEQ, Mean (SD)

9.1 (7.2)
53.9 (9.0)

5.8 (4.7)
51.6 (8.3)

3.3 (2.4)
56.1 (9.2)

1 (3.0)

Note. *The Chi square statistic reflects comparison of Caucasian vs. other between patients
and controls. SPAQ = Seasonal Pattern Assessment Questionnaire (Rosenthal et al., 1987);
MEQ = Morningness-Eveningness Questionnaire (Horne & Östberg, 1976).
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Table 2
Patterns of Included Data (N = 64)
Summer
Winter
________________________________________________________________________
SAD
Controls
SAD
Controls
(n = 28)
(n = 25)
(n = 23)
(n = 31)
_______________________________________________________________________________________________________
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BDI-II, Number (%)

28 (90.3)

25 (75.8)

23 (74.2)

31 (93.9)

SIGH-SAD, Number (%)

27 (87.1)

25 (75.8)

23 (74.2)

31 (93.9)

RRS, Number (%)

28 (90.3)

25 (75.8)

22 (71.0)

31 (93.9)

DAS, Number (%)

26 (83.9)

23 (69.7)

22 (71.0)

29 (87.9)

Cognitive Reactivity, Number (%)

24 (77.4)

11 (33.3)

-

-

SBQ, Number (%)

28 (90.3)

25 (75.8)

23 (74.2)

31 (93.9)

MEQ, Number (%)

28 (90.3)

25 (75.8)

23 (74.2)

31 (93.9)

Midsleep, Number (%)

22 (71.0)

19 (57.6)

22 (71.0)

25 (75.8)

DLMO, Number (%)

19 (61.3)

17 (51.5)

19 (61.3)

21 (63.6)

PAD, Number (%)*

17 (54.8)

16 (48.5)

19 (61.3)

21 (63.6)

Note. BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996), SIGH-SAD = Structured Interview Guide for
the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version (Williams et al., 1992); RRS = Ruminative
Response Scale (Nolen-Hoeksema & Morrow, 1991); DAS = Dysfunctional Attitudes Scale Form A (Weissman & Beck,1978);
SBQ = Seasonal Beliefs Questionnaire (Rohan, Nillni, Lippy, Roecklein, & Hillhouse, 2007); MEQ = Morningness –
Eveningness Questionnaire (Horne & Östberg, 1972); Midsleep = Midpoint of Sleep; DLMO = Dim Light Melatonin Onset;
PAD = Phase Angle Difference. *PAD-6 calculations were derived from PAD data, therefore missing data patterns for PAD
and PAD-6 are identical.
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Table 3
Depression Outcome Variable Descriptives (N = 64)

Summer
Winter
______________________________________________________________________________
SAD
Controls
SAD
Controls
(n = 28)
(n = 25)
(n = 23)
(n = 31)
_______________________________________________________________________________________________________________________
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BDI-II
Original Data
Raw Mean (SD)
SQRT Mean (SD)
Imputed Data (N = 64)
Raw Mean (SD)
SQRT Mean (SD)

4.7 (4.2)
1.8 (1.2)

1.3 (2.1)
0.7 (1.0)

26.5 (8.7)
5.1 (0.8)

1.1 (1.9)
0.6 (0.9)

4.5 (4.1)
1.8 (1.2)

1.7 (2.1)
0.9 (1.0)

22.8 (10.0)
4.7 (1.0)

1.8 (3.2)
0.8 (1.1)

SIGH-SAD
Original Data
Raw Mean (SD)
9.1 (4.1)
4.2 (3.8)
30.9 (6.8)
4.6 (3.4)
SQRT Mean (SD)
2.9 (0.8)
1.7 (1.3)
5.5 (0.6)
2.0 (0.8)
Imputed Data (N = 64)
Raw Mean (SD)
8.8 (4.0)
4.7 (3.6)
26.9 (9.1)
5.3 (4.5)
SQRT Mean (SD)
2.8 (0.7)
1.9 (1.1)
5.1 (0.9)
2.1 (1.0)
______________________________________________________________________________________________________________________
Note: BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996); SIGH-SAD = Structured Interview Guide for the Hamilton
Depression Rating Scale, Seasonal Affective Disorder Version (Williams et al., 1992); SQRT = Square root transformed Mean. Descriptive means
of depression severity are presented by patient status and controls in summer and winter, with raw and transformed outcomes. Imputed data means
reflect grand means across 20 imputations.

Table 4
Aim 1 Chronobiological Vulnerability Results, Estimated Marginal Means

Summer
Winter
__________________________________________________________
SAD
Controls
SAD
Controls
(n = 22)
(n = 19)
(n = 22)
(n = 25)
______________________________________________________________________________
Midsleep, Mean (SE)

2.9 (0.1)

2.9 (0.2)

3.0 (0.2)

2.9 (0.2)

20.9 (0.3)

20.4 (0.3)

20.8 (0.3)

20.1 (0.3)

PAD, Mean (SE)

6.0 (0.2)

6.5 (0.2)

6.3 (0.2)

6.9 (0.3)

PAD-6
Raw Mean (SE)
SQRT, Mean (SE)

0.6 (0.1)
0.7 (0.1)

1.1 (0.1)
1.0 (0.1)

1.1 (0.2)
0.9 (0.1)

1.2 (0.2)
1.0 (0.1)

DLMO, Mean (SE)

Note. Estimated marginal means of chronobiological vulnerabilities adjusted for significant influence by
season and patient status in Aim 1 analyses. Midsleep = Midpoint of sleep; DLMO = Dim Light Melatonin
Onset (3 pg/ml); PAD = Phase Angle Difference; PAD-6 = Absolute deviation from PAD - 6 hr; PAD-6
SQRT = square root transformation of PAD-6.
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Table 6
Zero-order Correlations between Depression Severity and Sample Variability

Variable

1. BDI-II, raw
2. SIGH-SAD, raw
3. BDI-II, SQRT
4. SIGH-SAD, SQRT
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5. Study Site
6. Season Order
7. Completer Status
8. Sex
9. Age
10. MEQ

1

1

2

.90**
1

3

4

5

6

7

8

9

10

.94**

.83**

-.16

.01

-.04

-.15

.16

-.17

.87**

.96**

-.16

.02

.00

-.11

.15

-.18*

.85**

-.18*

.01

-.11

-.20*

.19*

-.17

-.13

.03

-.07

-.11

.17

-.18*

.35**

-.33**

.28**

-.18*

-.07

-.02

-.05

.12

-.21*

1

-.01

.06

.13

.34**

.52**

1

.43**

1

1

1

1

1

1

Note. *p < .05; **p < .01. BDI-II = Beck Depression Inventory – II raw total score mean (Beck, Steer, & Brown, 1996); SIGH-SAD =
Structured Interview Guide for the Hamilton Depression Rating Scale raw total score mean, Seasonal Affective Disorder Version (Williams et
al., 1992); BDI-II (SQRT) = Square-root transformation of BDI-II total score mean; SIGH-SAD (SQRT) = Square root transformation of SIGHSAD total score mean; MEQ = Morningness- Eveningness Questionnaire (Horne & Östberg, 1976). Coefficients reflect averaged estimates
from imputed data.

Table 7
Zero-order Correlations of Chronobiological Vulnerability Measures and Depression Severity (SQRT)

Variable

1

2

3

4

5

6

7

8

9

10

11

12

1. SIGH-SAD, summer

1

.47**

.56**

.52*

-.13

-.08

-.07

-.14

-.13

.09

-.23

-.19

1

.34**

.91**

-.04

.08

.01

-.003

-.06

.04

-.16

-.28*

.45**

-.02

-.06

-.11

-.14

.05

.11

-.31**

-.28

-.01

.05

-.03

-.06

.02

.11

-.30*

-.29*

1

.50**

.19

.24

.21

.06

-.07

-.08

1

.11

.29

.13

.03

.03

-.17

2. SIGH-SAD, winter
3. BDI-II, summer
4. BDI-II, winter
5. Midsleep, summer
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6. Midsleep, winter
7. DLMO, summer
8. DLMO, winter
9. PAD, summer
10. PAD, winter
11. PAD-6, summer
12. PAD-6, winter

1

1

1

.35**

-.36**

-.29

.10

.06

1

-.10

-.58**

.07

-.06

1

.25

-.19

-.03

1

-.07

-.08

1

.04
1

Note. *p < .05; **p < .01. PAD = Phase Angle Difference; PAD-6 = Phase Angle Difference absolute deviation from 6 hr; DLMO = Dim
Light Melatonin Onset; Midsleep = Midpoint of sleep episode; BDI-II = Beck Depression Inventory – II (Beck, Steer, & Brown, 1996),

SIGH-SAD = Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version (Williams et al.,
1992). Correlations reflect imputed estimates. BDI-II and SIGH-SAD scores were square-root transformed outcomes for Aim 2 analyses.
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Table 8
Zero-order Correlations of Cognitive Vulnerability Measures and Depression Severity (SQRT)

Variable

1. SIGH-SAD, summer
2. SIGH-SAD, winter
3. BDI-II, summer
4. BDI-II, winter
5. BR, summer
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6. BR, winter
7. RRS, summer
8. RRS, winter
9. SBQ, summer
10. SBQ, winter
11. Cognitive Reactivity
12. DAS A, summer
13. DAS A, winter

1

2

3

1

.47**

.56**

.52**

.52** .44*

.48**

.34

.91**

1

1

4

5

6

9

10

11

12

13

.48**

.43**

.29*

.02

.23

.32*

.47** .71** .49**

.83**

.71**

.86**

.16

.31*

.61**

.45**

.34*

.27*

.34**

.33**

.45**

.27*

.17

.16

.24

1

.49**

.76**

.51**

.87**

.67**

.87**

.18

.29*

.61**

1

.61**

.89**

.63**

.55**

.43** -.03

.45**

.46*

.57**

.92**

.56**

.64**

.09

.44**

.60**

1

.63**

.60**

.43**

-.03

.42**

.49**

1

.65**

.75**

.16

.41*

.64**

1

.74**

.22

.29*

.51**

1

.17

.27*

.57**

1

-.25*

.12

1

7

8

1

.62**
1

Note. *p < .05; **p < .01. SIGH-SAD = Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective
Disorder Version (Williams et al., 1992); BDI-II = Beck Depression Inventory-II Beck, Steer, & Brown, 1996); BR = Brooding subscale of
Ruminative Response Scale (Treynor et al., 2003); RRS = Ruminative Response Scale (Nolen-Hoeksema & Morrow, 1991); SBQ =
Seasonal Beliefs Questionnaire (Rohan, Nillni, Lippy, Roecklein, & Hillhouse, 2007), Cognitive Reactivity (i.e., mood induction DAS
change score); DAS = Dysfunctional Attitudes Scale (Weissman & Beck,1978 ). Correlations reflect imputed estimates. BDI-II and SIGHSAD scores were square-root transformed outcomes for Aim 2 analyses.
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Table 16
Aim 2 Linear Mixed Modeling Results for State Rumination on BDI-II (SQRT)

Model 1

RRS

t

Model 2

b

SE

p

0.1

0.01 6.5 .0001

b

SE

t

0.1

0.01

5.2

0.02

Model 3*
p

Model 4

b

SE

t

p

b

.0001

0.1

0.01

5.9

.0001

0.1

3.1

.006

0.1

0.02 3.4
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RRS*Group

-

-

-

-

0.1

RRS*Season

-

-

-

-

-

-

-

-

RRS*Group*Season

-

-

-

-

-

-

-

-

-0.04 0.02
-

-

SE

t

p

0.1

5.9

.0001

.004

0.1 0.03

2.5

.036

-2.9

.006

-0.1 0.02

-2.9

.007

-

-

0.02 0.04

0.4

.572

Note. *Best fitting model. RRS = Ruminative Response Scale total score (Nolen-Hoeksema & Morrow, 1991); BDI-II = Beck
Depression Inventory – II (Beck, Steer, & Brown, 1996). Aim 2 Linear Mixed Modeling analyses examining the covariate effect of
state rumination (i.e., RRS summer and winter scores) on BDI-II square root transformed mean total scores.
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Table 21
Aim 2 Linear Mixed Modeling results for seasonal beliefs on SIGH-SAD (SQRT)
Model 1
b

SBQ

SE

t

Model 2
p

.0001

b

SE

t

0.02

0.01

3.6

0.01 -0.1

0.02

0.0

5.2

SBQ*Group

-

-

-

-

0.00

SBQ*Season

-

-

-

-

-

-

-

SBQ*Group*Season

-

-

-

-

-

-

-

Model 3*
p

Model 4

b

SE

t

p

.0001

0.03

0.01

5.0

.0001

.951

0.00

0.01

-0.1

-

-0.02

0.3
-

-

-

b

SE

t

p

0.03 0.01

-4.8

.0001

.757

-0.01

0.01

-1.3

.217

-1.0

.363

-0.04

0.01

-4.1

.001

-

-

0.03

0.01

2.2

.043
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Note. *Best fitting model. SBQ = Seasonal Beliefs Questionnaire, total score (Rohan, Nillni, Lippy, Roecklein, & Hillhouse, 2007);
SIGH-SAD = Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version (Williams
et al., 1992). Aim 2 Linear Mixed Modeling analyses examining the covariate effect of seasonal beliefs on SIGH-SAD square root
transformed mean total scores.
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